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Voor Die MaMa 
Geen dag uit mijn gedachte 
 Chapter 1  
General introduction 
  
Having two testes in the scrotum has been a symbol of manhood since old times. In the Middle 
ages only men with two scrotal testes, were able to candidate for papacy. After a scandal when 
a female pope gave birth to a baby during a papal procession in Rome the porphyry chair was 
produced (Figure 1). This chair had a cut out seat such that the elected candidate could sit 
suitably robed, while a junior cardinal could reach from behind and palpate the scrotum. If he 
chanted “duo testes bene pendulum” (he has two testes and they hang well) masculinity was 
confirmed and the candidate was eligible for the papacy. This excludes many boys since having 
undescended testis (UDT) is one of the most prevalent birth anomaly in boys. Testicular 
descent is a complex process and can go wrong at many stages during fetal development due 
to many different factors. 
 
Normal testicular descent 
During fetal development testes normally descend in two phases; the trans abdominal phase 
and the inguinoscrotal phase (1). During the transabdominal phase, the gubernaculum enlarges 
under influence of Insulin-like 3 peptide (INSL3), whereas at the same time the cranial 
suspensory ligament regresses under influence of testosterone (Figure 2). This causes the 
testis to remain close to the position of the future inguinal canal as the abdominal cavity 
enlarges. This phase is normally completed at the 15th week of gestation. In the inguinoscrotal 
phase, the gubernaculum with the attached testis migrates across the inguinal region into the 
scrotum (1). This phase is androgen dependent and is completed by the end of the 35th week of 
gestation.  
 
Normal testicular development in early childhood 
The testis has two compartments. The interstitial compartment in which male sexual 
hormones are produced and the tubular compartment consisting of seminiferous tubules in 
which spermatogenesis takes place. The most important cells in the interstitial compartment 
are Leydig cells which produce testosterone and INSL3. The tubular compartment contains 
Sertoli cells which are located on the basal membrane of the seminiferous tubule and germ 
cells which are located within the seminiferous tubule at different positions dependent on their 
stage within the spermatogenic process. During the first months after birth every boy goes 
through a so-called ‘mini puberty’ (Figure 3). During this hormone surge, which peaks at the 
age of 3 months, the number of Leydig cells and Sertoli cells increases with the increase of 
testosterone and Inhibin B (3). Also the total number of germ cells increases in these three 
months. During mini puberty, in the first six months of life, gonocytes migrate from the center 
of the tubule towards the basal membrane which triggers the transformation into adult dark 
spermatogonia (3,4). At the age of 3 to 4 years adult dark spermatogonia migrate back into the 
center of the tubule to mature into primary spermatocytes (3-5).  
 Normal testicular function in adults 
The testis has two main functions e.g. producing testosterone and spermatogenesis. 
Leydig cells are stimulated by luteinizing hormone, produced by the pituitary to produce 
testosterone. Testosterone in males is responsible for normal levels libido and energy, 
stimulating Sertoli cells, and normal bone density. 
Sertoli cells are stimulated by follicle stimulating hormone, also produced by the pituitary, to 
stimulate spermatogenesis. From puberty spermatozoa are produced in the testis and are 
gaining their motility in the epididymis. 
 
Background of undescended testes 
Congenital undescended testes 
2-8% of newborns have an UDT (8). Congenital UDT are testes that have never reached a stable 
scrotal position. In a vast majority of these cases the second phase (inguinoscrotal) went amiss 
(3). Testes can be palpable or impalpable. Nonpalpable testes are situated in the inguinal canal, 
intra-abdominally or are vanished testes. About 5% of operated UDT are localized intra-
abdominally (9,10). Palpable testes, at surgery, are situated suprascrotal (e.g. at or beyond the 
external ring, or in the superficial inguinal pouch) or high scrotal.  
The cause of congenital UDT is not yet clearly known. Congenital UDT are associated with 
being born prematurely, birth weight < 2.5 kg, being small for gestational age, and having 
other genital abnormalities (6). 
 
Other factors that might influence impaired testicular descent are described extensively in 
reviews from Virtanen and Toppari, Virtanen et al., and Hutson et al. and are summarized in 
table 1 (6-8).  It is most likely a combination of endocrine dysfunction, mechanical anomalies, 
and genetic factors. 
In the first year most undescended testes at birth descend spontaneously. At one year of age 1-
2% of boys remain to have one or two undescended testes (8). This spontaneous descent occurs 
mostly in the first three months of life due to the increase of testosterone. After 12 months of 
age spontaneous descent is rare. 
 
Acquired undescended testes 
Nowadays, acquired UDT is a well-accepted distinct form of UDT (11-13). The definition of an 
acquired UDT is a palpable testis that used to be in a normal scrotal position – as diagnosed 
and documented by a physician - and later has become entrapped outside of the scrotum. 1-
3% of boys develop an acquired UDT during childhood (14,15). The etiology and natural course 
for acquired UDT are still debated. Table 2 shows different hypotheses of the pathogenesis of 
acquired UDT (16-19). Figure 4 shows two of these possible hypotheses (16,17). Undescended testes 
diagnosed after the age of 5 years are likely to be acquired UDT, supposing that these boys had 
a well set up routine medical programme during their first years of life (14). The prevalence of 
acquired UDT is 1.2 to 2.2% between 6-year, 9-year and 13-year olds (14). In contrast to 
congenital UDT, which are not expected to descend spontaneously after the age of 12 months, 




A retractile testis is a testis which can alternately be found in the scrotum or groin region. It can 
be brought into a stable scrotal position but as a result of an active cremaster reflex moves up 
into the groin region (22). The prevalence of retractile testis varies between 0.2 and 41% (23). 
Retractile testes are usually considered a variant of normally descended testes but can become 
secondarily ascended over time (22).  
 
Consequences of undescended testes 
Fertility 
Undescended testis is thought to be a developmental disorder with disruption of embryonal 
programming and gonadal development during fetal life (24). The fact that the contralateral 
normally descended testis also shows histological deterioration strengthens the theory of a 
developmental disorder (5). In addition to already abnormal testes at birth, in boys with 
undescended testis the number of germ cells decreases dramatically within the first two years 
of life especially after 6 months of age. Also the maturation of germ cells or gonocytes at 2-3 
months of age into adult dark spermatogonia is delayed or defective (3,5). Furthermore the 
transformation into primary spermatocytes is compromised, which occurs between 3 and 4 
years of age (5). In adult men with a history of treatment for bilateral undescended testis a 
paternity rate of 65% is found (25). Paternity rate is 89.7% after treatment for unilateral UDT 
which is comparable with 93.2% found in the general population (25). A group of experts 
estimated the chance of paternity in untreated bilateral UDT around 5% (26).  Both Sertoli cell 
function as well as Leydig cell function is found to be hampered in undescended testis (8). 
For acquired UDT it is unknown what the consequences of being in a non-scrotal position are 
for fertility potential. It is suggested that these alterations are less severe since the crucial 
transformation of adult dark spermatogonia already occurred before the ascent (27).  
 
Malignancy 
Men with a history of undescended testis have a 4-5 fold increased risk of testicular cancer (28). 
The pathogenesis for testicular malignancies in previous UDT lies within the impaired 
transformation of gonocytes into adult dark spermatogonia. In UDT this transformation is 
interrupted or delayed followed by gonocytes undergoing apoptosis. It is hypothesized that 
the high temperature in undescended testis causes impaired transformation as well as 
prevention of apoptosis (4). The remaining gonocytes could be the source for carcinoma in situ 
cells and therefore later testicular malignancies (29). This is the reason why it is assumed that 
acquired UDT are not thought to have an increased risk for testicular malignancy. The 
transformation into adult dark spermatogonia already occurred and therefore no residual 
gonocytes that later form carcinoma in situ cell are thought to be present in acquired UDT later 
in childhood (2). However this remains to be proven. 
The problem with the current literature is that mostly no distinction is made between 
congenital and acquired UDT. Therefore the possible different consequences for outcome 
measures such as fertility and malignancy between congenital and acquired UDT are difficult 
to assess. 
 
Treatment of undescended testes 
Congenital UDT 
Orchiopexy is the treatment of choice for congenital UDT. Over the years the recommended 
age at orchiopexy shifted from before puberty to 6 months of age aiming to minimize fertility 
problems at adult age (30). This is based on several histological reports from biopsies taken at 
orchiopexy at different ages (31), and few studies which compared age of orchiopexy with rates 
of normal sperm count (8). The idea is that ones the testis is in the scrotum postnatal germ cell 
development can proceed as normal (2). However the literature remains inconsistent whether 
this has an effect on fertility. The Nordic consensus advises surgical intervention before the 
age of 12 months but after 6 months since spontaneous descent still occurs until 6 months of 
age (30). A review showed that patients undergoing orchiopexy before puberty have a 
decreased risk for developing testicular malignancies (32). Nowadays there is no place for 
hormonal therapy to induce testicular descent because of low success rates and high incidence 
of re-ascent of the testis (30). The Dutch guidelines also advise surgery between 6 and 12 
months of age for unilateral and bilateral congenital UDT (33). 
 
Acquired UDT 
The treatment for acquired UDT is still debated. In many countries it is unknown at diagnosis 
whether the UDT is a true acquired UDT or a missed congenital UDT. Therefore an orchiopexy 
mostly takes place at diagnosis. Two studies on the proportion of (pre) pubertal spontaneous 
descent in boys with acquired UDT found a prevalence of 57% and 71.4% for spontaneous 
descended testes (20,21). For unilateral as well as bilateral acquired UDT, the Dutch guidelines 
advice to discuss the choice between immediate surgery and awaiting spontaneous descent 
with parents and patient. In case of non-descent surgery should take place preferably before 
the age of 13 years (33). Especially for bilateral acquired UDT the optimal timing of surgery is 
determined by weighing the cosmetic aspect against the complications of anesthesia and 
surgery as well as the spontaneous decent rate. In a decision analysis they could not find 
evidence that the earlier timing of surgery adds to improved fertility (26).  
 
Retractile testes 
Since retractile testis can ascend over time, surveillance is advised until after puberty (14). The 
testis can spontaneously obtain a permanent scrotal position before or during puberty. Or the 
testis becomes an acquired UDT, which needs treatment accordingly. The last option is that 
the testis remains retractile in adulthood, which does not require treatment unless the testes 
cannot be brought down into the scrotum (22). Retractile testes fall out of the scope of this 
thesis and will not be further discussed. 
 
This thesis 
Objective of this thesis 
This thesis aims to elucidate differences between congenital and acquired UDT regarding 
natural course, fertility, endocrinology, and ultrasound anomalies. Literature available 
regarding acquired UDT and the differences between congenital and acquired UDT is rare. 
Most articles make no distinction between congenital and acquired UDT. In this thesis 
maximum effort was taken to distinguish between congenital and acquired UDT.  
 
Outline of this thesis 
In the first part of this thesis we describe surgical findings of acquired and congenital UDT. In 
Chapter 2 we try to find an explanation for the phenomenon that some acquired UDT descend 
spontaneously while others need orchiopexy. Chapter 3 reports on per operative clinical and 
surgical differences between congenital and acquired UDT. 
The second part of the thesis attempts to answer questions regarding the influence of the 
timing of surgery and/or ‘wait-and-see’- policy. We analyzed traditional fertility parameters 
(testicular volume, endocrinological values, and semen analyses) in adults with a history of 
congenital or acquired UDT in comparison with a healthy control group.  Chapter 4 tries to 
answer the following questions regarding congenital UDT; (1) What is the extent of fertility 
damage in men with a history of UDT in comparison with a healthy control group?; (2) What is 
the influence of age at orchiopexy on the fertility parameters in adult life?; and (3) Are there 
any differences in fertility parameters between men with unilateral and bilateral UDT?. Fertility 
parameters for acquired UDT are described in chapter 5 and 6. Chapter 5 focuses on the 
possible impact of acquired UDT on fertility parameters in comparison with controls and men 
with previously congenital UDT. Furthermore, it evaluates testicular function in men with 
acquired UDT after spontaneous descent or orchiopexy. In Chapter 6 fertility parameters of 
men with acquired UDT and orchiopexy at diagnosis are compared with those of men who had 
a ‘wait-and-see’-protocol for acquired UDT. Also the influence of age at orchiopexy, if operated 
upon, on fertility parameters in adult life was analyzed. 
 
The third part of this thesis describes less traditional methods to evaluate endocrinological 
function and semen quality. Chapter 7 examines differences in Leydig and Sertoli cell function 
between congenital and acquired UDT using Insulin-like peptide 3 (INSL3) and Anti -Müllerian 
hormone (AMH) serum levels. In addition, the influence of age at surgery in men with 
congenital UDT on these parameters as well as their association with spontaneous descent or 
orchiopexy in acquired UDT was examined. Also correlations of INSL3 and AMH with levels of 
other hormones of the pituitary-testis axis, semen parameters and testicular volume were 
investigated. Chapter 8 analyzes the differences in sperm DNA damage between congenital 
and acquired UDT using Sperm Chromatin Structure Assay (SCSA). In addition, the influence of 
early or late orchiopexy in men with congenital UDT on sperm DNA damage levels, as well as 
the association with spontaneous descent or orchiopexy in acquired UDT was analyzed. Finally, 
the sperm DNA levels in men with a history of UDT attempting fatherhood were evaluated. 
Chapter 9, the fourth part of this thesis, reports extensively on different anomalies found by 
physical examination and scrotal ultrasound. We describe the anomalies of the undescended 
testis but also of their normal contralateral testis for congenital and acquired UDT in 
comparison with each other and a control group.  
In the concluding fifth part of this thesis, Chapter 10, the main findings from this thesis will be 
reviewed and discussed in the general discussion. Recommendations for future research and 
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Surgical Findings in Acquired Undescended 
Testis: an Explanation for Pubertal Descent or 
Non-descent? 
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F.W. J. Hazebroek 
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Abstract 
Aim: 
Surgical findings were studied to find an explanation for the phenomenon that some acquired 
undescended testes (UDT) descend spontaneously whereas others need orchiopexy. 
Methods: 
In patients with acquired UDT spontaneous descent was awaited until at least Tanner stage 
P2G2. Orchiopexy was performed when a stable scrotal position had not been achieved by the 
end of follow-up. 
Results: 
Orchiopexy was needed in 57 of 132 cases (43%). In cases requiring orchiopexy, the difference 
in testis volume compared to the contralateral healthy testis was significantly larger than for 
spontaneously descended testes. 41 (72%) undescended testes were found in the superficial 
inguinal pouch; 16 (28%) at the external annulus. 26 of the 41 testes in the superficial inguinal 
pouch position (63%) could be manipulated preoperatively into a non-stable scrotal position; 
15 could only reach the scrotal entrance prior to surgery. None of the 16 testes located at the 
external annulus could reach a scrotal position. Inguinal exploration in most cases revealed a 
fibrous string or a partially open processus vaginalis. 
Conclusion: 
The mobility of acquired UDT located within the external annulus is limited. It is mainly the 
fibrous string and the partially open processus vaginalis that prevent normal elongation of the 
spermatic cord with growth. These testes are unlikely to descend spontaneously. Acquired 
UDT lying in the superficial inguinal pouch can often be pushed down well below the scrotal 
entrance. We speculate that under normal hormonal stimulation at puberty, some of these 
growing testes may overcome the strength of the fibrous string in the spermatic cord and 




It is generally accepted that congenital and acquired undescended testes (UDT) are 2 distinct 
entities although some etiological aspects are the same (1,2). The aetiology, natural course, and 
treatment of acquired UDT are still subject of debate (1,3,4). In a prospective study we followed 
boys with acquired UDT from referral until puberty; it appeared that 57% of testes descended 
spontaneously with a conservative wait-and-see approach (5). The chance of spontaneous 
descent became higher with increasing age at referral, but other parameters evaluated were 
not associated with spontaneous descent or non-descent. Therefore, we focused on another 
important aspect, namely, the surgical findings collected during orchiopexy in those boys 
whose testes did not descend spontaneously. We aimed to answer the following question: can 
the surgical findings in acquired UDT elucidate why some of these testes descend 
spontaneously whereas others need orchiopexy? 
 
Patients and methods 
Patients and methods were described earlier (5). In brief: from 1982 to 2004, boys with acquired 
UDT referred to our tertiary children’s hospital were offered conservative treatment and were 
examined annually at least until puberty stage P2G2 according to Tanner (6).  Acquired UDT 
was defined as a palpable UDT that previously had a stable scrotal position, as documented at 
least once by the Regional Youth Health Care Institution, general practitioner or the referring 
hospital. Exclusion criteria were any ipsilateral or inguinal pathological clinical findings or 
previous ipsilateral inguinal surgery. The annual genital examination was performed by 2 
senior authors (SdeMK-S and/or FH) with the patient in supine and in crossed-legged position. 
Since testis position may range, we registered its most caudal position after manipulation. 
Positions were categorized as inguinal region, at the scrotal entrance, unstable high scrotal or 
unstable low scrotal. Unstable was defined as moving to a non-scrotal position immediately 
after release. Retractile testes, i.e., testes that could be manipulated into the scrotum and 
maintained a stable scrotal position until induction of the cremaster reflex, were excluded. 
Spontaneous descent was awaited until at least Tanner stage P2G2 (end of follow-up) (6). 
Orchiopexy was performed when descent of the acquired UDT to a stable scrotal position had 
not occurred by the end of follow-up. Before operation, these patients were re-examined 
under general anaesthesia to exclude retractile testes and to assess most caudal testicular 
position. 
In all cases, testicular volume was estimated by means of the Prader orchidometer (7) at the end 
of follow-up. In the cases with an unilateral acquired UDT and a normally descended 
contralateral testis, difference in testicular volume at pubertal onset was calculated. Boys with 
bilateral acquired UDT and boys with unilateral acquired UDT with contralateral inguinal 
surgery were excluded from this analysis. 
Mean testis volume differences in boys with spontaneously descended testes and boys who 
needed orchiopexy were compared using the t test. SPSS®, PASW Statistics 17.0 was used to 
analyse the results and a p-value ≤ 0.05 was considered to be statistically significant (5). 
The most relevant anatomical findings of the boys who required surgery were registered as 
follows: 
Intraoperative position 
At the external annulus: lying in or just outside the external annulus underneath Scarpa’s fascia 
and caudal to the still unopened inguinal canal. 
In the superficial inguinal pouch: lying on the aponeurosis of the external abdominal muscle 
under Scarpa’s fascia and cranio-lateral to the external annulus. 
Processus vaginalis 
Closed: processus vaginalis has been obliterated to a fibrous string. 
Small open: small open communication between the peritoneal cavity and that part of the 
processus vaginalis immediately surrounding the testis that always remains open, the tunica 
vaginalis.  
Wide open: the testis can move freely in the open processus vaginalis, ranging from the most 
caudal position to intraperitoneal position. 
Epididymal anomalies 
Normal: caput and tail are firmly attached to the testis, the epididymis body is either complete 
attached to the testis or separated from the testis. 
Partial separation: the epididymis extends further than the length of the testis with only the 
head normally attached. 
Complete separation: there is a macroscopic, total separation of epididymis and testis. 
Long loop: the epididymis extends in a caudal direction, sometimes reaching the scrotum.  
During surgery only orchiopexy was performed and no biopsy was taken in any of the patients. 
Ethics 
The study was reviewed and approved of by the Medical Ethical Review Committee of the 
Erasmus Medical Centre in Rotterdam. Informed consent was obtained from all patients who 




Results up until the end of follow-up were published previously (5). 109 boys with 135 cases of 
acquired UDT were followed up at least until puberty stage P2G2. Mean age at referral was 8.9 
± 2.9 years (range: 1-14.9 years). Mean follow-up was 4.5 years (range: 0.3-12.1 years). 2 boys 
were excluded from analysis including one with unilateral UDT who was lost to follow-up, while 
orchiopexy was requested by the parents of a boy with bilateral UDT. In the remaining 132 
testes (82 unilateral and 50 bilateral), the previous scrotal position had been documented at 
least once for 53 testes, twice for 39 and 3 times or more for 40. Spontaneous descent to a 
stable scrotal position was noted for 75 testes (57%).  
Thus, orchiopexy was performed for 57 acquired UDT (27 left and 30 right-sided) in 45 boys. 
Mean age at orchiopexy was 12.7 years (range: 5.2-15.8 years). In 47 testes this took place after 
Tanner stage P2G2; in 10 testes (8 unilateral and 1 bilateral) before puberty. The predominant 
reasons for earlier operation were inguinal complaints or a newly detected, clinically present, 
ipsilateral inguinal hernia (5). The surgical findings of these 10 testes operated before puberty 
made a spontaneous descent very unlikely (5). The total number of documented scrotal 
positions of the testes and the most caudal testis position at referral did not differ significantly 
between spontaneous descended testes and the testes that needed orchiopexy (Table1). 
Moreover, no association was found between the total number of documented scrotal testes 
position and most caudal testicular position at referral in either of the groups (p=0.361 and 
p=0.164 for the spontaneous descent group and the non-descent group, respectively). 
Testicular volume differences were calculated for 63 of the 82 boys with unilateral acquired 
UDT. Excluded from this analysis were 19 boys (19 unilateral UDTs), including the above 
mentioned 8 who underwent orchiopexy before puberty and 11 with either previous 
contralateral orchiopexy for congenital UDT (n=9) or inguinal hernia (n=2). Of 17 testes that 
needed orchiopexy 12 (71%) had a volume more than 1 ml smaller than their healthy 
contralateral testis. This was noted in only 18 (39%) of 46 testes which descended 
spontaneously (chi-square: p=0.053) (5).  The difference in testicular volume of spontaneously 
descended testes was significantly smaller than that of testes which needed orchiopexy (mean 
± SEM: -1.5 ± 0.37 ml and -3.9 ± 0.97 ml, respectively t-test p = 0.030) (5). 
For 3 testes the most caudal position preoperatively was in the inguinal region, for 28 at the 
scrotal entrance, and 26 could be manipulated into an unstable scrotal position. 
Intraoperative findings 
 The intraoperative testicular position of the 57 testes that needed orchiopexy was the 
superficial inguinal pouch for 41 testes (72%), while the other 16 (28%) were located at the 
external annulus.  
We created cross-sectional tables to identify any relationships between the intraoperative 
testicular position and other differing surgical findings. Cross-referencing the testis position at 
surgery using the most caudal testicular position preoperatively provided information about 
the mobility of the acquired UDT (Table 2). 26 (63%) of the 41 testes lying in the superficial 
inguinal pouch could be manipulated into an unstable scrotal position, whereas the other 15 
could only reach the scrotal entrance. On the other hand, none of the testes located at the 
external annulus could reach a scrotal position: 13 (81%) of the 16 testes were moveable to the 
scrotal entrance; the other 3 were only palpable in the inguinal region.  
Table 3 gives the intraoperative testicular position in relation to the condition of the processus 
vaginalis. In 33 of the 57 cases (58%) – notably when the testis was located in the superficial 
inguinal pouch – the processus vaginalis was obliterated to a fibrous string. Inguinal 
exploration rarely revealed a wide open processus vaginalis. 
With regard to epididymal anomalies in relation to intraoperative testicular position (Table 4), 
4 of 16 testes situated at the annulus externus showed epididymal anomalies, vs. 3 of 41 testes 
in the superficial inguinal pouch. 
 
Discussion 
The natural course and treatment of acquired UDT is a source of dispute in the Netherlands (3). 
It is the Youth Health Care Centers task to register each boy’s testicular position from birth to 
puberty. The Youth Health Physicians have noted that previously scrotal testes that had 
ascended would often return into the scrotum again. In their opinion a ‘wait-and-see’ approach 
until puberty is preferable to referral for surgery at presentation. On the other hand, most 
(paediatric) surgeons and urologists assume that, despite the likelihood of spontaneous 
descent at puberty, immediate orchiopexy could possibly be advantageous in terms of fertility, 
as is assumed in congenital UDT (8). In the study presented here, more than half of acquired 
UDT indeed descended spontaneously before the onset of at least Tanner stage P2G2. 
To our knowledge only one other long-term follow-up study of boys with acquired UDT has 
been published: it reported a 76% spontaneous descent rate vs. 57% in our study (9). As the 
study designs of both studies are largely comparable, this discrepancy could be the result, in 
part, of small differences in methodology, such as the formulation of exclusion criteria. 
The present study focused on the question whether surgical findings could indicate the 
likelihood of a spontaneous descent of acquired UDT. A valid answer to this question cannot be 
made without insight into the aetiology of acquired UDT. 
Atwel has proposed that it is matter of partial absorption of the persistent open processus 
vaginalis into the partial peritoneum during growth of the boy (10). In 7 cases in our study there 
was a wide open processus vaginalis. Tanyel hypothesized that congenital and acquired UDT 
share the same aetiology (2). The process of obliteration of the processus vaginalis by apoptosis 
is hampered in congenital UDT; furthermore, if initial descent has occurred normally because 
the process of programmed cell death is more subtle but the process persists, the testis may 
ascend later in time. This hypothesis is largely in line with Clarnettte et al. who suggested that 
a persisting fibrous remnant of the processus vaginalis prevents natural elongation of the 
spermatic cord during growth (11). The last 2 hypotheses seem more likely to explain the 
aetiology of acquired UDT since this was indeed the case in the large majority of testes in the 
present study. The 58% incidence rate of completely obliterated processus vaginalis is in 
accordance with the 57-70% rates found in other studies (12,13). Although the above mechanisms 
are very likely to cause acquired UDT, they do not yet explain why some of these testes can 
descend spontaneously. 
Epididymal anomalies occur in 36-79% of undescended testes (14). However, most studies 
reporting these anomalies neither define normal epididymis nor are they focusing exclusively 
on acquired UDT. In the present study epididymal anomalies occurred in only 7 of the 57 cases 
(12%). There are 2 explanations for this low incidence. First, we classified anomalies as a 
separation of caput and/or cauda epididymis from the testis or a long looping epididymis. A 
widened mesentery between the body of the epididymis was considered normal in line with 
other studies (15,16). Secondly, since acquired UDT by definition have descended normally at an 
earlier stage, it is plausible to expect fewer anomalies in comparison to congenital UDT. To our 
knowledge, only one study by Guven and Kogan reports on epididymal anomalies in acquired 
UDT in compared to congenital UDT (17). In that study 28% of acquired UDT had epididymal 
anomalies, compared with 46% of patients with congenital UDT who were operated late due 
to parental delay or late referral. 
With regard to mobility, 16 testes located at the external annulus at surgery could never be 
brought down further than the scrotal entrance. It is unlikely that these testes will descend 
spontaneously, seeing that the fibrous remnant or (partially) open processus vaginalis prevents 
normal elongation of the spermatic cord. On the other hand, 26 of the 41 testes located in the 
superficial inguinal pouch could be brought down to an unstable scrotal position before 
operation. The superficial inguinal pouch, first described by Sir Denis Browne in 1938 (18), is a 
space situated between the Scarpa’s fascia and the external oblique muscle and runs parallel to 
the inguinal canal. Browne proposed that the so-called ‘high retractile testis’ remains 
habitually remains and moves freely in this pouch, and does therefore not descend during 
childhood. It can, however, be pushed down well below the external ring, over the pubic bone, 
and into a high scrotal position. Spontaneous descent to a stable scrotal position may occur 
when the testis reaches adult size and weight. Brown in fact defined what we now accept as an 
ascending testis. 
We speculate that acquired UDT, with a range of movement from the superficial inguinal 
pouch to an unstable scrotal position, can descend at puberty if massive enough to overcome 
the strength of the fibrous remnant in the spermatic cord. This supposition is supported by the 
fact that in the case of spontaneously descended testes the difference in volume to the 
contralateral healthy testis is smaller than in the case of testes which remained undescended 
and required surgery.  
There are several limitations in this study. First, for obvious reasons, we have no insight into 
the anatomy of spontaneously descended testes. Second, in 53 boys a previous stable scrotal 
position was documented only once. Therefore, it cannot be excluded that these boys had 
congenital undescended testes. If so, it seems reasonable to assume that these boys would be 
more frequently present in the operated group than in the spontaneous descent group since 
congenital UDT rarely descend spontaneously after the first year of life (19). This, however, is 
not the case in our study as shown in Table 1. Moreover, the most caudal position of the testis 
at referral did not differ between the 2 groups and was at a relatively low position in both 
groups of acquired UDT (Table 1). Since Meij-de Vries et al. (12) showed that testis position in 
congenital UDT is different from testis position in acquired UDT and that congenital UDT are 
located in a higher position compared to acquired UDT it seems unlikely  that  boys  included in 
our study  had congenital UDT. 
The key question remains if a ‘wait-and-see approach’ is a better treatment option than 
surgery of acquired UDT at presentation (1). To answer this question long-term follow-up 
studies are necessary to determine hormonal functioning, fertility potential, and cancer risks in 
three different groups of boys with acquired UDT: spontaneous descent at puberty, surgery 
immediate after diagnosis, or surgery delayed until puberty. 
 Conclusions 
Failure of the spermatic cord to elongate with growth of the boy is mainly caused by the 
presence of the fibrous string or incomplete open processus vaginalis. Acquired UDT located 
within the external annulus have limited mobility and are unlikely to descend spontaneously. 
Acquired UDT lying in the superficial inguinal pouch position can often be pushed down well 
below the scrotal entrance. Therefore, we speculate that under normal hormonal stimulation 
at puberty some of these growing testes can overcome the strength of the fibrous string in the 
spermatic cord and descend again spontaneously. The smaller volume difference between the 
undescended testes and their healthy contralateral testes in the group with spontaneous 
descent supports this assumption. Unfortunately, it is impossible to confirm this hypothesis 
since the anatomy of testes which descend spontaneously remains unknown.  
 
Acknowledgements 
The authors thank Ko Hagoort for editorial assistance 
 
References 
1. Bonney T, Hutson J, Southwell B, Newgreen D. Update on congenital versus acquired 
undescended testes: incidence, diagnosis and management. ANZ J Surg. 2008 Nov;78(11):1010-3. 
2. Tanyel FC. Obliteration of processus vaginalis: aberrations in the regulatory mechanism result 
in an inguinal hernia, hydrocele or undescended testis. Turk J Pediatr. 2004;46 Suppl:18-27. 
3. Hack WW, van der Voort-Doedens LM, Goede J, van Dijk JM, Meijer RW, Sijstermans K. Natural 
history and long-term testicular growth of acquired undescended testis after spontaneous descent or 
pubertal orchidopexy. BJU Int. 2010 Oct;106(7):1052-9. 
4. Taghizadeh AK, Thomas DF. Ascent of the testis revisited: fact not fiction. BJU Int. 2008 
Sep;102(6):676-8. 
5. Eijsbouts SW, de Muinck Keizer-Schrama SM, Hazebroek FW. Further evidence for 
spontaneous descent of acquired undescended testes. J Urol. 2007 Oct;178(4 Pt 2):1726-9. 
6. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 
1970 Feb;45(239):13-23. 
7. Prader A. Testicular size: assessment and clinical importance. Triangle. 1966;7(6):240-3. 
8. Ritzen EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, et al. Nordic consensus 
on treatment of undescended testes. Acta Paediatr. 2007 May;96(5):638-43. 
9. Sijstermans K, Hack WW, van der Voort-Doedens LM, Meijer RW, Haasnoot K. Puberty stage 
and spontaneous descent of acquired undescended testis: implications for therapy? Int J Androl. 2006 
Dec;29(6):597-602. 
10. Atwell JD. Ascent of the testis: fact or fiction. Br J Urol. 1985 Aug;57(4):474-7. 
11. Clarnette TD, Hutson JM. Is the ascending testis actually 'stationary'? Normal elongation of the 
spermatic cord is prevented by a fibrous remnant of the processus vaginalis. Pediatr Surg Int. 1997 Mar 
21;12(2/3):155-7. 
12. Meij-de Vries A, Hack WW, Heij HA, Meijer RW. Perioperative surgical findings in congenital 
and acquired undescended testis. J Pediatr Surg. 2010 Sep;45(9):1874-81. 
13. Rusnack SL, Wu HY, Huff DS, Snyder HM, 3rd, Zderic SA, Carr MC, et al. The ascending testis 
and the testis undescended since birth share the same histopathology. J Urol. 2002 Dec;168(6):2590-1. 
14. Elder JS. Epididymal anomalies associated with hydrocele/hernia and cryptorchidism: 
implications regarding testicular descent. J Urol. 1992 Aug;148(2 Pt 2):624-6. 
15. Turek PJ, Ewalt DH, Snyder HM, 3rd, Duckett JW. Normal epididymal anatomy in boys. J Urol. 
1994 Mar;151(3):726-7. 
16. Han CH, Kang SH. Epididymal anomalies associated with patent processus vaginalis in 
hydrocele and cryptorchidism. J Korean Med Sci. 2002 Oct;17(5):660-2. 
17. Guven A, Kogan BA. Undescended testis in older boys: further evidence that ascending testes 
are common. J Pediatr Surg. 2008 Sep;43(9):1700-4. 
18. Browne D. Diagnosis of Undescended Testicle. Br Med J. 1938 Jul 23;2(4046):168-71. 
19. Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR. Prevalence and 
natural history of cryptorchidism. Pediatrics. 1993 Jul;92(1):44-9. 
  
Chapter 3 
 Different surgical findings in congenital and 
acquired undescended testes. 
 
J. van Brakel 
G.R. Dohle 
S.M.P.F. de Muinck Keizer-Schrama 
F.W.J. Hazebroek. 
 





To compare surgical findings in congenital and acquired undescended testes (UDT). 
 
Patients and methods 
A review of 139 boys with a 158 congenital UDT and 69 boys with 84 acquired UDT was 
performed. The most caudal testicular position preoperatively, testis position at surgery, 
patency of the processus vaginalis, and epididymal anomalies were prospectively recorded. 
 
Results 
In the congenital group, orchiopexy had been performed at median age (range) 4.9 (1.5-14.6) 
years, while the median age (range) in the acquired group was 11.9 (3.8-23.3) years. 
Preoperatively, only congenital UDT were found not palpable or emergent inguinal, while only 
acquired UDT could be manipulated in an unstable scrotal position.  In comparison with 
congenital UDT, acquired UDT were significantly more often located at the scrotal entrance, 
27/158 vs. 32/84 respectively (P < 0.001). At surgery anorchia, vanished testis or testes lying 
intra-abdominally were only registered in the congenital UDT group. Also 37/158 congenital 
UDT were located in the superficial inguinal pouch vs. 52/84 of the acquired UDT (P = 0.04). In 
congenital UDT the processus vaginalis was wide open in 74/158, while in acquired UDT the 
processus vaginalis was closed in 46/84 (P < 0.001) and small open in 26/84 (P = 0.04). 
Epididymal anomalies were more often seen in the congenital UDT group (37%) than in the 
acquired group (11%).  
 
Conclusion 
Most caudal position of congenital UDT after manipulation before surgery was at the scrotal 
entrance. These testes were frequently associated with epididymal anomalies and wide open 
processus vaginalis. This was in contrast to acquired UDT, which can often be pushed down 
well below the scrotal entrance and are more likely to be situated in the supraficial inguinal 
pouch, with a normal epididymis and closed processus vaginalis. 
 
Introduction 
Undescended testes (UDT) are one of the commonest genital abnormalities in boys. Two types 
are distinguished: congenital and acquired UDT (1,2). 1% of all boys will have a testis that has 
not yet descended by 1 year of age (3). Congenital UDT are testes that have never reached a 
stable scrotal position.  Acquired UDT are testes that used to be in a scrotal position – as 
diagnosed by a physician – and later have become entrapped outside the scrotum. This is seen 
in 1-3% of boys during childhood (4). Much is known of the aetiology, natural course and 
treatment of congenital UDT, but these matters are less clear for acquired UDT and still 
debated. Furthermore, even less is known about anatomical differences between the two 
types of UDT. Several studies have examined anatomical findings in patients with UDT (5-19). 
However, most of these studies did not distinguish between congenital UDT and acquired 
UDT. The aim of the study reported here was to objectify possible clinical and surgical 
differences between the two types. 
 
Patients and methods 
Boys included in this study had at prepubertal age been referred for UDT to the Erasmus 
University MC-Sophia Children’s Hospital, Rotterdam. The surgical findings were registered in 
a standardised form. Previous testicular positions were retrospectively collected from medical 
documentation of the Regional Youth Health Care Institution, the general practitioner or 
hospital file to diagnose either congenital or acquired UDT. 
Congenital UDT group 
These boys participated in a placebo-controlled study of luteinising-hormone-releasing-
hormone (LHRH) nasal spray between 1982 and 1985 (20). They had been operated on by the 
same paediatric surgeon (FH) if LHRH did not achieve a permanent stable scrotal position.  
Acquired UDT group 
Acquired UDT is defined as a palpable UDT that had previously descended into a stable scrotal 
position. At least one medical document had to confirm previous stable scrotal position. 
Patients referred for acquired UDT between 1982 and 2004 were treated conservatively and 
examined annually at least until puberty stage P2G2 according to Marshall and Tanner (21). If 
spontaneous descent did not occur, operation followed.  
 
Definition of terms 
Preoperative location 
The most caudal testicular position found after admission and confirmed following induction of 
anaesthesia was classified as (i) not palpable; (ii) emergent inguinal: testis intermittently 
palpable; (iii) inguinal region; (iv) scrotal entrance; (v) unstable scrotal – testis replaced in non-
scrotal position immediately after release.  
Boys with retractile testes, i.e. testes that could be manipulated into the scrotum and 
maintained a stable scrotal position until induction of the cremaster reflex, were excluded. 
Intraoperative location 
The testicular location at the time of surgery was classified as: (i) absent – either true anorchia 
or “vanished testis”; (ii) intra-abdominal; (iii) inguinal canal; (iv) external annulus; (v) Superficial 
inguinal pouch. 
Processus vaginalis 
The condition of the processus vaginalis was classified as: (i) closed – obliterated to a fibrous 
string; (ii) small open – small open communication between the peritoneal cavity and tunica 
vaginalis; (iii)  wide open – testis can move freely within the processus vaginalis. 
Epididymis 
The condition of the epididymis was classified as: (i) absent; (ii) partially separated from testis; 
(iii) complete separated from testis; (iv) long loop epididymis and vas. 
 
Statistical analysis 
Data were analysed with SPSS, version 17.0. (SPSS Inc., Chicago, IL, USA). Variables were 
tested for power to distinguish between congenital or acquired UDT. For preoperative testis 
position an univariate linear regression analysis was done, and for the intraoperative findings 
(intraoperative testis position, condition of processus vaginalis and epididymal anomalies) a 
multivariate analysis. P <0.05 were considered statistically significant.   
 
Ethics 
The study was reviewed and approved by the Medical Ethical Review Committee at Erasmus 
University Medical Centre in Rotterdam (MEC number 2004-206).  
 
Results 
We analysed findings in 139 boys with congenital UDT (19 bilateral and 120 unilateral) and 69 
boys with acquired UDT (15 bilateral and 54 unilateral). In the congenital group, orchiopexy 
had been performed after diagnosis at median age (range) 4.9 (1.5-14.6) years. Median age 
(range) in the acquired group was 11.9 (range 3.8-23.3) years.  In 74 cases orchiopexy was 
performed after Tanner stage P2G2; in 10 before puberty. Most important reasons for earlier 
operation were inguinal complaints and a clinically present ipsilateral inguinal hernia.  
Table 1 shows the characteristics of the two groups.  Relevant differences between congenital 
and acquired UDT can be summarized as follows. 
In 27 boys with unilateral congenital UDT the testis was preoperatively not or intermittently 
palpable. At surgery of these boys 15 testes were absent, 4 were located intra-abdominally, 
and 8 were lying in the inguinal canal. Acquired UDT were always palpable preoperatively. The 
most caudal position of 66% of congenital UDT was in the inguinal region; most acquired UDT 
(54%) could be manipulated into an unstable scrotal position. Testes found at the scrotal 
entrance were significantly more often acquired UDT (odds ratio [OR] 0.06; 95% Confidence 
Interval (95% CI) 0.02 – 0.14, P < 0.001). The acquired group had more often testes situated in 
the superficial inguinal pouch (OR 0.48; 95% CI 0.24 – 0.96, P 0.04). 
In the congenital group the patency of the processus vaginalis was more often small or wide 
open, i.e. in 78% vs. 45% in the acquired group. Acquired UDT had significantly more a closed 
or small open processus vaginalis (Table 1). Correlations between the patency of the processus 
vaginalis and the intraoperative positions are shown in Table 2.  
Epididymal anomalies were more often seen in the congenital UDT group than in the acquired 
group, 37% vs. 11% respectively. Table 3 shows the condition of the epididymis in relation to 
intraoperative testis position. The higher the intraoperative testis position, the higher is the 
number of epididymal anomalies. In both groups epididymal anomalies were associated with a 
patent processus vaginalis, especially a wide open processus vaginalis (Table 4). 
 
Discussion 
This study aimed at objectifying anatomical differences between congenital and acquired UDT 
observed at surgery. First we need to address the nature of the two study groups. The 
congenital group received LHRH nasal spray prior to orchiopexy. It is very unlikely that this 
hormonal treatment influenced the surgical findings because we found no evidence of 
stimulation of the hypothalamo-pituitary-gonadal axis and our data did not support the 
presence of hormonal abnormalities in the cryptorchid boys (20). Following international 
recommendations, boys with congenital UDT are operated on before 1 year of age (22).   
In The Netherlands the natural course and treatment options in acquired UDT are still being 
debated (2,23). Our acquired UDT study group consisted of boys in whom spontaneous descent 
failed to occur, mostly until the onset of puberty. Therefore the median age of this group is 
higher than that of the congenital group. However, the key question here is whether a ‘wait 
and see approach’ until puberty – with surgery if the testis does not spontaneously descend – is 
to be preferred over surgery immediately following diagnosis (24,25). This question falls outside 
the scope of this paper, but nevertheless we would recommend long-term follow-up studies 
comparing fertility potential and hormonal functioning between the two approaches.  
Apart from differences in preoperative positions, there were indeed differences in surgical 
findings, supporting the idea that these two types are distinct entities. In the congenital group 
the most caudal position of the testes before surgery was mainly outside the inguinal canal, 
but no further than the scrotal entrance. In the acquired group, however, most testes could be 
manipulated to the scrotal entrance or to an instable scrotal position. Unfortunately, a similar 
study by Meij-de Vries et al. (15) does not document preoperative testes positions. The 
distribution of intraoperative testis positions significantly differed between the two groups. In 
the congenital group significantly more testes were lying in the inguinal canal than was the 
case in the acquired group. This was also reported by Meij-de Vries et al. (15), whose study, 
however, distinguished slightly different intraoperative testis locations. Also in other 
publications related to acquired UDT, the position of ascending testes at surgery was more 
likely to be in the superficial inguinal pouch (10,16,18).  
Earlier studies found a patent processus vaginalis in 44-93% of patients with UDT (5,8,11,14). 
However, these studies did not distinguish between congenital and acquired UDT and 
commenting on these rates is of little use because processus vaginalis status of normal boys is 
unclear (8,14). We found the processus vaginalis was more often patent in congenital UDT, 
notably wide open, than in acquired UDT. To our knowledge three studies clearly 
distinguishing between congenital and acquired UDT present data on the patency of the 
processus vaginalis (10,15,19). One reports similar results but that does not distinguish between 
small open and wide open processus vaginalis (15). The second found fewer cases of patent 
processus vaginalis in the congenital group than in the acquired group. They suggested that a 
patent processus vaginalis could explain the late descend or that testes with a patent 
processus vaginalis might be more at risk to ascent, however, to our knowledge this is the only 
study with these findings and different opinion  (10). The third also specifies whether the 
processus vaginalis is small open or wide open and findings are largely comparable with ours 
(19). Furthermore, Clarnette et al. (6) found a closed processus vaginalis in all acquired UDT, and 
two other studies – reporting only on acquired UDT – found an incidence of closed processus 
vaginalis of 45% and 48%, respectively (16,18).  
The incidence of epididymal anomalies in boys with UDT was reported to be higher than in 
boys with a hydrocele/hernia without cryptorchidism (5,7,9,11). In our study more epididymal 
anomalies were seen in congenital UDT than in acquired UDT, 31% vs. 11% respectively. In the 
literature, proportions of boys with UDT showing epididymal anomalies range widely (5,7,9-14,17). 
For example, in an overview by Elder they vary from 36 to 79% in boys with UDT (7). There are 
two explanations for this wide range. First, most authors did not define the normal epididymis. 
We classified separation of caput and/or cauda epididymis from the testis or a long looping 
epididymis as anomalies. A completely attached or a widened mesentery between the body of 
the epididymis was considered normal, in line with Turek et al. (26). Second, most studies make 
no distinction between the two types of UDT. Since acquired UDT by definition have 
descended normally at an earlier stage, it is plausible to expect fewer anomalies than in 
congenital UDT, as in our study. Different patient selection could thereby cause this wide 
range. To our knowledge, only one other study also compared epididymal anomalies in 
acquired UDT and in congenital UDT (10). In that study 28% of boys with acquired UDT had 
epididymal anomalies, vs. 46% of boys with congenital UDT who were operated on late due to 
parents’ delay or late referral.  
Kucukaydin et al. (27) and Heath et al. (13) found that testes in superficial inguinal position had 
fewer epididymal anomalies than had other forms of UDT. In our study, most testes in the 
superficial inguinal pouch were acquired UDT. Those two studies did not distinguish between 
congenital and acquired UDT. One might speculate, however, that they in part were acquired 
UDT. This would confirm our finding that epididymal anomalies mostly occur in congenital 
UDT. 
Our data showed that epididymal anomalies were most frequent in patients with a wide open 
processus vaginalis. An open processus vaginalis is indeed most common in congenital UDT. 
All studies on the association between epididymal anomalies and the patency of the processus 
vaginalis report higher incidences of epididymal anomalies in patients with an open, especially 
wide open, processus vaginalis (5,7,9,11-13). 
Finally, although surgical findings between congenital and acquired UDT unmistakably differ, 
it is debatable whether these two conditions represent two truly different aetiologies or rather 
a spectrum of anomalies, i.e. congenital UDT, retractile testis and acquired UDT. Retractile 
testes have been reported to progress to acquired UDT during follow-up. In addition, reduction 
in germ cells have been reported not only for congenital UDT but also for retractile testes and 
acquired UDT (2). Long-term studies of testicular function of these latter testes, which are not 
always situated in the scrotal environment, might provide more insight into the aetiological 
differences. 
In summary, we found major differences in preoperative testis position as well as 
intraoperative anatomical findings between congenital and acquired UDT. First, the most 
caudal testis position in congenital UDT was at the inguinal region or at the scrotal entrance, 
whereas most of the acquired UDT could often be pushed down well below the scrotal 
entrance into an unstable scrotal position. Second, at surgery most congenital UDT were found 
inside or just outside the inguinal canal, whereas acquired UDT were mostly located in the 
superficial inguinal pouch. Third, congenital UDT were associated with more epididymal 
anomalies combined with a small open or wide open processus vaginalis in comparison with 
acquired UDT.  
 
Acknowledgements 
The authors thank Ko Hagoort for editorial assistance 
References 
1. Bonney T, Hutson J, Southwell B, Newgreen D. Update on congenital versus acquired 
undescended testes: incidence, diagnosis and management. ANZ J Surg. 2008 Nov;78(11):1010-3. 
2. Taghizadeh AK, Thomas DF. Ascent of the testis revisited: fact not fiction. BJU Int. 2008 
Sep;102(6):676-8. 
3. Virtanen HE, Toppari J. Epidemiology and pathogenesis of cryptorchidism. Hum Reprod 
Update. 2008 Jan-Feb;14(1):49-58. 
4. Hack WW, Sijstermans K, van Dijk J, van der Voort-Doedens LM, de Kok ME, Hobbelt-Stoker 
MJ. Prevalence of acquired undescended testis in 6-year, 9-year and 13-year-old Dutch schoolboys. 
Arch Dis Child. 2007 Jan;92(1):17-20. 
5. Barthold JS, Redman JF. Association of epididymal anomalies with patent processus vaginalis in 
hernia, hydrocele and cryptorchidism. J Urol. 1996 Dec;156(6):2054-6. 
6. Clarnette TD, Rowe D, Hasthorpe S, Hutson JM. Incomplete disappearance of the processus 
vaginalis as a cause of ascending testis. J Urol. 1997 May;157(5):1889-91. 
7. Elder JS. Epididymal anomalies associated with hydrocele/hernia and cryptorchidism: 
implications regarding testicular descent. J Urol. 1992 Aug;148(2 Pt 2):624-6. 
8. Favorito LA, Costa WS, Sampaio FJ. Relationship between the persistence of the processus 
vaginalis and age in patients with cryptorchidism. Int Braz J Urol. 2005 Jan-Feb;31(1):57-61. 
9. Favorito LA, Costa WS, Sampaio FJ. Analysis of anomalies of the epididymis and processus 
vaginalis in human fetuses and in patients with cryptorchidism treated and untreated with human 
chorionic gonadotrophin. BJU Int. 2006 Oct;98(4):854-7. 
10. Guven A, Kogan BA. Undescended testis in older boys: further evidence that ascending testes 
are common. J Pediatr Surg. 2008 Sep;43(9):1700-4. 
11. Han CH, Kang SH. Epididymal anomalies associated with patent processus vaginalis in 
hydrocele and cryptorchidism. J Korean Med Sci. 2002 Oct;17(5):660-2. 
12. Hazebroek FW, de Muinck Keizer-Schrama SM, van Maarschalkerweerd M, Visser HK, 
Molenaar JC. Why luteinizing-hormone-releasing-hormone nasal spray will not replace orchiopexy in 
the treatment of boys with undescended testes. J Pediatr Surg. 1987 Dec;22(12):1177-82. 
13. Heath AL, Man DW, Eckstein HB. Epididymal abnormalities associated with maldescent of the 
testis. J Pediatr Surg. 1984 Feb;19(1):47-9. 
14. Jackson MB, Gough MH, Dudley NE. Anatomical findings at orchiopexy. Br J Urol. 1987 
Jun;59(6):568-71. 
15. Meij-de Vries A, Hack WW, Heij HA, Meijer RW. Perioperative surgical findings in congenital 
and acquired undescended testis. J Pediatr Surg. 2010 Sep;45(9):1874-81. 
16. Meijer RW, Hack WW, van der Voort-Doedens LM, Haasnoot K, Bos SD. Surgical findings in 
acquired undescended testis. J Pediatr Surg. 2004 Aug;39(8):1242-4. 
17. Mollaeian M, Mehrabi V, Elahi B. Significance of epididymal and ductal anomalies associated 
with undescended testis: study in 652 cases. Urology. 1994 Jun;43(6):857-60. 
18. Rabinowitz R, Hulbert WC, Jr. Late presentation of cryptorchidism: the etiology of testicular re-
ascent. J Urol. 1997 May;157(5):1892-4. 
19. Rusnack SL, Wu HY, Huff DS, Snyder HM, 3rd, Zderic SA, Carr MC, et al. The ascending testis 
and the testis undescended since birth share the same histopathology. J Urol. 2002 Dec;168(6):2590-1. 
20. deMuinck Keizer-Schrama SM, Hazebroek FW, Matroos AW, Drop SL, Molenaar JC, Visser HK. 
Double-blind, placebo-controlled study of luteinising-hormone-releasing-hormone nasal spray in 
treatment of undescended testes. Lancet. 1986 Apr 19;1(8486):876-80. 
21. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 
1970 Feb;45(239):13-23. 
22. Ritzen EM. Undescended testes: a consensus on management. Eur J Endocrinol. 2008 Dec;159 
Suppl 1:S87-90. 
23. Hack WM, Goede J, Pierik FH, Sijstermans K. Re: Ascent of the testis revisited: fact not fiction. 
BJU Int. 2008 Nov;102(10):1477-8; author reply 8. 
24. Eijsbouts SW, de Muinck Keizer-Schrama SM, Hazebroek FW. Further evidence for 
spontaneous descent of acquired undescended testes. J Urol. 2007 Oct;178(4 Pt 2):1726-9. 
25. Sijstermans K, Hack WW, van der Voort-Doedens LM, Meijer RW, Haasnoot K. Puberty stage 
and spontaneous descent of acquired undescended testis: implications for therapy? Int J Androl. 2006 
Dec;29(6):597-602. 
26. Turek PJ, Ewalt DH, Snyder HM, 3rd, Duckett JW. Normal epididymal anatomy in boys. J Urol. 
1994 Mar;151(3):726-7. 
27. Kucukaydin M, Ozokutan BH, Turan C, Okur H, Kose O. Malformation of the epididymis in 




Part II  
Evaluation of traditional fertility parameters  
after different treatments for congenital and  
acquired undescended testes 
  
Chapter 4 
Fertility potential in men with a history of 
congenital undescended testes: a long-term 
follow-up study. 
 
J. van Brakel 
R. Kranse 
S.M.P.F. de Muinck Keizer-Schrama 
A.E.J. Hendriks 
F.H. de Jong 
C.H. Bangma 
F.W.J. Hazebroek 
G. R. Dohle 
 
Andrology. 2013 Jan;1(1):100-8. doi: 
10.1111/j.2047-2927.2012.00024.x. Epub 2012 
Oct 23 
Abstract 
Men with a history of congenital undescended testes (UDT) have an increased risk of fertility 
problems. Despite no definitive proof, current guidelines recommend early surgical 
intervention because this may have a positive effect on future fertility potential by preventing 
degenerative changes of the testes in early life. Also surgical intervention facilitates 
observability of the testes in view of possible malignancy. We evaluated testicular function in 
adult men with previous UDT treated at different ages before puberty. 
A long-term follow-up study of men with previous UDT was performed. Andrological 
evaluation included medical history taking, physical examination, scrotal ultrasound, 
determination of reproductive hormones, and semen analysis. Findings were compared with 
those of a control group of men with normal testicular descent. The influence of age at 
orchiopexy on future fertility parameters was evaluated in a multivariate regression analysis.  
62 men were included of whom seven had had bilateral UDT. 24 patients had had their 
orchiopexy before the age of 24 months of whom eight men before 12 months of age. 48 men 
had had unsuccessful luteinizing-hormone-releasing-hormone (LHRH) nasal spray treatment 
during childhood, whereas 14 of 24 men operated before 24 months of age had not received 
LHRH treatment before orchiopexy. Fertility potential in men with a history of UDT is 
compromised in comparison with controls. We could not detect any influence of age at 
orchiopexy on fertility parameters. However the number of patients operated before the age 
of 12 months is limited. 








Congenital undescended testis (UDT), also known as congenital cryptorchidism, occurs in 2-9% 
(1) of male newborns. Spontaneous descent may occur in the first year of life, especially during 
the first 3 months (1). UDT may lead to fertility problems later in life, especially in bilateral 
cases(2-4). Randomized controlled studies have shown overall low success rates of hormonal 
therapy. Therefore, hormonal therapy is no longer recommended for the treatment of 
cryptorchidism (5). The standard treatment today is a surgical one: orchiopexy.  Judging from 
histopathological degenerative changes in the testis by the 18th month of life, early orchiopexy 
may prevent testicular maldevelopment and thus have a beneficial effect on fertility (6). Current 
guidelines recommend that orchiopexy should be performed before the age of 18 months (7). 
We report a long-term follow-up study aimed at measuring fertility potential in men treated 
for congenital UDT at various prepubertal ages. We aimed to answer the following: (i) What is 
the extent of fertility damage in men with a history of UDT in comparison with a healthy 
control group?, (ii) What is the influence of age at orchiopexy on the fertility parameters in 
adult life?, and (iii) Are there any differences in fertility parameters between men with 
unilateral and bilateral UDT.  
 
Participants and methods  
Participants  
Subjects from a placebo-controlled study on effects of luteinizing-hormone-releasing-
hormone (LHRH) nasal spray, carried out between 1982 and 1985, were assessed for eligibility 
(8). Those subjects were boys aged between 1 and 12 years with unilateral or bilateral UDT who 
underwent orchiopexy at different ages before puberty if the UDT did not descend after LHRH 
nasal spray treatment. 
To increase discriminative power of the present study we also assessed eligibility of men 
operated on before 2 years of age in our hospital between 1982 and 1990, applying the same 
inclusion and exclusion criteria as for the LHRH-study (8). A total of 225 men, with 252 
congenital UDT, could be contacted for the present study. 
The presence of retractile testes had been excluded under general anaesthesia. Surgical 
findings were available for all men, classified as published previously (9). In short:  
Intraoperative location: (i) Absent; (ii) Intraabdominal; (iii) Inguinal canal; (iv) External annulus; 
(v) Superficial inguinal pouch.  
Processus vaginalis: (i) Closed; (ii) Small open; (iii) Wide open.  
 
Methods 
All 225 men were sent an invitation by post, including the request to return the enclosed 
response card. A reminder was sent to those who did not return the response card. Additional 
information about the study was sent to men who considered participating in the study. Again, 
eligible candidates who did not respond were contacted by post. Those who declined 
participation were asked for their reasons and were invited to fill in a questionnaire regarding 
fertility and risk factors for subfertility or infertility other than UDT. Participation involved a 
single hospital visit including medical history taking, physical examination, scrotal ultrasound, 
venous puncture, and semen sample delivery.  
 
History  
We focused on risk factors for fertility problems other than cryptorchidism. Special attention 
was paid to attempting fatherhood, duration of child-wish (months), and time to first 
pregnancy (TTP) (months).  
 
Physical examination and scrotal ultrasound  
Two investigators (including first author) conducted a physical examination and performed a 
scrotal ultrasound to measure testicular volume and to check for the presence of a varicocele in 
a standardized procedure using a high-resolution duplex ultrasound machine (Toshiba Nemio 
model 17 SSA-550A; Toshiba Medical Systems Corporation, Otawara-shi, Tochigi, Japan) with 
a transducer frequency of 7.5-12 MHz.. A testicular volume of 15 ml or greater was considered 
normal.  
Blood analysis  
A venous blood sample was taken, preferably before 10:00 AM and before 11:00 AM at the 
latest. Serum samples were assayed for luteinizing hormone (LH, reference value 1.5-8 IU/L) 
and follicle stimulating hormone (FSH, reference value 2-7 IU/L) using fluorescence-based 
immunometric methods (Immulite 2000; Siemens-DPC, Los Angeles, CA, USA), testosterone 
(reference value 10-30 nmol/L) using a coated tube radioimmunoassay (Siemens-DPC), and 
inhibin B (InhB, reference value ≥ 150 ng/L) using an enzyme-immunometric method (Oxford 
BioInnovation, Oxford, UK). 
 
Semen analysis  
A semen sample produced by masturbation after a 3-5 day ejaculatory abstinence was 
analysed according to the recommendations from the most recent WHO-manual (10). Within 
one hour, after liquefaction, semen volume (reference value ≥1.5 ml), sperm concentration 
(reference value ≥15 10*6/ml), total sperm count (reference value ≥39 10*6/ ejaculate), 
progressive motility (reference value ≥32%), and morphology (reference value ≥4% normal 
forms) were determined.  
 
Control group  
Fifty-three healthy men without a history of UDT served as a control group. These men took 
part in a study investigating fatherhood in tall men (n=153) after the use or non-use of sex 
steroid treatment in adolescence to reduce final height (11). These men had the same 
evaluation as the study participants, except for morphological evaluation of semen.  
In that study men with endocrine or metabolic disorders were excluded. As a control group we 
used the 56 men who did not receive sex steroids, of whom we excluded 3 men referable to a 
history of orchiopexy or treatment with radio- or chemotherapy (11).  
 
Statistical analysis  
Continuous variables were tested with the Mann-Whitney U test; categorical variables with 
Fisher’s exact test. First, characteristics of participants were compared with those of non-
participants. Second, participants’ information regarding medical history and paternity was 
compared with that of non-participants who returned the questionnaire.  
The Kaplan-Meier survival method served to estimate the probability of conception in 
participants and controls; the Wilcoxon (Breslow) test served to test if the participants’ average 
conception rate differed from that in controls. Furthermore, fertility parameters (testicular 
volume, endocrinological values, and semen parameters) were compared between the two 
groups. In case of bilateral UDT, testicular volume was taken to be the mean of the volumes of 
the two testes. 
Age at surgery was analysed as a continuous variable in several multivariate logistic regression 
analyses performed to establish relationships between fertility parameters (testicular volume, 
endocrinological results, and all semen parameters) and age at surgery. Fertility parameters 
were analysed by means of the chance of being below or above the reference value. Known 
confounders such as smoking, varicocele, and Body Mass Index (BMI) were corrected for in 
these analyses (12). Other independent variables were uni-/bilateral UDT, intraoperative testis 
position, and patency of processus vaginalis. For all analyses a two-sided p-value of less than 
0.05 was considered statistically significant.  
 
Ethics  
The study was reviewed and approved by the Medical Ethical Review Board at Erasmus 
University Medical Center in Rotterdam (MEC number 2004-206). Written informed consent 





Sixty-two out of the 225 eligible men (28%) participated (Fig. 1). Non-participants stated time 
constraints and bothersomeness of the investigations as main reasons for refusal. Age at 
orchiopexy, present age, and distribution of unilateral and bilateral UDT did not significantly 
differ between participants and non-participants (Table 1). The participation rate of men 
operated at younger age was not statistically different from that of men operated at older age 
when the cut-off was set at 12, 18 or 24 months of age at orchiopexy (age ≤12 months p-value 
0.248; age ≤18 months p-value 0.176; and age ≤24 months p-value 0.652). 
Thirty-eight men who responded but did not participate returned the questionnaire. Present 
age and age at orchiopexy did not significantly differ between participants and men who 
returned the questionnaire without further participation. Proportions of men attempting 
fatherhood, number of pregnancies, TTP, and proportions of men having an active child-wish 
at time of recruitment did not differ between the participants and non-participants returning 
the questionnaire. In neither group TTP exceeded 12 months. The duration of child-wish was 
significantly longer in participants than in non-participants who had returned the questionnaire 
[median (range); 12 (2-36) vs. 2 (0-5) months respectively; p-value 0.03].  
 Comparison of fertility parameters; participants with a history of 
unilateral UDT vs. healthy controls (Table 2) 
Physical examination and scrotal ultrasound:  
Participants’ volume of the previously UDT, measured by ultrasound, was significantly smaller 
than the controls’ mean testicular volume. Moreover, the volume of the normally descended 
contralateral testis was also significantly smaller compared with the control group. All men in 
the control group had a normal testicular consistency; 29 of 55 participants (53%) had uni- or 
bilateral soft testicular consistency (p-value <0.001). Varicocele occurred more often in the 
control group, but the difference was not statistically significant.  
 
Endocrine function:  
Endocrinological data were obtained from 54 participants; one participant refused blood 
sampling. Both Leydig cell function represented by LH and testosterone as well as Sertoli cell 
function represented by FSH and InhB did not differ between the control group and the 
participants.  
 
Semen analysis:  
Five men in the control group had undergone vasectomy and therefore semen analysis was not 
performed. Participants had a significantly lower median concentration, more often 
oligozoospermia according to the WHO-reference values(10), and less progressive motile sperm 
than the control group. None of the participants was diagnosed with azoospermia.  
 
Paternity:  
 A higher proportion of men in the control group attempted fatherhood. More men in the 
control group succeeded in comparison with the participants, however this difference was not 
statistically significant (participants: 6 of 11 (55%) vs. controls: 25 of 29 (86%); p-value 0.08). 
Based on low numbers of men who attempted fatherhood, TTP and duration of child-wish 
were not statistically significantly different between these two groups (data not shown). The 
result of the Breslow test, which took time to conception into account was that the control 
group had a higher probability of conceiving, however, this was not statistically significant 
(0.07 pregnancy/month for unilateral group vs. 0.12 pregnancy/month for controls; p-value 
0.28) (Fig. 2).  
 
Influence of age at orchiopexy on fertility parameters 
The participants’ median age at orchiopexy was 3.0 years (range 0.1 - 14.6 years). Eight boys 
had been operated on before the age of 1 year, 12 before 18 months of age, and 24 before the 
age of 2 years. 
 
Physical examination and scrotal ultrasound: 
In the complete group as well as in the unilateral group only, testicular volume of the previous 
UDT, testicular volume of the contralateral normally descended testis, testicular consistency, 
and incidence of varicocele did not statistically differ when cut-off values for age at surgery 
were used (12 months, 18 months, and 24 months at operation). 
 
Endocrine function: 
Both in the complete group of participants and the unilateral group only, hormone levels 
except LH did not differ at the cut-off values of 12 months, 18 months or 24 months at 
orchiopexy. LH levels were significantly lower in the group operated at older age when 
applying cut-off values for age at orchiopexy (12 months, 18 months, and 24 months at 
operation) (Mann-Whitney U test).  
 
Semen analysis: 
Both in the complete group of participants and in the unilateral group only, sperm parameters 
did not differ at the cut-off values of 12 months, 18 months, and 24 months at orchiopexy. 
 
Multiple regression analyses:  
Figure 3 shows scatter plots of the relations of age at orchiopexy with testicular volume, FSH, 
InhB, and sperm concentration, respectively. We could not detect any influence of age at 
orchiopexy on these fertility parameters.  
Table 3 presents the results of the multiple regression analyses for age at orchiopexy as a  
continuous variable and its effect on testicular volume, hormonal values, and semen 
parameters.  
Age at orchiopexy had no significant influence on fertility parameters, after correction for 
known confounders and other independent variables (smoking, varicocele, BMI, uni-/bilateral 
UDT, intraoperative testis position, and patency of processus vaginalis). 
 
Influence of bilateral UDT on fertility parameters; comparisons with 
controls and unilateral UDT 
Seven men of 62 had a history of bilateral UDT, two men had had an orchiopexy before the age 
of two and five men were operated after 2 years of age. 
 
Physical examination and scrotal ultrasound: 
The mean testicular volume in the group of men with bilateral UDT was statistically smaller in 
comparison with the control group [median (range): 7.6 ml (6.2 – 18.1) vs. 15.8 ml (8.1 – 27.0) 
respectively; p-value 0.01]. Five of seven men (71%) had uni- or bilateral soft testicular 
consistency compared with none of the men in the control group (p-value <0.001). No 
differences in physical examination or scrotal ultra sound results were found when comparing 
the bilateral group with the unilateral group. 
 
Endocrine function: 
In comparison with the control group, the bilateral group showed values, which indicate worse 
Sertoli cell function represented by both FSH and InhB. The median FSH-value was 8.2 IU/L 
(range 1.6 – 28.8) for the bilateral UDT group and 4.5 IU/L (range 1.6 – 13.9) for the control 
group (p-value 0.05). The median InhB value in the bilateral group was significantly lower 
compared with that in the control group: median (range) 125.0 ng/L (1.0 – 364.0) vs. 168.0 ng/L 
(96.0 – 488.0) respectively (p-value 0.02).  
When comparing participants with unilateral UDT with participants with bilateral UDT no 
statistically significant differences in endocrine function were found. Borderline significant 
values were found for FSH and InhB. FSH was higher in the bilateral group [median (range) 8.2 
IU/L (1.6 – 28) vs. 4.8 IU/L(0.7 – 21.2); p-value 0.08). InhB was lower in the bilateral group 
[median (range)125 ng/L (1.0 – 364.0 vs. 157.0 ng/L (22.0 – 554.0); p-value 0.09]. 
 
Semen analysis: 
In comparison with the control group, men with previously bilateral UDT had significantly 
lower sperm concentration [median (range): 0.6 x10*6/ml (0.1 – 364.0) vs. 54.5 x10*6/ml (0.1 – 
213.0); p-value <0.001] and motility [median (range): 36% (1 - 60) vs. 52% (9 – 91); p-value 
0.02). 
Sperm concentration in men with bilateral UDT was significantly lower than that in men with 
unilateral UDT [median (range): 0.6 x10*6/ml (0.1 – 46.0) vs. 21.0 x10*6/ml (0.1 – 276.0); p-
value 0.03]. When the cut-off value for oligozoospermia stated in the WHO 2010 guideline was 
used, no significant difference was found between men with unilateral and those with bilateral 
UDT.  
 
Fertility parameters in participants operated before 24 months of age; 
comparison of men receiving LHRH nasal spray before orchiopexy vs. 
men not receiving LHRH nasal spray  (Table 4) 
Of the 62 men included in this study 24 men had had the orchiopexy before the age two years. 
14 men of 24 did not receive LHRH nasal spray prior to the orchiopexy. These men were 
significantly younger at orchiopexy compared with the men who had received LHRH nasal 
spray. 
 
Physical examination and scrotal ultrasound:  
Testicular volume of the previously cryptorchid testis was significantly smaller in the group 
treated with LHRH nasal spray prior to orchiopexy compared with the testis volume of the men 
not treated with LHRH nasal spray. No difference was found when comparing testicular 
volume of the normally descended testis between the group treated with LHRH nasal spray 
and men not treated with hormonal therapy. The volume of the previously UDT of men not 
treated with hormonal therapy did not statistically differ between men operated before or 




No differences could be observed in endocrine function between men who were and were not 
treated with LHRH nasal spray prior to orchiopexy. 
 
Semen analysis: 
No significant differences were found in semen parameters when comparing men who had had 
LHRH nasal spray before surgery and men who were only treated with orchiopexy.  
 
Discussion 
The most important finding of this study is the lack of an age-dependent effect of orchiopexy 
on fertility parameters in men with previous congenital UDT.  
Fertility potential can be evaluated using semen analysis. In this study both semen 
concentration and motility were significantly lower in participants than that in the control 
group. Cortes et al. published data on semen parameters in patients with unilateral and 
bilateral UDT. In comparison with our study, the sperm parameters found in their studies were 
better (3,4). However, in those studies the age at surgery was relatively high, which might 
indicate a higher proportion of men having acquired UDT instead of congenital UDT. Also it is 
not clear whether retractile testes have been excluded in those studies. Many studies have 
been published on semen parameters in patients with UDT. Such studies are not always easy 
to compare because of several reasons; (i) different therapeutic strategies, (ii) variation in 
reporting the results (mean values, median values or percentage normal/abnormal), (iii) the 
WHO-reference values for semen analysis have changed over time, (iv) uncertainty whether 
groups contain only congenital UDT or also acquired UDT, (v)  groups may contain  unilateral 
or bilateral UDT or a combination of both, (vi) unclear about the exclusion of retractile 
testis(3,4,13-19). In this study, men with retractile testis or acquired UDT were excluded this might 
be an explanation for our low sperm concentration in comparison with the literature.    
Although some studies have suggested that orchiopexy at younger age results in better semen 
parameters (13,15,18) results of this study show no favourable effect of early treatment on semen 
characteristics, in line with other studies (14,16,17,19). No study which evaluates age at surgery as a 
continuous variable finds statistically significant correlations with semen parameters (14,16,17,19). 
Two studies found an effect of age at surgery for patients with bilateral UDT, but not for 
unilateral UDT (15,18). Canavese et al., in a study on orchiopexy within the first 2 years of life 
found that age at surgery was inversely related to sperm concentration and motility(13).  
Different results on the effect of hormonal treatment on fertility potential or germ cell 
development have been reported. In the study by Canavese, men operated at a younger age 
had significantly more often received hormonal therapy (LHRH nasal spray and subsequently 
human chorionic gonadotropin i.m.) prior to surgery (13). In a study by Hadziselimovic et al., in 
which the effect of LHRH nasal spray on testicular descent was analysed, neither a stimulatory 
effect nor an inhibitory effect on the number of germ cells was seen (20). This in contrast to 
Cortes et al., who found a negative effect on germ cells in 1 to 3-year-old boys with 
cryptorchidism after gonadotropin releasing hormone (GnRH) (21). They hypothesized that 
these young boys may be sensitive for exogenous GnRH stimulation resulting in increased 
FSH, LH, and testosterone, which may have a negative impact on germ cells. In this study, all 
participants who were operated after 24 months of age received LHRH nasal spray prior to 
orchiopexy, although 10 of the 24 men who were operated before 24 months received this 
hormonal treatment and 14 men did not.  We hypothesize that our LHRH treatment, at 
younger age, is very unlikely to have influenced later fertility because at the time of treatment 
no evidence of stimulation of the hypothalamo-pituitary-gonadal axis was found (8). At adult 
age only testicular volume of the previously undescended testis appeared to be smaller in the 
group treated with LHRH nasal spray prior to surgery compared with men treated with only 
orchiopexy. Thereby testis volume of the contralateral testis in case of unilateral UDT did not 
differ between men with or without hormonal therapy. Endocrinological values and semen 
analysis did not show statistical differences between participants receiving hormonal therapy 
and those not receiving hormonal therapy below the age of 24 months.  
Testicular volume is an accepted predictor for spermatogenesis (22). In this study, participants’ 
testicular volume was significantly lower than that of the control group. However, age at 
orchiopexy did not influence testicular volume in adulthood. As stated above, the group of 
men of this study who had not received hormonal therapy had  larger testicular volumes. When 
evaluating the age effect in this group also no effect of age at orchiopexie on adult testicular 
volume could be found.  Other studies on testicular volume and age at orchiopexy imply that 
younger age at surgery might result in higher testicular volume (15,23,24). To our knowledge only 
one randomized prospective study showed a beneficial effect of early orchiopexy on testis 
volume. At 4 years of age testis volume was larger in patients operated at 9 months compared 
with patients operated at the age of 3 years (25). However, the follow-up period differed 
between the two groups and the question remains whether adult testicular volume would still 
be different between the two groups and if so, what the effect would be on fertility.  
Other indicators of spermatogenesis are FSH and InhB levels. UDT have been related to lower 
InhB and higher FSH levels (2). In this study, FSH levels and InhB levels did not significantly 
differ between participants and the control group. Age at orchiopexy was not significantly 
correlated with FSH and InhB levels. This in contrast to a study by Coughlin et al., in which age 
at surgery negatively correlated with InhB and positively with FSH levels (14). However, in that 
study a multivariate analysis correcting for known confounders was not performed. Some 
histological studies not only suggest maldevelopment of germ cells but also of Leydig cells (26). 
Hormonal evidence for Leydig cell dysfunction was found in adult patients after a late 
orchiopexy (27). In this study,  age at orchiopexy had no statistically significant influence on 
Leydig cell function.  
Men with a history of bilateral UDT face more fertility problems than do men with previously 
unilateral UDT (16,18). In this study sperm concentration was significantly lower in patients with 
bilateral UDT (Mann-Whitney U test). Multivariate analyses, however, showed that having uni- 
or bilateral UDT did not predict the chance of having a sperm concentration below or above 15 
x 10*6/ml. The analysis might be flawed, however, by low number of men with bilateral UDT 
(N=7).  
Another way to evaluate fertility is looking at paternity. Lee et al. reported paternity 
proportions of 89.7%, 65.3%, and 93.2% in, respectively, unilateral UDT, bilateral UDT, and 
healthy controls (2). Likewise, in this study, paternity in the participants was borderline 
significantly lower than in the control group. Lee et al. found that age at orchiopexy was not 
correlated with paternity (28). Due to the small numbers of men who fathered children or 
attempted fatherhood in our study we cannot confirm this result.  
Early operation is hypothesized to have a favourable effect on germ cell development. In the 
first year of life, neonatal germ cells transform into spermatogonia. This process is important 
for future fertility because spermatogonia are the progenitor cells for future spermatogenesis. 
In boys with UDT, the process of germ cell maturation is impaired (26). Germ cell numbers start 
to deviate as from 18 months old (6).  Based on these observations the recommended age for 
orchiopexy was gradually lowered to under the age of 12 months (6). The Nordic consensus 
recommends surgery between 6 to 12 months of age, but not earlier given the possibility of 
spontaneous descent during the first months of life (5). The question remains why early 
operation, which might prevent histological changes, had no beneficial effect on fertility 
parameters in this study. As only eight patients were operated on or before the age of 12 
months, a definite conclusion cannot be drawn. Our results suggest a congenital malfunction 
of the testis that cannot be influenced by reducing duration of the non-scrotal position. Huff et 
al. found similar, but less severe histological changes in the contralateral normally descended 
testis (29). Also Zivkovic found significantly lower numbers of germ cells per tubule in 
contralateral normally descended testes in patients with unilateral UDT in comparison with 
spontaneously descended testes in healthy controls (30). Indeed, both testes might be affected 
in case of unilateral UDT, for in our study the volume of the contralateral normally descended 
testis was also significantly smaller than that of controls. 
A limitation of our study is the fairly low inclusion rate (28%). The inclusion rate in other studies 
varied between 29 and 73%(3,4,13,15,16,18). Three studies had a higher number of participants than 
our study (3,14,16). A possible explanation for our low inclusion rate is the long interval between 
operation and inclusion. Thereby, in our study patients had no regular check-ups after 
operation. Patients might be more motivated to participate when the treatment is more recent 
or when follow-up is more frequent. In this study age at orchiopexy, uni- or bilateral 
cryptorchidism, and current age did not differ between men who did not respond and men who 
responded by questionnaire or participated. This suggests that the group of men who 
completed follow-up is a representative part of the whole group. The number of men having an 
active child-wish did not differ between the men who responded by questionnaire and the men 
participating. Selection bias may have occurred, however, because the participants’ duration 
of child-wish was significantly longer than that of those who only returned the questionnaire. 
The duration of child-wish is not to be mistaken for actual clinical infertility. The questionnaire 
was not validated to produce such information. Selection bias is always an issue in fertility 
studies, because men with fertility problems might be more motivated than fertile men to 
participate. We presume that the risk for selection bias because of fertility problems is the 
same in both the participants and the control group (the participation rate in the control group 
was 31%) as the control group was not a group of chart-selected, mostly fertile men. A high 
occurrence of varicocele in tall men is described (31). In this study the incidence of varicocele in 
the control group was twice as high compared with that in the patient group. In our 
multivariate regression analyses we corrected for varicoceles.  
In conclusion, the present long term follow-up study could not find a relation between the age 
at orchiopexy and fertility parameters for patients with a history of unilateral UDT, most of 
them after unsuccessful LHRH treatment. As only eight patients had had their orchiopexy in 
the first year of life, this conclusion has to be taken with caution for patients operated before 
12 months of age. This conclusion might also not be legitimate for bilateral UDT because no 
more than seven men with bilateral UDT participated. As congenital UDT are not expected to 
descend spontaneously after the first year of life, orchiopexy is needed for psychosocial 
reasons, prevention of torsio, and better observability of the testes in view of possible 
malignancy in young adulthood.  
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To evaluate testicular function in men with previously acquired undescended testes (AUDT) in 




Andrological evaluation including paternity, scrotal ultrasound, reproductive hormones, and 
semen analysis was performed in three groups: men with AUDT, healthy controls, and men 
with previously congenital undescended testes (CUDT).  
 
Results: 
In comparison with controls, men with AUDT more often had significantly abnormal testicular 
consistency, smaller testes, lower sperm concentration, and less motile sperm.  
Except for more often a normal testicular consistency in men with AUDT, no differences were 
found between men with AUDT and CUDT.  
Also, no differences were found between men with AUDT which had spontaneously descended 
and men who underwent orchiopexy. 
 
Conclusions: 
Fertility potential in men with AUDT is compromised in comparison with healthy controls, but 
comparable with men with CUDT. This suggests that congenital and acquired UDT share the 
same aetiology.  
No significant difference could be found between men who had spontaneous descent and men 
needing orchiopexy. However fertility potential is unknown for men after immediate surgery at 
diagnosis, and this should be subject for future studies.  
Introduction 
Undescended testis (UDT) is a frequent urogenital abnormality in boys with an incidence 
around 1% at one year of age (1). The abnormality may be of congenital or acquired origin (2,3). 
In the congenital type a stable scrotal position was never reached. Acquired UDT is defined as a 
palpable UDT that previously had a normal scrotal position, as documented by a physician. 
Acquired UDT is seen in 1-3% of boys during childhood (4,5) and its aetiology, natural course, 
and treatment are still debated. Two studies on the proportion of (pre) pubertal spontaneous 
descent in boys with acquired UDT found a prevalence of 57% and 71.4% spontaneous 
descended testes (6,7). Congenital UDT is associated with infertility (8,9). However, little is known 
about fertility in men with previously acquired UDT (AUDT) and the effect of a “wait-and-see 
until puberty” policy (6). The aim of our study was to evaluate the impact of AUDT on fertility 
parameters in comparison with controls and men with previously congenital UDT (CUDT). 
Furthermore, we evaluated testicular function in men with AUDT after spontaneous descent or 
orchiopexy. 
 
Materials and Methods 
Acquired UDT group 
Between 1982 and 2004, boys with acquired UDT referred to Erasmus Medical Center-Sophia 
Children’s Hospital, Rotterdam, and the Medical Center, Alkmaar, were followed by three 
experienced physicians (S.de.M.K.-S., F.W.H., or W.H.) annually until puberty. Acquired UDT 
implied that a previous normal stable scrotal position was documented at least once either by 
the Regional Youth Health Care Institution, general practitioner, or hospital. Furthermore, the 
testis had to be palpable without ipsilateral, inguinal, clinically present pathological findings or 
previous ipsilateral, inguinal surgery, and the most caudal testicular position after 
manipulation had to be nonscrotal or unstable scrotal position. Spontaneous descent was 
awaited until at least Tanner stage P2G2, after which orchiopexy was performed in case of 
nondescent. Findings at physical examination were registered on a standardized form. 
Retractile testes were excluded. Orchiopexy was performed by paediatric surgeons with years 
of experience performing orchiopexies. 
In 2009, a total of 231 men with 287 AUDT were screened for eligibility for this study, of whom 
99 men had undergone orchiopexy. Seven men were excluded mostly because of 
chromosomal abnormalities and dysmorphic syndromes besides UDT. For 17 no current 
address was available, thus 207 were invited to participate. 
 Control group and congenital UDT group 
Fifty-three healthy men without a history of UDT served as controls. These men previously 
participated in a study evaluating fatherhood after use or non-use of sex steroids treatment 
during adolescence to reduce final height. Men, who were not treated, were used as our 
control group. Furthermore, we created a CUDT group (N=62, 69 testes) of men who 
participated in a study evaluating fertility potential after treatment of congenital UDT during 
childhood. Both groups were previously described in detail (10,11). These men had the same 
evaluation as men with AUDT, except for morphological evaluation of semen, which was not 
performed in the controls.  
 
Methods 
The methods for recruitment and andrological evaluation were published previously (11). In 
short, all 207 men were invited to participate by post. Those who refused were invited to fill out 
a questionnaire on fertility and risk factors for subfertility or infertility. Participation involved a 
single hospital visit including medical history taking, physical examination, scrotal ultrasound, 
venous puncture, and semen sample delivery. Special attention was paid to attempting 
fatherhood, duration of child-wish, and the time to first pregnancy (TTP). 
Testicular volume and presence of testicular and epididymal abnormalities and varicocele were 
assessed by physical examination and confirmed by scrotal ultrasound.  
The following endocrinological values were evaluated: luteinizing hormone (LH) and follicle 
stimulating hormone (FSH), testosterone, and inhibin B. 
Semen parameters that were evaluated were analysed according to the WHO manual of 2010 
(12), which included volume, concentration, total sperm count, progressive motility, and 
morphology. 
 
Statistical analysis  
Continuous variables were tested with the Mann-Whitney U test; categorical variables with 
Fisher’s exact test. The Kaplan-Meier survival method was used for time-to-event analyses, 
Wilcoxon's test was used to test between group differences in such cases. Multivariate logistic 
regression analyses were used to test the relationship between bivariate categories and their 
predictors. For example, we have studied the relationship between fertility parameters 
(bivariate classes: being below or above the reference value) and the predictor "type of UDT" 
controlling for known confounders: smoking, varicocele, and Body Mass Index (BMI) and 




The study was reviewed and approved by the Medical Ethical Review Committee at Erasmus 
University Medical Center in Rotterdam (MEC number 2004-206). Written informed consent 
was obtained from all participants. 
 
Results 
Inclusion of men with AUDT  
Sixty-five (31%) out of the 207 eligible men participated (Fig. 1). Most of the 49 nonparticipants 
who nevertheless returned the questionnaire (35%) mentioned time constraints and 
bothersomeness of the investigations as reasons for refusal. Only two men reported that 
having fathered children was also a reason to decline participation. Table 1 shows the 
characteristics of study participants and nonparticipants. No significant differences were found 
between participants and men returning the questionnaire in terms of the proportion of men 
attempting fatherhood, number of pregnancies, TTP, and proportions of men having an active 
child-wish. One nonparticipant with bilateral acquired UDT with spontaneous descent replied 
that he had azoospermia. 
Fifty out of the 65 men with AUDT had unilateral AUDT. Spontaneous descent had occurred in 
32 participants (24 unilateral and 8 bilateral). Median age at orchiopexy (N=33; 26 unilateral 
and 7 bilateral) was 13.2 years (range 4.75 to 17.8 years). Most important criteria for 
prepubertal orchiopexy were inguinal complaints or ipsilateral inguinal hernia.  
 
Comparisons of fertility parameters 
Men with unilateral AUDT vs. controls (Table 2) 
Testicular volume, both of the previously undescended one and the contralateral testis was 
significantly smaller than that of controls. Testicular consistency was normal in all controls; 13 
men with AUDT (26%) had unilateral or bilateral soft testicular consistency (p-value < 0.001). 
Endocrinological data were obtained from 49 men with AUDT: 1 of them refused blood 
sampling. Endocrine function did not differ significantly between men with AUDT and controls.  
One man with AUDT was unable to produce semen. Semen of five controls who had 
undergone vasectomy was not analysed. Concentration and progressive motility in men with 
AUDT were significantly lower than those in controls. Azoospermia was noted in four men with 
AUDT (three spontaneous descent and one orchiopexy). 
Controls, who were significantly older than men with AUDT, significantly more often 
attempted fatherhood. However fatherhood, TTP, cumulative probability of conception, and 
duration of child-wish did not statistically significantly differ between men with AUDT and 
controls.  
Two partners of controls had undergone intra uterine insemination. The reason was unknown 
for one couple and for the other couple it was caused by a female problem. The partner of one 
man with AUDT who had had orchiopexy, needed assisted reproductive treatment (ART) 
because she had a fertility problem.  
 
Men with unilateral AUDT vs. men with unilateral CUDT (Table 2) 
Normal testicular consistency was significantly more often found in men with AUDT than in 
men with CUDT (74% vs. 53%; p-value = 0.03).  
Endocrine function and semen analysis did not differ between the AUDT group and the CUDT 
group.  
Paternity did not differ between men with AUDT and men with CUDT. As stated above, one 
couple, with a man with AUDT, needed ART because of a female factor fertility problem. None 
of the unilateral CUDT attempting fatherhood needed ART. 
 
Men with bilateral AUDT vs. controls vs. men with bilateral CUDT (Table 3) 
Testicular consistency was normal in 9 of 15 men with bilateral AUDT, while it was normal in all 
controls (p-value < 0.001). Mean testicular volume of men with bilateral AUDT was significantly 
smaller than that of controls [median (range) 10.9 (5.2 – 14.6) vs. 15.8 (8.1 – 27.0); p-value < 
0.001]. Testicular volume did not differ between the AUDT group and the CUDT group. 
Men with bilateral AUDT had significantly higher LH and FSH, and lower inhibin B, semen 
concentration and motility compared with controls. Azoospermia was noted in one man with 
bilateral AUDT; both testes had descended spontaneously. 
Endocrine function and semen analysis did not differ between the AUDT group and the CUDT 
group. 
In the group of men with bilateral AUDT (N=15) only 1 (25%) of 4 men attempting fatherhood 
succeeded vs. 25 (86%) of the 29 controls (p-value = 0.02).  
Men with bilateral CUDT significantly more often attempted fatherhood than men with 
bilateral AUDT, but success rates did not differ. Two couples with men with bilateral AUDT 
who had had orchiopexy needed ART. One couple had male fertility problems and for the other 
couple a female factor was identified. 
 
Men with unilateral AUDT vs. men with bilateral AUDT (Table 4) 
When evaluating unilateral AUDT with bilateral AUDT only significant differences were found 
in comparing semen analysis. Unilateral AUDT had a higher semen concentration [median 
(range) 20.0 (0 – 205.0) vs. 8.2 (0 – 60) p-value = 0.04] and higher percentage of motile sperm 
[median (range) 42.0 (3 – 75) vs. 25.0 (0 – 61); p-value = 0.06] and less often oligozoospermia 
[number (percentage) 19 (39) vs. 10 (71); p-value = 0.04] and astenospermia [number 
(percentage) 10 (22) vs. 8 (62); p-value = 0.01] in comparison with bilateral AUDT. All other 
variables did not show statistically significant differences. 
 
Men with AUDT: spontaneous descent vs. orchiopexy (Table 5) 
Testicular volume, testicular volume of contralateral healthy testis in case of unilateral AUDT, 
testicular consistency, reproductive hormones, and semen analysis did not significantly differ 
between men with AUDT whose UDT descended spontaneously and those who underwent 
orchiopexy. This was the same for the evaluation of the complete group of men with AUDT, 
men with unilateral AUDT, and men with bilateral AUDT. 
In the orchiopexy group more attempts at fatherhood were noted, also when evaluating only 
men with unilateral AUDT; however fatherhood, TTP, and duration of child-wish did not differ. 
 Multivariate logistic regression analyses 
Men with AUDT vs. men with CUDT 
Type of UDT had no significant influence on any of the fertility parameters except testicular 
volume [Odds ratio (OR) 0.24, 95% confidence interval (CI) 0.08 – 0.70; p-value = 0.009]. Men 
with AUDT had a lower chance of having a volume equal or greater than 15 ml. Having bilateral 
UDT was associated with oligozoospermia and astenospermia [OR 0.23, 95% CI 0.08 – 0.64; p-
value = 0.005 and OR 0.32, 95% CI 0.11 – 0.88; p-value = 0.03, respectively].  
 
Men with AUDT: spontaneous descent vs. orchiopexy 
No significant differences in fertility parameters were found between men with a spontaneous 
descent and men with orchiopexy. Having bilateral UDT decreased the chance of having a 
normal sperm concentration and motility [OR 0.21, 95% CI 0.06 – 0.80; p-value = 0.02 and OR 
0.15, 95% CI 0.04 – 0.67; p-value = 0.01]. Age at orchiopexy had no influence on fertility 
parameters (data not shown). 
 
Discussion 
To our knowledge, this is the first study regarding fertility parameters in men with previously 
acquired UDT. Fertility parameters in these men were poorer than those in controls but did not 
differ from those in men with previously congenital UDT. Finally, fertility potential did not 
significantly differ between men with AUDT in whom spontaneous descent was successfully 
awaited and those who underwent orchiopexy. 
The timing of orchiopexy in acquired UDT is debated (3). Some studies advise immediate 
surgical intervention because of significant risk of developing degenerative histological 
changes, comparable to histological changes found in congenital UDT (13). A consensus 
meeting in 2006 recommended immediate surgery despite the fact that many of these testes 
will descend spontaneously. It was argued that spermatogenic and endocrine function and not 
anatomical position should be the primary aim for treatment (14). So far, no evidence is 
available that fertility improves with immediate surgery. There may be fewer fertility 
problems, however, since the crucial development of type A spermatogonia has probably 
already occurred during the first year of life before the testis ascended (15). This, however, 
remains to be proven.  
Fertility can be evaluated by semen analysis. Unfortunately, evaluating fertility with semen 
analyses has some shortcomings. Biological variation of consecutive semen samples in an 
individual can be substantial (16). Also, semen analyses have large inter- and intralaboratory 
variability. In our study both concentration and motility in the AUDT group were lower than 
those in controls. Thereby, we found higher semen concentration and higher percentage of 
progressive motile sperm in men with unilateral AUDT in comparison with bilateral AUDT. This 
is in line with other studies that show better semen parameters in men with unilateral UDT 
(17,18). Ong et al. suggested that in ascended testes subfertility is caused by heat-induced 
defective spermatogenesis (19), whereas Rusnack et al. hypothesized that an endocrine defect 
can diminish the number of germ cells (13). In both studies germ cell count in acquired and 
congenital UDT was comparable. Moreover, the total and differential germ cell counts were 
similarly diminished for the contralateral normally descended testis in acquired as well as 
congenital unilateral UDT compared with controls. Therefore, Rusnack et al. argued against a 
heat-induced defect since no thermal effect can influence the normally descended testis. This 
is in line with our previous study, in which sperm quality after orchiopexy is independent of age 
at surgery and thus independent of duration of possible thermal damage (11). The present 
study, also could not detect an age-specific influence on fertility potential. Some studies, not 
distinguishing between acquired and congenital UDT, showed a beneficial effect of early 
orchiopexy (18,20,21) on sperm quality, while others did not find such a correlation (17,22-24). It is 
difficult to draw any conclusion from these studies for acquired UDT since previous testicular 
position is not documented. 
Approximately one-third of retractile testes later become acquired UDT (2,5). A study by Han et 
al. showed histopathological changes in 40% of biopsied retractile testes (25). Another study 
found a mean decreased tubular fertility index value in men with acquired UDT, implying 
impaired spermatogenesis similar to that in congenital UDT (26). Tanyel hypothesized that 
congenital and acquired UDT share the same aetiology (27). Our findings seem to confirm this 
hypothesis, seeing that there were no significant differences in semen parameters between 
men with AUDT and men with CUDT. Therefore, in our view UDT could be a spectrum of 
anomalies encompassing congenital UDT, retractile testes, and acquired UDT. This theory is 
also suggested by Hack et al. (28). They speculate that acquired UDT are actually previously 
missed congenital UDT. These testes are in scrotal position at birth in spite of a short funiculus. 
However, the testis ascends while the boy grows owing to the inadequate length of the 
funiculus. 
Testicular volume is an accepted predictor for spermatogenesis (29). In a study by Meij-de Vries 
et al. the volume of the AUDT after prepubertal orchiopexy measured by ultrasound was 
smaller than that of the contralateral healthy testis and of the normative volume described in 
the literature (30). In our study testicular volume of AUDT was significantly lower than that of 
controls, like in our previous study comparing CUDT with controls (11). Univariate analysis 
revealed no significant difference between testicular volume in the AUDT group and that in the 
CUDT group. In the multivariate analysis, however, men with AUDT had a significantly higher 
chance than men with CUDT of having a testicular volume below 15 ml. Note that a cut-off 
value of 14 ml would have resulted in no difference. Neither spontaneous decent nor 
orchiopexy or age at orchiopexy influenced later testicular volume. Meij-de Vries et al. 
reported a similar finding regarding age at orchiopexy (30).  
Reproductive hormones are indicators of testicular function and represent both testes. In our 
univariate analysis we did not find significant differences in reproductive hormones between 
unilateral and bilateral AUDT. We corrected for unilateral and bilateral UDT in our multivariate 
analyses. FSH and inhibin B are indicators of spermatogenesis, and levels were found to be 
higher and lower, respectively, in a previous study in patients with UDT (31). In our study, this 
only held true for men with bilateral AUDT in comparison with controls. Also higher LH levels 
were found in bilateral AUDT compared with controls. Lee and Coughlin found no significant 
difference in Leydig cell function between men with UDT and controls (32).  
Another method to evaluate fertility is looking at paternity. Lee et al. found a decreased 
paternity rate in men with previous bilateral UDT compared with unilateral UDT and controls 
(31). Information on paternity rates in acquired UDT has not been reported. In our study, 
controls significantly more often attempted fatherhood; this could be explained by the 
significant age difference between controls and men with AUDT. In our study relatively few 
men with AUDT attempted fatherhood. Success rates only significantly statistically differed 
between men with bilateral AUDT and controls: significantly more controls succeeded in 
becoming a father. The lack of significant differences in successful attempts to fatherhood 
between unilateral AUDT, unilateral CUDT, and controls could be caused by a power problem. 
Using paternity to evaluate fertility has some shortcomings; first female fertility should be 
taken into account; second, men with compromised fertility with a fertile partner might still be 
able to father children; and third, the man presuming to be the father may not be the biological 
father. 
This study has several limitations. First, it is uncertain whether the participants are 
representative for the whole group. Although, characteristics did not differ. Second, our 
control group might not be an optimal control group since these men are participants of a tall 
stature study, albeit without hormonal treatment. However, the inclusion rate for both our 
study as well as the tall stature study was 31%; therefore selection bias because of fertility 
problems seems unlikely. Also, tall height is associated with varicoceles (33). Controls had 
almost twice as much varicoceles compared with participants. However this was not 
statistically significant and we corrected for varicoceles in our multivariate analyses. Third, this 
study cannot answer the question what the fertility potential would have been if all patients 
were operated on immediately after diagnosis. Fourth, we tested only one sperm sample for 
each man and therefore cannot account for biological variation of semen quality in these men. 
An article by Christman et al., however, found that a single measurement might be appropriate 
to classify fertility problems in young men with a history of cryptorchidism (34).  
In conclusion fertility in men with AUDT is compromised in comparison with men with 
normally descended testes but comparable with men with CUDT. These results suggest that 
acquired UDT and congenital UDT share the same aetiology. Acquired UDT merely represent a 
part of a spectrum of UDT and is not a variant of normally descended testes. Moreover, no 
significant differences could be found between men who had AUDT which descended 
spontaneously and men needing orchiopexy. Fertility potential is unknown for men after 
immediate surgery at diagnosis; this should be the subject for future studies. 
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The aim of this study was to evaluate testicular function in men with previous acquired 
undescended testis (UDT) in whom orchiopexy was performed at diagnosis compared with a 
similar group of men in whom spontaneous descent was awaited until puberty.  
Secondly, we examined the influence of age at orchiopexy on fertility parameters in adult life. 
 
A total of 169 men of the ‘orchiopexy at diagnosis’-group and 207 men of the ‘wait-and-see’-
protocol group were invited for participation.  
All participants underwent an andrological evaluation, including medical history, physical 
examination, scrotal ultrasound, determination of reproductive hormones, and semen 
analysis.  
Results were compared for men in whom orchiopexy was performed at diagnoses with men in 
whom spontaneous descent was awaited until puberty followed by orchiopexy in case of non-
descent.   
 
In the ‘orchiopexy at diagnosis’- group 63 men, of whom 14 with bilateral UDT, and in the ‘wait-
and-see’-protocol group 65 men, of whom 15 with bilateral UDT, were included.  
 For unilateral UDT Inhibin B was found to be significantly lower and median progressive 
motility was higher in men with orchiopexy at diagnosis.  
For bilateral UDT, semen concentration and progressive motility showed a trend towards a 
favourable outcome for orchiopexy at diagnosis. 
Age at orchiopexy being under or above 10 years of age had no significant influence on the 
fertility potential.  
 
The outcome of physical examination, scrotal ultrasound, endocrine function, and semen 
analysis indicates a compromised fertility potential in men with previous acquired UDT. None 
of the protocols proved to be superior. For bilateral UDT, a trend towards favourable outcome 
of orchiopexy at diagnosis was seen. Furthermore, age at orchiopexy did not have an influence 
on fertility parameters. Therefore, in our opinion a ‘conservative policy’ is warranted for 




Undescended testis (UDT) is a common urogenital abnormality in boys and is associated with 
impaired spermatogenesis and an increased risk of testicular malignancy (1). 
Based on previous testis position UDT can be categorized in congenital and acquired forms (2,3). 
For congenital UDT, it is currently recommended to perform orchiopexy at 6-12 months of age 
(4). However, it is often performed at a later age. Up to 2/3 of these ‘late’ orchiopexies concern 
boys with acquired UDT (5,6). Surgical correction at diagnosis for acquired UDT is often advised 
(7). However, in over 50% of boys with acquired UDT spontaneous descent occurs before 
puberty (8,9). Therefore, in The Netherlands, a ‘wait-and-see’-protocol is used in which 
spontaneous descent is awaited until puberty followed by orchiopexy in case of non-descent. 
Little is known about fertility in men with acquired UDT and the effect of orchiopexy at 
diagnosis or the ‘wait-and-see’-protocol. The aims of our study were two-folded. Firstly, we 
objectified the impact of orchiopexy at diagnosis in patients with acquired UDT on fertility 
parameters in comparison with men who had had a ‘wait-and-see’-protocol for acquired UDT. 
In other words, is a ‘wait-and-see’-protocol as used in The Netherlands safe, in terms of fertility 
potential, to diminish the number of orchiopexies for acquired UDT. Secondly, we examined 
the influence of age at orchiopexy, if operated upon, on fertility parameters in adult life. 
 
Patients and methods 
All patients were part of an historical cohort. Patients were treated with one of the two 
different treatment protocols depending on the hospital they visited. Patients were 
retrospectively included in this follow-up study. Data on fertility potential was prospectively 
collected.  
 
Definition and exclusion criteria 
Acquired UDT implied that a previous normal stable scrotal position was documented at least 
once either by the Regional Youth Health Care Institution, general practitioner, or hospital. 
The most caudal testicular position after manipulation had to be non-scrotal or unstable 
scrotal position at diagnosis. 
Exclusion criteria were: previous ipsilateral inguinal or scrotal surgery, previous hormonal 
treatment, chromosomal abnormalities, and dysmorphic syndromes. Age at time of follow-up 




Between 1986-2009, boys with acquired UDT referred to the Medical Center Alkmaar and 
Juliana Children’s Hospital, The Hague were operated at diagnosis by three experienced 
paediatric surgeons.   
 
‘Wait-and-see’-protocol group 
Between 1982 and 2004, boys with acquired UDT referred to Erasmus Medical Center-Sophia 
Children’s Hospital, Rotterdam, and the Medical Center, Alkmaar, were followed by three 
experienced physicians annually until puberty. Spontaneous descent was awaited until at least 
Tanner stage P2G2, after which orchiopexy was performed in case of non-descent. Findings at 
physical examination were registered on a standardized form. Orchiopexy was performed by 
paediatric surgeons with years of experience performing orchiopexies. 
The group is described in detail in a recent article by van Brakel et al. (10). 
 
Methods 
In total 376 men (169 men from the ‘orchiopexy-at-diagnosis’-group and 207 men from the 
‘wait-and-see’-protocol group) were recruited by post. The methods for recruitment and 
andrological evaluation were published previously (10,11). Men declining participation were 
asked for their reasons to decline. Participation involved a single hospital visit at the Erasmus 
Medical Center Rotterdam, including medical history taking, physical examination, scrotal 
ultrasound, venous puncture, and semen sample delivery.  
Medical history focused on risk factors for fertility problems other than cryptorchidism and to 
the proportion of men attempting fatherhood. Physical examination and scrotal ultrasound 
were performed to measure testicular volume and to observe the presence of testicular and 
epididymal abnormalities and varicocele. Testicular volume was measured with an automated 
formula from the ultrasound machine; testicular volume = width x height x depth x 10-3 x 0.523* 
(*= 4/3π x ½ x ½ x ½). The reference value for normative testicular volume was set at 13.4 mL, 
based on previous studies in healthy adults (12-14). Testicular volume of UDT was measured; in 
case of bilateral UDT the mean testicular volume was used. The following parameters were 
evaluated: Leydig cell function, represented by luteinizing hormone (LH) (reference value 1.5-8 
IU/L) and testosterone (reference value ≥ 10 nmol/L), as well as Sertoli cell function, 
represented by follicle stimulating hormone (FSH) (reference value 2-7 IU/L) and Inhibin B 
(reference value ≥ 150 ng/L). The venous blood sample was taken, preferably before 10:00 AM 
and before 11:00 AM at the latest. 
Semen samples were produced by masturbation after at least 3 days ejaculatory abstinence. 
The following reference values were considered as normal; semen volume ≥ 1.5 mL, sperm 
concentration ≥ 15x10*6/mL and progressive motility ≥ 32% (15). 
 
Statistical analysis  
Continuous variables were tested with the Mann-Whitney U-test; categorical variables with 
Fisher’s exact test. First, characteristics of participants were compared with those of non-
participants. Second, fertility parameters (testicular volume, endocrinological values, and 
semen parameters) were compared between the men previously treated in Medical Center 
Alkmaar and the men treated in the Juliana Children’s hospital. We compared the two 
treatment protocols (orchiopexy at diagnosis vs. ‘wait-and-see’-protocol) for uni- and bilateral 
UDT separately. 
Multivariate logistic regression analyses served to test the relationship between these bivariate 
categories and their predictors; that is, the relationship between fertility parameters (bivariate 
classes: being below or above the reference value) and the predictor "type of treatment 
protocol". Known confounders such as uni-/bilateral UDT, smoking, varicocele and Body Mass 
Index (BMI) were corrected for in these analyses.  
For all operated men from either treatment group (n=96), we compared men operated under 
the age of 10 years to men operated after the age of 10 years. Multivariate logistic regression 
analyses served to analyse the relationship of fertility parameters and the predictor “operation 
before or after the age of ten years”. Type of treatment protocol was corrected for. For all 
analyses a two-sided p-value of less than 0.05 was considered statistically significant.  
 
Ethics 
The study was reviewed and approved by the Medical Ethical Review Committee at Erasmus University 





Sixty-three of 169 eligible men (37%) participated. Most non-participants mentioned time 
constraints and objection to the investigations as main reasons for refusal. Three men did not 
show up. For two men ‘having fathered children’ was a reason to decline participation. One 
man had no wish to father children and for that reason did not want to participate. Another 
man had known infertility (azoospermia) and refused to participate. There was no significant 
difference in age at recruitment, age at surgery or the proportion of bilateral UDT between 
participants and non-participants.  
In total, we included 63 patients with 77 previously operated acquired UDT (14 bilateral, 49 
unilateral). Median age at orchiopexy was 10.3 years (3.7 – 15.2). The reason for older age at 
orchiopexy was late diagnosis. One man refused to give blood.  
 
‘Wait-and-see’-protocol group 
Sixty-five of 207 eligible men (31%) participated. Most men mentioned time constraints and 
objection to the investigations as main reasons for refusal. Six men did not show up. Two men 
reported that having fathered children was a reason to decline participation. One non-
participant with bilateral acquired UDT with spontaneous descent replied that he had an 
azoospermia. There was no significant difference in age at recruitment, age at surgery or the 
proportion of bilateral UDT between participants and non-participants. 
In total, we included 65 men with 80 acquired UDT. Spontaneous descent had occurred in 32 
participants (24 unilateral and 8 bilateral). Median age at orchiopexy (N=33; 26 unilateral and 7 
bilateral) was 13.2 years (range 4.7 - 17.8 years). Most important criteria for prepubertal 
orchiopexy were inguinal complaints or ipsilateral inguinal hernia. One man was unable to 
produce semen for the study and one man refused to give blood. 
 
Unilateral UDT; orchiopexy at diagnosis vs. ‘wait-and-see’-protocol 
(Table 1) 
In the ‘orchiopexy-at-diagnosis’-group age at orchiopexy was [median (range)] 10.1 years (3.7 – 
15.2). The ‘wait-and-see’-protocol group contained 50 men with unilateral UDT of whom 26 
men had an orchiopexy as spontaneous descent did not occur. Age at orchiopexy was [median 
(range)] 12.9 years (4.8 – 17.8). Boys operated at diagnosis were significantly younger (p-value 
0.02).  
Seven men (14.3%) who underwent orchiopexy at diagnosis had a history of a venereal disease 
in comparison with none of the men after the ‘wait-and-see’-protocol (p-value 0.01).  
 
Physical examination and scrotal ultrasound  
Men who had orchiopexy at diagnosis were significantly taller [median (range) 187.5 cm (169.0 
– 203.0) vs. 184.5 cm (166.0 – 198.5); p-value 0.04], and had a lower BMI [median (range) 22.4 
kg/m2 (19.1 – 32.1) vs. 23.3 kg/m2 (17.6 – 36.8); p-value 0.04], in comparison with men after the 
‘wait-and-see’-protocol. 
 
Endocrine function  
The only significant difference was found in Inhibin B levels, which was significantly lower in 
men with orchiopexy at diagnosis [median (range) 134.0 ng/L (44.0 – 278.0) vs. 161.0 ng/L (10.0 
– 345.0); p-value 0.03]. 
 
Semen analysis 
Progressive sperm motility was significantly higher in the group with orchiopexy at diagnosis 
[median (range) 47.5% (10 - 69) vs. 45.0% (3 - 75); p-value 0.03].  
 
Bilateral UDT; orchiopexy at diagnosis vs. ‘wait-and-see’-protocol 
(Table 2) 
In the ‘orchiopexy-at-diagnosis’-group age at orchiopexy was [median (range)] 10.7 years (4.9 – 
12.8). The ‘wait-and-see’-protocol group contained 15 men with bilateral UDT of whom 7 men 
had an orchiopexy as spontaneous decent did not occur. Age at orchiopexy was [median 
(range)] 13.2 years (7.7 – 15.1). 
Men who had had bilateral UDT and orchiopexy at diagnosis did not attempt fatherhood 
significantly more often (6 out of 14 vs. 4 out of 15; p-value 0.45), however they did succeed 
significantly more often (6 out of 6 vs. 1 out of 4; p-value 0.03).  
 
Physical examination and scrotal ultrasound  
No significant differences were found in physical examination and ultrasound parameters. 
Testicular volume was smaller than the reference value of 13.4 mL in both treatment groups, 
median 8.5 mL (range 3.0 - 13.4) after orchiopexy at diagnosis; 10.9 mL (range 5.2 - 14.6) after 
the ‘wait-and-see’ protocol (p-value= 0.28). 
 
Endocrine function and semen analysis  
No significant differences were found when evaluating endocrine function and semen analysis. 
There was a notable, albeit insignificant difference in the median of concentration of 
spermatozoa of men operated at diagnosis, 22.0x10*6/mL (range 0-135), compared with 
median 8.2x10*6/mL (range 0.0-60.0) after the ‘wait-and-see’-protocol (p-value= 0.18). 
 
Multivariate regression analyses for treatment protocol 
In Table 3, we compared all outcomes of men from the ‘orchiopexy-at-diagnosis’-group with 
the ‘wait-and-see’-protocol group for fertility parameters being the normal value, corrected for 
possible confounders that is, smoking, varicocele, BMI, uni- or bilateral UDT. A relative risk < 
1.0 indicates a lower chance of having normal fertility parameters in the ‘wait-and-see’ group. 
The change of having a normal testicular volume (e.g. volume ≥ 13.4 mL) and normal Inhibin B 
level (e.g. ≥ 150 ng/L) are higher in the ‘wait-and-see’-protocol group [(Testicular volume: 
relative risk (RR) 3.19; 95% confidence interval (CI) 1.24 – 8.2, p-value 0.02) and Inhibin B: RR 
1.51; 95% CI 1.03 – 2.22, p-value 0.04]. The change of normal semen motility (≥ 32%) is higher 
in the ‘orchiopexy-at-diagnosis’-group (RR 0.80; 95% CI 0.66 – 0.97, p-value 0.02). 
The outcomes were comparable for the univariate regression analyses and the multivariate 
regression analyses. The changes of normal semen concentration (≥15 x 10*6/ml) or normal 
semen motility (≥ 32%) are higher in the group of men with a history of unilateral UDT. None of 
the other possible confounders were of significant influence on outcome.   
 
Unilateral UDT; Influence of age at orchiopexy on fertility parameters 
using a cut-off of 10 years of age 
Seventy-five men with unilateral UDT had an orchiopexy (‘orchiopexy-at-diagnosis’-group 
N=49 and ‘wait-and-see’-protocol group N=26). Thirty-two out of 75 had had orchiopexy 
before 10 years of age, at median age 6.7 years (range 3.7-9.9). Forty- three men were 
operated after 10 years at a median age of 12.8 years (range 10.0-17.8). Outcome at follow-up 
of physical examination, scrotal ultrasound, endocrine function, and semen analysis did not 
statistically differ between the age groups (data not shown). 
 
Bilateral UDT; Influence of age at orchiopexy on fertility parameters 
using a cut-off of 10 years of age 
Twenty-one men with bilateral UDT had had an orchiopexy (‘orchiopexy-at-diagnosis’-group 
N=14 and ‘wait-and-see’-protocol group N=7). Eight out of 21 men had had bilateral orchiopexy 
before 10 years of age. The median age at orchiopexy was 8.4 years (range 4.9-9.5). Thirteen 
men were operated on after 10 years at a median age of 12.4 years (range 10.4-15.1) (p-value < 
0.005). Men operated on after the age of 10 had significantly larger testicular volume at follow-
up than the men operated on before 10 years of age [median (range) 11.3 mL (3.4-13.4) and 8.0 
mL (5.3-9.5) respectively (p-value < 0.05)] Outcome of physical examination, endocrine 
function and semen analysis did not statistically differ. There was a notable, albeit insignificant 
difference in the median semen concentration, i.e. median 8.0x10*6/mL (range 0.0-42.0) for 
men operated on bilaterally under the age of 10 vs. median 26.0x10*6/mL (range 0.0-135.0) for 
men operated after the age of 10 (p-value= 0.1) 
 
Multivariate regression analyses for age at orchiopexy using a cut-off 
of 10 years of age (Table 4) 
We combined both treatment protocols and compared men who had orchiopexy before the 
age of 10 years versus orchiopexy after the age of 10 years. Changes of having normative 
fertility parameters were not statistically different between the group who had surgery before 
the age of 10 years and the group who had surgery after the age of 10 years after correction for 
possible confounders, that is, treatment protocol, smoking, varicocele, BMI, uni- or bilateral 
UDT. For LH we could not perform the multivariate analyses since only 2 men had an LH above 
the reference value. The chance of normal testicular volume was lower with increasing BMI.  
 
Additional analysis; Influence of age at orchiopexy without the outliers 
(Table 5) 
Since the difference of age at orchiopexy between the two groups was smaller than previously 
expected, we performed an additional analysis in order to evaluate the effect of age at 
orchiopexy on fertility parameters. We compared the ‘early’ diagnosed boys of the 
‘orchiopexy-at-diagnosis’-group, e.g. operated before the age of 8 years, with ‘older’ patients 
of the ‘wait-and-see’-protocol group operated after the age of 12 years. Hereby we excluded 
from the ‘orchiopexy-at-diagnosis’-group, the boys that were referred late. We excluded from 
the ‘wait-and-see’-protocol group, boys that had orchiopexy before puberty. Table 5 shows 
that no differences were found for neither of the fertility parameters for uni- or bilateral cases. 
 
Discussion 
To our knowledge, this is the first study evaluating fertility parameters in men with previous 
acquired UDT managed with either of two protocols, that is, orchiopexy performed at 
diagnosis or awaiting spontaneous descent until puberty. The outcome of physical 
examination, scrotal ultrasound, endocrine function, and semen analysis indicates a 
compromised fertility potential in men with previous unilateral or bilateral acquired UDT. 
However, differences between the two groups were small. For unilateral acquired UDT the 
‘wait-and-see’-protocol used in the Netherlands does not compromise fertility potential to a 
greater extent than does orchiopexy at diagnosis. For bilateral UDT, a trend towards 
favourable outcome of orchiopexy at diagnosis was seen, however, these results should be 
interpreted with caution as numbers were small. Furthermore, age at orchiopexy was not of 
influence on fertility parameters.  None of the protocols proved to be superior, both with 
regard to unilateral and bilateral UDT. For unilateral UDT Inhibin B, which is an indicator for 
spermatogenesis was found to be significantly lower in men with acquired UDT and orchiopexy 
at diagnosis. However, sperm concentration was comparable between treatment groups. For 
unilateral UDT, the median sperm concentration was above the WHO reference values of 15 
x10*6/mL in both groups. Nevertheless, some men with sperm counts above the lower limit of 
the normal range, defined by WHO, may in fact be subfertile.  
A population-based study of 430 first-pregnancy planners showed an increased probability of 
conception with increased sperm concentration up to 40 x10*6/mL (16). For the range of sperm 
concentrations between 15 x10*6/mL and 40 x10*6/mL, small differences may be critical. 
Therefore, men with unilateral acquired UDT in both groups may in fact be subfertile. It is 
difficult to predict fertility based on semen analyses as paternity rates are also depending on 
fertility potential of the partner.  
Alternately the difference in median progressive motility was higher in the ‘orchiopexy-at-
diagnosis’-group, nevertheless this was only 2.5%, and both median values were above 32%, 
which is the cut-off value for progressive motility according to the WHO manual (15). Therefore, 
the significant differences that were found are not explicit and even alternately indicate better 
fertility potential in the group who had had immediate orchiopexy at diagnosis and men who 
had a ‘wait-and-see’-protocol. Therefore, none of the protocols proved to be superior in terms 
of fertility potential.  
For bilateral UDT, the only significant difference was found for successful attempt to 
fatherhood in favour of the ‘orchiopexy-at-diagnosis’-group.  Furthermore, semen 
concentration and progressive motility also showed a favourable outcome for the orchiopexy 
at diagnosis group. The wide range of sperm concentrations in this small group of men may 
have caused the striking but insignificant, difference in median concentration. The results 
between the bilateral groups should be interpreted carefully because of the small numbers.  
In the multivariate regression analyses, we corrected for uni and bilateral UDT. The chance of a 
normal testicular volume and Inhibin B level was higher in the ‘wait-and-see’- protocol group. 
Alternately, the chance of normal motility was higher in the ‘orchiopexy-at-diagnosis’-group.  
Orchiopexy and its impact on fertility has been studied extensively (17). However, most studies 
did not differentiate between congenital and acquired UDT. There is increasing evidence that 
acquired UDT and congenital UDT share the same aetiology (18,19). Our results seem to confirm 
this, implicating that acquired UDT is not a variant of normally descended testes without 
pathological consequences. In the present study, fertility potential appeared to be 
compromised in men with previously acquired UDT. Median testicular volume in all evaluated 
groups was smaller than the norm value of 13.4 mL (12-14). For reproductive hormones, median 
Inhibin B was lower than 150 ng/L for both unilateral and bilateral UDT after orchiopexy at 
diagnosis and for men with bilateral UDT who had the ‘wait-and-see’-protocol. Semen analysis 
showed that oligozoospermia occurred in 27 and 43% of, respectively the uni- and bilateral 
group who had orchiopexy at diagnosis. After the ‘wait-and-see’-protocol, oligozoospermia 
occurred in 38 and 67% of, respectively, the uni- and bilateral group. Astenospermia was found 
in 11% of the uni- and in 23% of the bilateral group who had orchiopexy at diagnosis and in, 
respectively, 22 and 57% of the uni- and bilateral group after ‘wait-and-see’-protocol. This 
study shows that fertility parameters were impaired with respect to cut-off values used in the 
literature, irrespective of the protocol used.  
Fewer fertility problems were expected in acquired UDT because the crucial development of 
type A spermatogonia for future fertility has probably already occurred during the first year of 
life before the ascent occurs (1,17). However, biopsies of acquired UDT showed similar 
histopathological changes as biopsies of congenital UDT (19). So far, no evidence is available 
that fertility improves with treatment at diagnosis in acquired UDT. The recommendation of 
surgical correction at the time of diagnosis for acquired UDT is mainly based on the supposed 
negative influence of the thermal inguinal environment on testicular development and future 
spermatogenesis (3,20,21). Conversely, a conservative attitude for acquired UDT has also been 
advocated, restricting orchiopexy to cases of non-descent at puberty.  At puberty, 
spontaneous descent will occur in 50-75% of the patients (8,9,22). In such cases, surgery is 
redundant. In the study group of the ‘wait-and-see’-protocol spontaneous descent had 
occurred in 50% of the included men. Fertility potential did not differ between men who had 
spontaneous descent and men who underwent orchiopexy after the ‘wait-and-see’-protocol 
(10).  
Regarding unilateral UDT, age at orchiopexy in the ‘orchiopexy-at-diagnosis’-group was 
significantly lower than that in the ‘wait-and-see’-group, although the difference in median 
age at orchiopexy was relatively small.  Some men in the former group were relatively old at 
diagnosis, whereas in the latter group ,some were at prepubertal age at orchiopexy. Reasons 
to perform prepubertal orchiopexy were inguinal complaints or ipsilateral inguinal hernia (10). 
Apparently this is the clinical practice in which acquired UDT can become obvious at later age 
and on the other hand reasons for performing orchiopexy at prepubertal age despite the 
intention to await spontaneous descent. As the difference of age at orchiopexy between the 
two groups (egg., ‘orchiopexy-at-diagnosis’-group and ‘wait-and-see’-group) was smaller than 
previously expected, we performed an additional analysis in order to evaluate the effect of age 
at orchiopexy on fertility parameters. We compared the ‘early’ diagnosed boys of the 
‘orchiopexy-at-diagnosis’-group, for example, operated before the age of 8 years, with 
patients of the ‘wait-and-see’-protocol group operated after the age of 12 years. No 
differences were found for neither of the fertility parameters. When evaluating fertility 
parameters between men operated before and after the age of ten from the complete group of 
men who had had orchiopexy, we only found that men with bilateral UDT operated after the 
age of 10 years had a higher testicular volume. In the multivariate analysis normative values 
were not significantly more often found in either group. 
In the literature variable effects of younger age at orchiopexy in congenital UDT are 
documented. While some studies suggest a positive effect on fertility parameters later in life 
(23-25), others cannot find a favourable effect of early treatment (11,26-29). To our knowledge, no 
previous studies have examined the effect of age at orchiopexy in boys with acquired UDT.  
This study addresses fertility potential in men with acquired UDT. The risk of testicular cancer 
and especially the potential different risk of developing a testicular malignancy between the 
two treatment protocols fall out of the scoop of this article. 
Several limitations of this study need to be addressed. Unfortunately this study is not a 
randomised controlled trial. We included patients from two historical cohorts, treated with two 
different protocols. Prospectively patients were included for follow-up, comparing long-term 
outcome of both treatment protocols.  
Participation rates of the two protocol groups (33 vs. 30%) were comparable, also with earlier 
published studies (11,30).   Reasons for non-participation may have introduced a selection bias. 
However, this selection bias can give either an overestimation or an underestimation of fertility 
potential as suspected infertility or prolonged intent to attempt fatherhood can be a reason for 
both participation and refusal. Therefore, we presume that the risk for selection bias because 
of fertility problems is the same in both protocol groups.  
The difference of age at orchiopexy between both treatment protocols was small,  
despite the aim to perform immediate orchiopexy at diagnosis in one treatment protocol. This 
observation underlines that in clinical practice patients with acquired UDT may be diagnosed 
at later age for the first time.  Another confounding factor is the unknown time between 
acquirement of UDT and diagnosis, those who were operated soon after diagnosis may have 
had UDT for a longer time.  
Using paternity for the evaluation of fertility potential is another limitation as it has 
shortcomings; it measures the function of the whole male and female fertility potential. 
Besides, a presumed father may not be the biological father. 
Lastly, each man produced only one sperm sample for analysis and we are therefore not 
informed about the biological variation of semen quality. However, a recent study has shown 
substantial agreement between consecutive semen analysis in young men (31).  
 
 Conclusion 
Fertility potential in men with a history of acquired UDT in whom spontaneous descent is 
awaited until puberty is compromised to a degree comparable as in men in whom orchiopexy 
at diagnosis is performed. Our results for unilateral UDT illustrate that acquired UDT merely 
represents part of a spectrum of UDT and that orchiopexy at diagnosis does not seem to 
restore the long-term outcome on fertility parameters. Age at orchiopexy, which was relatively 
late in both groups, did not seem to have influenced fertility potential later in life. As a result of 
several confounding factors in our study, no strong recommendations can be made based on 
these data for neither treatment, in our opinion a ‘conservative policy’ is warranted for 
unilateral UDT, because over 50% of acquired UDT descend spontaneously and orchiopexies 
can be omitted. For bilateral UDT, although no significant differences were found in favour of 
either of the groups, we cannot advice for a ‘conservative policy’ as these results are based on 
small numbers.  
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In previous reports no difference in Leydig and Sertoli cell function was found between 
congenital undescended testis (CUDT) and acquired UDT (AUDT) on basis of levels of 
luteinizing hormone, testosterone, follicle stimulating hormone or inhibin B. The present study 
was set out to detect differences in Leydig and Sertoli cell function between CUDT and AUDT 
using Insulin-like peptide 3(INSL3) and Anti-Müllerian hormone (AMH) serum levels.  
Serum samples of 118 men with a history of UDT (CUDT N=55 of whom 6 bilateral, AUDT N=63 
of whom 15 bilateral) were investigated. Firstly, differences between CUDT and AUDT were 
analysed. Secondly, influence of age at surgery in CUDT and effect of spontaneous descent or 
orchiopexy in AUDT were evaluated.  
For INSL3, no significant differences were found between the various groups of patients. 
However the bilateral congenital UDT group was very small. AMH was significantly higher in 
men with unilateral CUDT who had their orchiopexy before 24 months of age compared with 
after 24 months of age (16.8 (3.9 – 43.7) (median and range) vs 10.1 (2.4 – 40.4) μg/l, p=0.02).  
AMH levels in bilateral CUDT were significantly lower compared with bilateral AUDT (6.4 (1.7 – 
11.4) vs 13.2 (6.1 – 30.1) μg/l, p=0.02). When comparing unilateral CUDT with bilateral CUDT, 
AMH levels in unilateral CUDT were significantly higher (12.1 (2.4 – 43.7) vs. 6.4 (1.7 – 11.4) μg/l, 
p=0.02).  
It is concluded that no differences in Leydig cell function between the different UDT groups 
were found on basis of INSL3 levels. Sertoli cell function evaluated by AMH, was more 
negatively affected in bilateral CUDT in comparison with bilateral AUDT and in bilateral CUDT 
in comparison with unilateral CUDT. Moreover, in unilateral CUDT earlier orchiopexy positively 
influenced Sertoli cell function. 
Introduction 
Undescended testis (UDT) is a frequent urogenital abnormality in boys and can be of 
congenital or acquired origin (1-3). In congenital UDT a stable scrotal position was never 
reached. Acquired UDT is defined as a palpable UDT that previously had a normal scrotal 
position, as documented by a physician. Acquired UDT is seen in 1-3% of boys during childhood 
(4,5) and its aetiology, natural course, and treatment are still debated. The proportion of (pre) 
pubertal spontaneous descent in boys with acquired UDT is between 57% and 71% (6,7). Men 
with a history of UDT have a higher risk of developing impaired fertility later in life (8,9). It was 
suggested that men with acquired UDT might have fewer fertility problems, since their testes 
initially descended and the crucial development of type A spermatogonia had probably already 
occurred during the first year of life before the testes ascended (10). However, in our previous 
long-term follow-up study no statically significant differences in traditional fertility parameters 
were seen between men with congenital and acquired UDT (11). In that study, we evaluated 
Leydig cell function by measuring serum levels of luteinizing hormone (LH) and testosterone. 
Serum follicle stimulating hormone (FSH) and inhibin B (InhB) were used to evaluate Sertoli 
cell function. In the present study we more extensively evaluated endocrinological function 
(e.g. Insulin-like peptide 3 (INSL3), Anti -Müllerian hormone (AMH), sex hormone binding 
globulin (SHBG), oestradiol)  in the same group of patients to discover whether more subtle 
differences in Leydig cell and Sertoli cell function between different patient groups with UDT 
can be found. These endocrinological results were not reported previously. 
INSL3, produced by Leydig cells, is essential for the abdominal part of testicular descent (12-14).  
At adult age, INSL3 has been suggested to be a more sensitive parameter to detect impaired 
Leydig cell function than testosterone, since  men with hypospermatogenesis had normal 
levels of testosterone and LH but reduced INSL3 levels (15-19). AMH is produced by Sertoli cells. 
Lower serum AMH levels were found in subfertile men (20). In healthy men, serum AMH cannot 
discriminate between fertile and infertile men; serum AMH does not show a correlation with 
impaired spermatogenesis (21,22). However in men with UDT, AMH has been suggested to be a 
marker for Sertoli cell function (23). In the present study we set out to detect differences in 
Leydig and Sertoli cell function between congenital and acquired UDT on basis of INSL3 and 
AMH serum levels. In addition, we evaluated the influence of age at surgery in men with 
congenital UDT on these parameters as well as their association with spontaneous descent or 
orchiopexy in acquired UDT. Also correlations of INSL3 and AMH with levels of other 
hormones of the pituitary-testis axis, semen parameters and testicular volume were 
investigated.  To our knowledge, this is the first study to evaluate these specific hormone 
levels in adult men with a history of congenital or acquired UDT. 
 
Material and methods 
Patients 
Men with a history of congenital or acquired UDT who participated in two long term follow-up 
studies on fertility potential performed at the Erasmus Medical Center were included 
retrospectively (11,24). Data on hormone concentrations were prospectively collected between 
2005 and 2010. Inclusion and exclusion criteria of participants in these studies were described 
previously (11,24). Figure 1 shows an overview of included men. In the present study only men 
with two testes at follow-up were included. In short: The congenital UDT group (N=56, of 
whom 6 bilateral UDT)  consisted of men who participated in a study evaluating fertility 
potential after treatment (24). Subjects in that study were part of a historical cohort of boys who 
underwent orchiopexy during childhood at various ages and boys operated on before two 
years of age (25). Median age at orchiopexy was 3.3 years (range 0.1 to 14.6 years). The acquired 
UDT group (N=64, of whom 15 bilateral UDT) consisted of men who participated in a study 
evaluating fertility potential in men with previously acquired UDT after follow-up  during 
childhood (11). Subjects in that study were part of a historical cohort with men with acquired 
UDT who had annual follow-up examination until puberty (6). For acquired UDT this implies 
that a previously normal stable scrotal position was documented at least once at birth and/or 
at follow-up either by the Regional Youth Health Care Institution, general practitioner, or 
medical specialists. Furthermore, at inclusion the testis had to be palpable without ipsilateral 
inguinal clinically present pathological findings or previous ipsilateral inguinal surgery, and the 
most caudal testicular position after manipulation had to be non-scrotal or unstable scrotal. 
Spontaneous descent was awaited until at least Tanner stage P2G2 and followed by 
orchiopexy in case of non-descent. Spontaneous descent had occurred in 32 participants, of 
whom 8 had had bilateral UDT. Median age at orchiopexy in 32 participants (25 unilateral and 7 
bilateral) was 13.3 years (range 4.75 to 17.8 years). For both historical cohorts maximum effort 
was taken to ascertain previous testicular position at inclusion for the initial study (6,25). 
Blood analysis  
A venous blood sample was taken, preferably before 10:00 AM and before 11:00 AM at the 
latest. Serum samples were assayed for INSL3 using radioimmunoassay (Phoenix 
Pharmaceuticals, Burlingame, CA, USA). AMH was measured using an in-house enzyme 
immunometric assay (Gen II, Beckman-Coulter, Webster, TX, USA) as previously described (26), 
LH,  FSH and sex hormone binding globulin using fluorescence-based immunometric methods 
(Immulite 2000, Siemens-DPC, Los Angeles, CA, USA), testosterone and oestradiol using 
coated tube based radioimmunoassays (Siemens-DPC), and InhB using an enzyme-
immunometric method (Oxford BioInnovation, Oxford, UK). Reference ranges for all hormone 
concentrations are given in Table 1. All reference ranges were from the laboratory where the 
assays were performed, with the exception of those for INSL3, where literature data obtained 
with the same assay were used (15) . Intra- and interassay coefficients of variation for the 
various assays were as follows: INSL3 <9%, AMH < 5 and <10%, LH < 5 and <11%, FSH <3 and 
<8%, SHBG < 4 and <5%, testosterone <3 and <5%, oestradiol < 5 and <7%, and InhB <9 and 
<15% , respectively. Concentrations of non-SHBG bond testosterone and oestradiol were 
calculated using the method described by de Ronde et al. with a fixed concentration for 
albumin of 42 g/l (27).  
 
Semen analysis 
Semen samples were analysed according to the WHO-manual of 2010 (28). The following 
reference values were considered as normal; semen volume ≥ 1.5 ml, sperm concentration ≥ 




Differences in hormone levels between different groups were analysed using the Mann-
Whitney U test. Firstly, we compared hormone levels between the congenital UDT group and 
acquired UDT group. Secondly, we evaluated the influence of age at surgery in the congenital 
group by comparing men who were operated before 12 months of age vs after 12 months of 
age, before 18 months of age vs after 18 months of age, and before 24 months of age vs after 
24 months of age.  Lastly, in the acquired group we compared men who had spontaneously 
descended UDT with men who needed orchiopexy. We performed these analyses for unilateral 
and bilateral UDT separately. Subsequently, we compared hormone levels in the groups with 
unilateral and bilateral UDT with each other in the congenital and the acquired UDT group. 
Furthermore, we evaluated correlations between the levels of INSL 3 and AMH and the 
concentrations of the other hormones, semen parameters, and total testicular volume using 
Spearman Rank Correlation test followed by partial correlation analyses. For all analyses a 
two-sided p-value of less than 0.05 was considered statistically significant. Statistical analysis 
was performed with IBM SPSS Statistics version 21.  
 
Results 
Figure 1 shows an overview of included men and missing data. When comparing hormone 
concentrations in our patients with the reference ranges the following results were notable: in 
4 out of the 96 men (4.2%) in whom INSL3 was known, the INSL3 level was normal, all others 
had INSL3 levels below the lower limit of the reference range. Over 80% of men had a normal 
AMH level (unilateral congenital UDT N=39 (80%), bilateral congenital UDT N=5 (83%), 
unilateral acquired UDT N=39 (80%), and bilateral acquired UDT N=13 (87%). FSH was above 
the reference range in approximately half of the patients with bilateral UDT (congenital UDT 
N=3 (50%), acquired UDT N=7 (47%)) in comparison with approximately 30% in the unilateral 
groups (congenital UDT N=14 (29%), acquired UDT N=15 (31%). InhB levels were more often 
below the lower limit of the reference range in the bilateral UDT groups than in the unilateral 
UDT groups and more often in the congenital groups than in the acquired groups (unilateral 
congenital UDT N=23 (47%), bilateral congenital UDT N=4 (67%), unilateral acquired UDT N=19 
(39%), and bilateral acquired UDT N=8 (53%)). 
 
Unilateral UDT 
Congenital UDT vs Acquired UDT (Table1) 
Oestradiol levels in congenital UDT patients were significantly higher compared with those in 
the acquired group (p = 0.005). All other hormone concentrations, including non-SHBG bound 
oestradiol, did not show statistically significant differences. 
Congenital UDT; influence of age at orchiopexy (Table 2) 
AMH was significantly higher in men who had had their orchiopexy before the age of 24 
months (p = 0.02). LH was significantly higher in men operated before the age of 18 months (p 
= 0.03). Oestradiol was significantly lower in men operated at younger age (orchiopexy <12 
months vs orchiopexy >12 months: p = 0.001; orchiopexy < 18 months vs orchiopexy > 18 
months: p-value <0.001; and orchiopexy < 24 months vs orchiopexy > 24 months: p = 0.009). 
Non-SHBG bound oestradiol, did not show statistically different values. 
Acquired UDT; spontaneous descent vs orchiopexy (Table 3) 
LH was significantly higher in men who had had a spontaneous descent in comparison with 
men who needed orchiopexy (p = 0.04). None of the other measured hormones showed 
statistically different concentrations. 
 
Bilateral UDT  
Congenital UDT vs Acquired UDT (Table 1) 
AMH levels in congenital UDT were significantly lower compared with those in the acquired 
group (p = 0.02). Non-SHBG bound testosterone levels in men with congenital UDT were 
significantly lower compared with those in the acquired UDT group (p = 0.01). None of the 
other measured hormones showed statistically different concentrations 
Congenital UDT; influence of age at orchiopexy 
None of the measured hormones showed statistically different concentrations when analysing 
the different age groups (data not shown). However, we included only 6 men with bilateral 
congenital UDT, of whom one patient had been operated at 17 months of age and the other 5 
patients after 24 months of age.  
Acquired UDT; spontaneous descent vs orchiopexy (Table 3) 
No significant differences were found in hormone concentrations between men whose testis 
descended spontaneously in comparison with men who needed orchiopexy. 
 
Unilateral versus bilateral UDT (Table 1) 
Only in the congenital group significant differences were found comparing the unilateral UDT 
group with the bilateral UDT group. AMH levels in the unilateral UDT group were significantly 
higher compared with the bilateral group (p = 0.02). Non-SHBG bound testosterone levels in 
the unilateral group were significantly higher compared with those in the bilateral group (p = 
0.02). In the acquired group no significant differences between unilateral and bilateral UDT 
were found. 
 
Correlation between concentration of INSL3 and AMH with the other 
hormone levels, semen parameters, and total testicular volume 
Levels of INSL3 were positively correlated with LH (N=96, correlation coefficient (CC) 0.22, p = 
0.03), FSH (N=96, CC 0.233, p = 0.02), testosterone (N=96, CC 0.303; p = 0.003), non-SHBG 
bound testosterone (N=95, CC 0.332, p = 0.001), and negatively with  InhB (N=96, CC -0.234, p 
= 0.02). No significant correlation was found when performing partial correlation between 
INSL3 and LH after correction for FSH or between INSL3 and FSH correcting for LH. A 
significant correlation between INSL3 and testosterone was found when performing partial 
correlation correcting for LH (Correlation 0.22, degrees of freedom 93; p = 0.03).  
AMH was negatively correlated with LH (N=116, CC -0.185, p = 0.05), FSH (N=116, CC -0.47; p = 
<0.001), oestradiol (N=115, CC -0.208; p = 0.03),and positively with InhB (N=116, CC 0.413; p 
<0.001), semen concentration (N=114, CC 0.239; p = 0.01), semen motility N=109, CC 0.249; p = 
0.009), and total testicular volume (N=116, CC 0.394; p <0.001). A significant correlation was 
found when performing a partial correlation for AMH and FSH correcting for LH (Correlation – 
0.362, degrees of freedom 113; p <0.001). No significant partial correlation was found for AMH 
and LH when correcting for FSH.  After performing a partial correlation for AMH and InhB 
corrected for FSH no significant correlation was found. This was also seen for the correlation 
between AMH and semen concentration corrected for InhB.  
 
Discussion 
In this study we evaluated Leydig and Sertoli cell function using INSL3 and AMH respectively. 
The concentrations of these hormones might reflect functional status of both Leydig and 
Sertoli cells more accurately than LH, testosterone, FSH, and InhB, which we used in our 
previous study and  therefore might uncover more subtle differences between congenital and 
acquired UDT. In our previous study no explicit differences were found in semen parameters 
when comparing different congenital and acquired UDT groups (11,24). However, we did find 
that bilateral UDT patients were more negatively affected with regards to semen parameters 
than men with previously unilateral UDT. In the present study, INSL3 showed impaired Leydig 
cell function for both congenital and acquired UDT. However, INSL3 could not discriminate 
between the different UDT groups. In bilateral congenital UDT in comparison with bilateral 
acquired UDT Sertoli cell function analysed on basis of AMH was more negatively affected. 
This was also the case for bilateral congenital UDT in comparison with unilateral congenital 
UDT. AMH showed a possible advantage for early surgery in unilateral congenital UDT. 
Testicular descent is mostly described as a biphasic process with a transabdominal and an 
inguinoscrotal phase (14,29). INSL3 controls the transabdominal phase (12-14). Age-related 
patterns of testosterone and INSL3 are comparable: a small increase during mini puberty, very 
low during childhood, increasing during puberty and high levels in adults (30). Foresta et al. 
found that INSL3 was lower in men with testicular damage involving Leydig cells and men with 
hypospermatogenesis when compared with normal adult men (15). In the present study, 
although most INSL3 levels were low no significant differences were found in INSL3 levels 
between the different UDT groups.  However, this data should be interpreted with caution 
since the groups are small, especially the bilateral groups, and this could possibly cause false 
negative conclusions. Non-SHBG bound testosterone in men with bilateral congenital UDT had 
significantly lower concentrations compared with men with bilateral acquired UDT, possibly 
indicating that Leydig cell function in congenital UDT is more affected than in acquired UDT. In 
the congenital group men with unilateral UDT had higher non-SHBG bound testosterone 
compared with men with bilateral UDT. This may indicate that Leydig cell function in bilateral 
UDT is more affected than in unilateral UDT in congenital UDT. We found significant positive 
correlations between INSL3 and LH, testosterone, and non-SHBG bound testosterone and a 
negative correlation with InhB. Foresta et al. described a positive correlation between INSL3 
and LH and testosterone in normal men (15).  Bay et al. found a positive correlation between 
INSL3 and testosterone in the general population and in men with normospermia but not in 
infertile men when evaluating correlations between INSL3 with LH, FSH, testosterone and 
InhB (31). However, they found no correlation between INSL3 and semen parameters conform 
our data (31). Since INSL3 correlates with testosterone and LH and not with semen parameters 
in normal men and men with a history of UDT, the additional clinical value of INSL3 to evaluate 
Leydig cell function is questionable.  
AMH is secreted by immature Sertoli cells and is responsible for regression of de Müllerian 
ducts (32). In boys, AMH steeply increases during the first few months of life, followed by a 
decline to a stable relatively high level until puberty. Under the influence of testosterone, 
between Tanner stage T2 and T3 AMH levels rapidly decline to a low stable level in adulthood 
(33-35). In adult men, AMH levels are indicative for the total number of Sertoli cells (34,36). Lower 
AMH serum levels are found in subfertile men in comparison with controls (20). In the congenital 
UDT group we found that men with unilateral UDT had higher AMH levels than those with 
bilateral UDT and in the unilateral congenital UDT group AMH was significantly higher in men 
operated before the age of 24 months. This implies that Sertoli cell function at adult age is 
better when patients with congenital UDT are operated at younger age. This, however, did not 
result in statistically significant differences in FSH, InhB and semen parameters as was shown 
previously (24). When comparing the UDT groups, the bilateral congenital UDT group had 
significantly lower AMH levels compared with the bilateral acquired UDT group. Sertoli cell 
function in congenital UDT is apparently more severely affected than in acquired UDT. This is 
also the case for bilateral UDT vs. unilateral UDT. However, the data on AMH levels in bilateral 
UDT should be regarded with caution since only 6 men were included with bilateral congenital 
UDT. In the literature, as in our study, a negative correlation between AMH and FSH and a 
positive correlation between AMH and InhB, semen concentration, motility and total testicular 
volume in serum from fertile men, infertile men and men with UDT is found (23,37). Plotton et al. 
described that AMH was negatively correlated with FSH and positively with InhB, total 
testicular volume, and bioavailable testosterone in patients with genetic spermatogenic failure 
but not in patients with cytotoxic azoospermia (38). These observations lead to the suggestion, 
that AMH is a measure of the number of Sertoli cells present, whereas InhB depends on both 
Sertoli cell number and the quality of spermatogenesis. In this way, low numbers of Sertoli 
cells will lead to decreased AMH levels, as found in the bilateral congenital UTD patients and in 
the unilateral congenital UTD patients operated after 24 months of age.  In a review by Sharpe 
et al. two periods of increasing Sertoli cell numbers before adulthood are described: the first is 
until approximately 18 months of age and the second just before puberty (39). In our results 
boys operated after 24 months had lower AMH levels at adult age compared with boys 
operated before the age of 24 months, possibly indicating a defect in proliferation of Sertoli 
cells when the testis is non scrotal during the first months of life. 
The present study has some shortcomings. The groups, especially bilateral UDTs  are relatively 
small.  For example, for bilateral congenital UDT only 6 men were included. We are aware that 
hard statistically significant conclusions cannot be made. We advise further evaluation of AMH 
in a bigger group of men with a history of UDT to confirm our results. Furthermore, due to 
logistical problems INSL3 measurements were not performed in all patients. Also, we have no 
reference values for INSL3 from our own laboratory but used data from the literature. Despite 
this we think this study adds to the current literature for the following reasons: [1] it is the first 
study to report on both INSL3 as well as AMH in a group of adults with a history of congenital 
or acquired UDT, [2] to our knowledge this is the largest study regarding INSL3 and AMH in 
men with UDT, [3] it reports on a group of patients with congenital and acquired UDT instead 
of a group with UDT in whom previous testis position has not been taken into account, and [4] 
uni- and bilateral UDT are considered separately. 
In conclusion, Leydig cell function evaluated by INSL3 showed impairment for congenital and 
acquired UDT but did not discriminate between the different UDT groups. Sertoli cell function 
evaluated using AMH, was more negatively affected in bilateral congenital UDT in comparison 
with bilateral acquired UDT and in bilateral congenital UDT in comparison with unilateral 
congenital UDT. Moreover, in unilateral congenital UDT earlier orchiopexy positively 
influenced Sertoli cell function.  
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Previous follow-up studies showed no statistical differences in traditional fertility parameters 
between men with congenital undescended testis (CUDT) and men with acquired undescended 
testis (AUDT). In this study we evaluated differences in sperm DNA damage between CUDT 
and AUDT using Sperm Chromatin Structure Assay (SCSA). In addition, we evaluated the 
influence of age at orchiopexy in men with CUDT and the difference between men whose testis 
descended spontaneously and men who needed orchiopexy after a ‘wait-and-see’-protocol 
(e.g. awaiting spontaneous descent until puberty and perform an orchiopexy in case of non-
decent) in AUDT on sperm DNA damage. 
 
Material and methods 
In 50 men with CUDT and 49 men with AUDT the DNA fragmentation index (DFI) was 
measured. 22 healthy proven fertile men served as controls. Decreased fertility potential was 
considered if DFI was above 30%.  
 
Results 
Sperm DNA damage in CUDT and AUDT was not statistically different. DFI was higher in the 
complete group of congenital UDT and men with bilateral congenital UDT in comparison with 
a control group. Age at orchiopexy in CUDT had no statistical effect on DNA damage. In AUDT 




This study supports the hypothesis that UDT is a spectrum containing congenital UDT and 
acquired UDT. Early treatment during childhood for congenital UDT and the outcome of a 
‘wait-and-see’-protocol for acquired UDT has no influence on sperm DNA damage at adult age. 
Introduction 
Undescended testis (UDT) is a common urogenital abnormality. A distinction into two different 
types of UDT can be made (1,2). Approximately, 1% of boys at the age of one year have a 
congenital UDT (3). Moreover, 1-3% of boys with a previously normally descended testis 
develop UDT during childhood, an acquired UDT (4,5). Men with a history of UDT have a higher 
risk of developing impaired fertility later in life (6,7). Little is known about the differences in 
fertility potential between patients with congenital UDT and acquired UDT. In our previous 
long-term follow-up study no statically differences in traditional fertility parameters were seen 
between men with congenital and acquired UDT (8). Therefore, we hypothesized that acquired 
UDT and congenital UDT share the same aetiology.  
Conventional semen analysis is the routine test to diagnose sub- or infertility in males. 
However semen analysis has limitations such as inter-individual variations as well as large 
inter- and intralaboratory variability (9,10). Moreover classic semen parameters are poor 
predictors for fecundity (11). Semen quality can also be evaluated by determining sperm DNA 
damage. A review showed that sperm DNA damage testing can be used as a discriminator for 
fertility potential, since the level of sperm DNA damage correlates with spontaneous 
pregnancy and results of intra-uterine insemination (12). Also, the biological variation of sperm 
DNA fragmentation is lower than conventional semen parameters (13). 
In this study we aimed to explore the differences in sperm DNA damage between congenital 
and acquired UDT, using Sperm Chromatin Structure Assay (SCSA). Since in our previous 
studies no differences in traditional fertility parameters were found, we hypothesize that we 
will not find differences in the level of sperm DNA damage between the different groups 
either. In addition, we evaluated the influence of early or late orchiopexy in men with 
congenital UDT on sperm DNA damage levels, as well as the difference between men whose 
testis descended spontaneously and men who needed orchiopexy in acquired UDT. Finally, the 
sperm DNA levels in men with a history of UDT attempting fatherhood were evaluated. To our 
knowledge, this is the first study to determine fertility potential, by using SCSA, in men with a 
history of congenital and acquired UDT. 
 
Material and Methods 
Participants 
Men with a history of congenital or acquired UDT who participated in two long term follow-up 
studies on fertility potential performed at the Erasmus Medical Center were included (8,14). 
These men were invited to visit the andrology outpatient clinic for fertility screening, which 
included medical history taking, physical examination, scrotal ultrasound, determination of 
reproductive hormones, and semen analysis. Inclusion of participants in both studies was 
described previously. In short: the congenital UDT group  (N=62) consisted of men who were 
treated for congenital UDT during childhood by orchiopexy at various ages (14). Participants in 
the acquired group (N=65) were men who were diagnosed with acquired UDT as a child for 
which they were referred to the Erasmus Medical Center-Sophia Children’s Hospital and 
Medical Center Alkmaar (8). They were offered follow-up annually until puberty. Spontaneous 
descent was awaited until at least Tanner stage P2G2 and followed by orchiopexy in case of 
non-descent. Acquired UDT was defined as an UDT for which at least twice youth health care 
physicians had documented a previous scrotal position. 
Twenty-two healthy proven fertile men served as controls and donated a semen sample for 
sperm DNA fragmentation prior to vasectomy. The study was reviewed and approved by the 
Medical Ethical Review Board at Erasmus University Medical Center in Rotterdam (MEC 
number 2004-206). Written informed consent was obtained from all men who agreed to 
participate in the study.  
 
Semen analysis 
A semen sample was produced by masturbation after a 3-5 day ejaculatory abstinence. These 
samples were analysed according to the WHO-manual of 2010 (15). Within one hour, after 
liquefaction, sperm concentration (reference value ≥15 10*6/ml), total sperm count (reference 
value ≥39 10*6/ ejaculate), progressive motility (reference value ≥32%), and morphology 
(reference value ≥4% normal forms) were determined.  
 
Sperm Chromatin Structure Assay (SCSA) 
For the SCSA analysis part of the ejaculate was stored at -80°C. Sperm DNA fragmentation 
was assessed using SCSA previously described by Evenson and Jost (16). A FACScan from 
Becton Dickinson (San Jose, CA, USA) was used to perform the SCSA. Frozen semen samples 
were quickly liquefied in a warm water bath of 37°C and diluted to a concentration sperm cells 
of 1 - 2x106/ml. After exposure to acid detergent solution the sample was stained with acridine 
orange. Three minutes after adding the acid detergent solution, data collection of the 
fluorescence patterns in 5000 cells was done. As recommended by Evenson and Jost bacteria, 
leucocytes and debris were removed from the total cell count during acquisition. A reference 
sample was used to adjust the voltage gains of the flow cytometer FL3 and FL1 
photomultipliers that analyse red and green fluorescence respectively before the actual sample 
and after every 5 - 10 samples. The reference sample was used to adjust the voltage gains to 
acquire stable mean red (X) and green (Y) values at 110 and 370 channels, respectively, with a 
maximum discrepancy of five channels. If the fluorescent signal of the reference sample drifted 
the voltage gains were re-adjusted. The DNA fragmentation index (DFI) expresses the amount 
of sperm DNA damage and is a reflection of red fluorescence to total fluorescence. The DFI 
was calculated using Cell Quest Pro and Winlist software. Each sample was measured twice 
and the mean of both DFI’s was used for analysis. Decreased fertility potential was considered 
if DFI was above 30% (17,18).  
 
Statistics 
Mann-Whitney U test and Fisher’s exact test 
Continuous variables were tested with the Mann-Whitney U test; categorical variables with 
Fisher’s exact test. When analysing the level of sperm DNA damage the median DFI was used 
as a continuous variable and furthermore the cut off value of 30% was used to dichotomize the 
DFI. The difference in DFI was analysed between participants with congenital and acquired 
UDT and a control group. Also the influence of age at orchiopexy before and after 12 months, 
18 months and 24 months of age in the congenital group, and the effect in the acquired group 
of orchiopexy or spontaneous descent was evaluated. Furthermore the difference in DFI 
between men who succeeded in attempting fatherhood was compared with men who were 
unsuccessful. 
Logistic regression analysis 
To evaluate the effect of the type of UDT (congenital or acquired) on sperm DNA damage we 
modelled the percentage of sperm DNA damage as a function of other measured or otherwise 
known variables. We performed a logistic regression model in which sperm DNA damage is 
categorized as poor fertilizing potential or normal fertilizing potential using the 30% threshold 
for the percentage of DNA damage.  
We corrected for age, smoking, varicocele, FSH, inhibin B, leucocytes in the ejaculate, days of 
ejaculatory abstinence, BMI, sperm concentration, sperm motility, and sperm morphology (19-
28). A backwards elimination procedure was used to delete insignificant variables (using a p-
value threshold of 0.2). Another independent variable was uni-/bilateral UDT. For all analyses a 
two-sided p-value of less than 0.05 was considered statistically significant. The statistical 
analyses were performed with SPSS 15.0 (SPSS Inc., Chicago, Il) and with Stata Data Analysis 
and Statistical Software v.11.0 (StataCorp, College Station, TX, USA). 
 
Results 
Figure 1 shows the inclusion of 127 men for this study including the reasons why in 28 men the 
DFI was unknown (Figure 1). In 99 men the DFI was successfully measured in duplo (congenital 
group N=50 and acquired group N= 49). Table 1 shows the traditional semen analyses for the 
congenital group (N=62) and the acquired group (N=63, 2 men excluded due to no ejaculate), 
unilateral and bilateral UDT separately. The median values of the traditional semen 
parameters were around WHO reference cut-off values in both unilateral groups. Median 
concentration and total sperm count in the bilateral groups were clearly below the reference 
values in both groups. This was less clear for motility and morphology. No statistically 
significant differences in sperm parameters were found when comparing unilateral congenital 
UDT with unilateral acquired UDT or bilateral congenital UDT with bilateral acquired UDT. 
However, median concentration and total sperm count was remarkably lower in the bilateral 
congenital group in comparison with the bilateral acquired group. 
  
Congenital UDT vs. acquired UDT (Table 2)  
We found no statistically significant differences in median DFI levels or the percentage of men 
having a DFI >30% between congenital and acquired UDT when evaluating all UDT, unilateral 
UDT group, and bilateral UDT group. However, the median DFI and the percentage of men 
having a DFI above 30% were remarkably higher in the bilateral congenital group than in the 
other groups. The bilateral acquired group had the second highest number of men with a DFI 
>30%. No statistically significant differences were observed when unilateral UDT was 
compared with bilateral UDT in the congenital as well as the acquired UDT group.   
 
 Congenital UDT and acquired UDT vs. control group (Table 2) 
No statistically significant differences were found in median DFI levels between the UDT 
groups and the control group. When taking the threshold of 30% into account men with 
congenital UDT (unilateral and bilateral UDT together) significantly more often had a DFI >30% 
(9 out 50 (18%)) compared with none in the control group (p-value 0.049). This also applies for 
men with bilateral congenital UDT compared with controls (3 out 7 (43%)) vs. 0 out 22; p-value 
0.01). For all other analyses no significant differences were found. 
 
Congenital UDT: influence of age at orchiopexy on DFI (Table 3) 
In the unilateral group, in total 19 men were treated with orchiopexy on or before the age of 24 
months, 9 before the age of 18 months, and 7 before the age of 12 months. In the bilateral 
group 2 men were surgically treated before 24 months of age of whom one before the age of 
18 months. Age at orchiopexy did not have a significant influence on the level of sperm DNA 
damage (median DFI as well as percentage of men with DFI> 30%) when using a cut off age at 
surgery of 24 months (Table 3), or 18 months or 12 months in both the unilateral as well as the 
bilateral group (data not shown). 
 
Acquired UDT: influence of spontaneous descent or orchiopexy on DFI 
(Table 3) 
In the unilateral group in 18 out the 38 men (47%) testicular descent was successfully awaited. 
Orchiopexy was needed in 20 men. In the bilateral group 6 out of 11 men (55%) had a 
spontaneous descent. No significant differences in median DFI or percentage of DFI >30% 
could be detected between men who had had a spontaneous descent in comparison with men 
needing orchiopexy in both the unilateral as well as the bilateral group.  
 
Paternity: Effect of sperm DNA damage on the success rate of men 
attempting fatherhood 
23 out of 99 men attempted fatherhood of whom 14 (61%) succeeded. There was no significant 
difference in DFI levels in men who succeeded in attempting fatherhood and the ones who 
were unsuccessful (median (range): men succeeding 14.2 (6.8 – 58.9) vs unsuccessful men 14.1 
(1.5 – 35.9); p-value 0.69).  
 
Logistic regression analyses 
The type of UDT (congenital or acquired) did not correlate with a DFI above or below 30%. 
Univariate logistic regression analyses showed that FSH (IU/l) and days of ejaculatory 
abstinence had a positive correlation with DFI. The higher the FSH (IU/l) and the longer the 
ejaculatory abstinence the higher the odds of having a DFI above 30%. Motility was negatively 
correlated with DFI, the lower the number of progressive sperm the higher odds of having a 
DFI above 30%. When using multivariate logistic regression analyses only FSH (IU/l) remained 




In literature, higher levels of sperm DNA damage are found in patients with a history UDT (25,29-
31). Most articles report sperm DNA fragmentation in men with a history of UDT visiting fertility 
clinics. The participants of the present study were from historical cohorts with UDT and 
therefore we feel that this is of great advantage because this study group reflects normal UDT 
population better. Moreover, our study is the first to report fertility assessed by SCSA in men 
with acquired UDT.  
In our previous study no differences in fertility potential were found between congenital UDT 
and acquired UDT using ‘traditional’ fertility parameters (testicular volume, endocrinological 
evaluation and semen parameters) However, men who earlier had bilateral UDT (congenital or 
acquired) had the lowest fertility potential (8). In that study a shared aetiology of congenital and 
acquired UDT was suggested. We hypothesized that UDT is a spectrum encompassing 
congenital UDT and acquired UDT while bilateral UDT is more severely affected than unilateral 
UDT.  
In the present study the DFI was used as a reflection of the severity of spermatogenic failure 
(25,29-31). If congenital and acquired UDT share the same aetiology little differences are expected 
in the level of sperm DNA damage between congenital and acquired UDT as was the case in 
our study. Also, one would expect the highest level of DFI in the bilateral groups. In this study, 
bilateral UDT especially bilateral congenital UDT seem more severely affected than unilateral 
UDT.  Men with a history of bilateral congenital UDT had the highest median DFI and the 
highest percentage of DFI > 30%, followed by bilateral acquired UDT for a DFI above 30%, 
albeit all without significance. This might implicate that within the spectrum of UDT acquired 
and congenital UDT are not equally affected. Different assumptions on the differences 
between acquired and congenital UDT are made in the literature. On the one hand fewer 
fertility problems are assumed in acquired UDT since the crucial development of type A 
spermatogonia has probably already occurred during the first year of life before the testis 
ascended (32). On the other hand a study by Garcia found a mean decreased tubular fertility 
index value in men with acquired UDT, indicating impaired spermatogenesis similar to that in 
congenital UDT (33). As mentioned before, the present study suggests a shared aetiology in 
congenital and acquired UDT, which is also suggested in two other studies (34,35).  
In our previous studies, fertility was compromised in both the congenital group as well as the 
acquired group in comparison with a healthy control group (8,14). In this study, all UDT groups 
had more often a DFI above 30% compared with the control group. However this only reached 
significance for the complete congenital UDT and bilateral congenital UDT group. Smith et al. 
reported on DFI measured by SCSA in men with UDT in comparison with a normospermic 
control group (29). They also found that the DFI was significantly higher in the UDT group. The 
mean DFI measured in their patients with UDT was higher than in our participants. This could 
be due to the fact that all men included in their study had fertility problems attending a fertility 
clinic. The normospermic control group of that study had lower DFI levels compared to 
controls of our study. Our control group were men with proven fertility opting for vasectomy; 
their semen analyses, however, were unknown. A study by Smit et al., showed the same 
results; the DFI was significantly higher in patients with UDT in comparison with the control 
group (25). Again the DFI in these patients was higher compared with our study, which again 
could be explained by the fact that the men in the study by Smit et al. were men with fertility 
problems attending an andrology outpatient clinic.  
The influence of early orchiopexy on fertility in congenital UDT is still debated. While some 
studies suggest that orchiopexy at younger age results in better semen parameters (36-38) 
others, including ours, show no favourable effect of early treatment on semen characteristics 
(14,39-42). High levels of sperm DNA damage found in humans with UDT can be explained by 
primary testicular dysfunction and/or high levels of reactive oxygen species (ROS) (29). ROS are 
harmful for cells because they damage proteins, lipids, and DNA and have been associated 
with various diseases such as cancer, cardiovascular diseases, and diabetes (43). ROS in testes 
induce apoptosis, and accelerate apoptotic cell death (44,45). In rats, UDT is associated with ROS 
caused by hyperthermia and lower intratesticular testosterone levels (44-47). It is unknown 
whether reducing the time of hyperthermia during childhood has an impact on sperm DNA 
damage in adult life. In case of congenital UDT, age at orchiopexy is a surrogate for the time of 
hyperthermia in the non-scrotal position. In our congenital UDT group, age at orchiopexy, did 
not have a significant effect on the amount of DNA damage. 
 In the acquired group, median DFI and the number of men with a DFI > 30% did not differ 
between men whose testis descended spontaneously and men who needed orchiopexy. It 
seems that the eventual outcome of the ‘wait-and-see’-protocol does not lead to different 
fertility potential in adulthood. The level of sperm DNA damage remains unknown if men had 
had immediate orchiopexy at diagnosis. However, we do not expect a great influence from 
immediate surgery on the amount of sperm DNA damage since other fertility parameters are 
not significantly different between  men with immediate orchiopexy at diagnosis and men for 
who spontaneous descent was awaited (48).  
Men from infertile couples and normal semen parameters more often have high levels of 
sperm DNA fragmentation (49,50). In our study, 23 out of 99 men attempted fatherhood of 
whom 14 men succeeded. However, we found no difference in DFI between men who 
attempted fatherhood and succeeded compared with men who were unsuccessful. This is 
possible due to the low numbers of men attempting fatherhood. 
This study has some limitations. The numbers in our study are relatively small, especially 
bilateral UDT, and due to logistical problems not all patients had a SCSA evaluation. The men 
from the historical cohorts included in this study were not part of randomized control trials. In 
the congenital group relatively few men were operated before the age of two years. Despite 
this we think this study adds to the current literature for the following reasons: [i] men 
included in this study are participants from historical cohorts and better reflect the normal 
UDT population than studies including men with UDT attending fertility clinics, [ii] it reports on 
a group of patients with congenital and acquired UDT instead of a group with UDT in whom 
previous testis position has not been taken into account, [iii] uni- and bilateral UDT are 
considered separately. 
In conclusion, firstly, no significant differences between congenital and acquired UDT were 
found. Secondly, in comparison with a control group a DFI >30% was significantly more often 
found in the complete (i.e. unilateral and bilateral combined) congenital and bilateral 
congenital group. Furthermore, we could not demonstrate that age at orchiopexy in congenital 
UDT has an influence on sperm DNA damage. Finally, the outcome of the ‘wait and see’-
protocol for acquired UDT did not influence the eventual level of sperm DNA fragmentation. 
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Summary 
The aim of this study was to report on different anomalies found by physical examination and 
scrotal ultrasound in men with previously unilateral congenital undescended testes (UDT; 
N=50), acquired UDT (N=49), their contralateral normally descended testis (CNDT), and 
control testes (N=53). 
Acquired UDT significantly more often had a testicular volume being <15ml than congenital 
UDT (88% vs. 68%). In the congenital group, significant differences were found between UDT 
and CNDT for soft consistency (UDT 36% vs. CNDT 14%), epididymal diameter (UDT 7.6mm vs. 
CNDT 8.9mm), testicular volume (UDT 9.8ml vs. CNDT 13.8ml), and inhomogeneous 
parenchyma (UDT 38% vs. CNDT 14%). In the acquired group, significant differences were 
found between UDT and CNDT for epididymal diameter (UDT 7.5mm vs. CNDT 8mm), 
testicular volume (UDT 9.3ml vs. CNDT 14.1ml), testicular volume <15ml (UDT 88% vs. CNDT 
59%), and inhomogeneous parenchyma (UDT 27% vs. CNDT 6%). The following parameters of 
congenital UDT, acquired UDT, congenital CNDT, and/or acquired CNDT significantly differed 
compared with controls: soft testicular consistency (congenital UDT 36%, acquired UDT 20%, 
congenital CNDT 14%, acquired CNDT 12% vs. controls 0%), epididymal diameter (congenital 
UDT 7.6mm, acquired UDT 7.5mm, acquired CNDT 8mm vs. controls 9.2mm), testicular 
volume (congenital UDT 9.8ml, acquired UDT 9.3ml, congenital CNDT 13.8ml, acquired CNDT 
14.1ml vs. control testes 15.8ml), testicular volume <15ml (congenital UDT 68%, acquired UDT 
88%, congenital CNDT 66% vs. controls 43%), inhomogeneous parenchyma (congenital UDT 
38%, acquired UDT 27%, congenital CNDT 14% vs. controls 0%), and testicular microlithiasis 
(congenital CNDT 24% vs. control testes 8%).  
Few differences between congenital and acquired unilateral UDT and congenital and acquired 
CNDT support the hypothesis of a spectrum of maldescended testes containing congenital and 
acquired UDT instead of them being two different entities. The CNDT also has anomalies albeit 
less severe than the UDT, indicating that in unilateral UDT both testes are affected. 
 
Introduction 
Undescended testes (UDT) are a frequent urogenital abnormality that may be present at birth 
(congenital form) or develop later in life (acquired form) (1,2). The congenital form never 
reaches a stable scrotal position after birth; and has an incidence around 1% at 1 year of age (3). 
Moreover, 1-3% of boys develop an acquired UDT during childhood (4,5). Acquired UDT is 
defined as a palpable UDT that previously had a normal scrotal position. Spontaneous descent 
during follow-up of children with acquired UDT is expected in 57-71% of patients (6,7). UDT is 
associated with impaired fertility and testicular malignancies.  
Physical examination and scrotal ultrasound is often performed in men with fertility problems, 
testicular abnormalities, paratesticular and testicular swellings, acute and chronic scrotal pain, 
and scrotal trauma (8). Anomalies of the testes observed in patients with UDT can be caused by 
the primary condition, but also by testicular damage during orchiopexy (9). Scrotal ultrasound 
as a diagnostic modality is widely used, but reference values in healthy adult men are scarce; 
there is no standardization and different formulas are used, for example to calculate testicular 
volume. 
In our previous study we evaluated more traditional fertility parameters (e.g. testicular volume, 
endocrinological factors, and semen parameters) (10).  In this study, we more extensively 
describe anomalies found by physical examination and scrotal ultrasound (e.g. epididymal 
diameter (mm), presence of epididymal cyst(s), testicular volume, inhomogeneous 
parenchyma, presence of testicular microlithiasis (TM) and testicular cyst(s)). The anomalies 
described in this study can be associated with fertility problems, but also with the testicular 
dysgenesis syndrome which is associated with UDT (11). We describe these anomalies for the 
UDT, their contralateral normally descended testis (CNDT) and a healthy control group. Most 
of the anomalies described in this study as well as all the results of the CNDT were not reported 
previously. 
First, we evaluated the differences between congenital and acquired UDT. Fertility parameters 
between congenital and acquired UDT were not found to be significantly different in a previous 
study (10). Therefore, we don’t expect to find great differences for the prevalence of ultrasound 
anomalies between the two groups either, which would further support our hypothesis that 
congenital and acquired UDT are part of a spectrum of UDT instead of two different entities. 
Second, we compared the CNDT with their UDT and a control group which could further 
enlighten whether scrotal anomalies in patients with UDT are affecting both testes or that it is 
an isolated problem of the UDT. Furthermore, ultrasound observations were compared 
between men with previously acquired UDT who had had a spontaneous descent and men with 
previously acquired UDT who had an orchiopexy. 
 Patients  
Patients and controls were retrospectively included and data on physical examination and 
ultrasound were prospectively collected between 2005 and 2010. 
Men included in the two patient groups described below all participated in studies evaluating 
fertility potential after treatment of congenital or acquired UDT performed at the Erasmus 
Medical Center. Inclusion and exclusion criteria of participants in those studies were described 
previously (10,12). For this study we only selected men with a history of unilateral UDT and who 
had both testes at follow-up. In short: 
The congenital UDT group (N=50) consisted of men treated for unilateral congenital UDT 
during childhood at various ages. Median = age at orchiopexy was 2.6 years (range = 0.1 - 10.3 
years).  
 The acquired UDT group (N=49) consisted of men with previously acquired unilateral UDT who 
had annual follow-up examination until puberty (10). For acquired UDT this implied that a 
previous normal stable scrotal position was documented at least once at birth and/or at follow-
up either by the Regional Youth Health Care Institution, general practitioner, or hospital. 
Furthermore, at inclusion the testis had to be palpable without ipsilateral, inguinal, clinically 
present pathological findings or previous ipsilateral, inguinal surgery, and the most caudal 
testicular position after manipulation had to be non-scrotal or unstable scrotal position. 
Spontaneous descent was awaited until at least Tanner stage P2G2 and followed by 
orchiopexy in case of non-descent. Spontaneous descent had occurred in 24 participants. 
Median = age at orchiopexy in 25 participants was 13.3 years (range = 4.8 - 17.8 years). Reasons 
for earlier operation were inguinal complaints, a clinically present ipsilateral inguinal hernia or 
a completely immobile testis in the inguinal area.  
Men from the control group (N=53) previously participated in a study evaluating fatherhood 
after use or non-use of sex steroid treatment during adolescence to reduce final height. Only 
those who had not received steroid treatment, had no history of UDT, and had no history of 
oncological treatment were included in this control group. These men had the same physical 
examination, and ultrasonic evaluation at our department as the men with previous congenital 




Physical examination and ultrasound 
Consistency of the testis was examined with physical examination and was classified as normal 
or soft consistency. Scrotal ultrasound was performed in all men according to a standardised 
procedure using a high-resolution duplex echo machine (the Toshiba Nemio model SSA-550A) 
with a transducer frequency ranging from 7.5-12 MHz. The following parameters were 
registered: epididymal diameter (mm), presence of epididymal cyst(s), testicular volume, 
inhomogeneous parenchyma, and presence of TM, and testicular cyst(s).  
For the measurement epididymal diameter, the diameter of the epididymal head in 
longitudinal direction was measured and a diameter above 12.0 mm was considered abnormal 
(14,15). Epididymal cyst(s) were defined as sharply anechoic round lesions in the epididymis. 
Testicular volume was measured with an automated formula from the ultrasound machine; 
testicular volume = width x height x depth x 10-3 x 0.523* (*= 4/3π x ½ x ½ x ½). A volume of 
15.0 ml or higher was considered normal, based on the cut-off value used in the guidelines on 
male infertility from the European Association of Urology and in our department (16). 
Inhomogeneous parenchyma was defined as heterogeneous parenchyma with hypoechogenic 
and/or hyperechogenic areas within the testis. TM were hyperechogenic spots in the range = 2-
3 mm without shadowing as previously defined (17). Total number of spots in the entire testis 
was counted. Physical examination as well as the scrotal ultrasound was performed by two 
experienced physicians.  
 
Statistical analysis  
The testes of participants were categorised into three categories: UDT of congenital or 
acquired origin, CNDT of congenital or acquired origin, and control testes.  
Differences in frequency of the anomalies found with physical examination and scrotal 
ultrasound between the different categories were analysed. First, we analysed the differences 
between congenital UDT and acquired UDT, and between congenital CNDT and acquired 
CNDT. Second, we evaluated the differences between the control group and all the patient 
groups (e.g. control group vs. congenital UDT, congenital CNDT, acquired UDT, and acquired 
CNDT). Subsequently the differences between UDT and CNDT for the congenital and the 
acquired group were analysed. Lastly, we analysed the differences between acquired UDT who 
had had spontaneously descended vs. acquired UDT that needed orchiopexy. Continuous 
variables were tested with the T-test; categorical variables with Chi squared test. When 
relevant the Fisher’s exact test was used. For all analyses a two-sided p-value of < 0.05 was 
considered statistically significant.  
 Ethics 
The study was reviewed and approved by the Medical Ethical Review Committee at Erasmus 
University Medical Centre in Rotterdam (MEC number 2004-206). Written informed consent 
was obtained from all patients who agreed to participate in the study. 
 
Results 
Congenital UDT vs. Acquired UDT (Table 1)  
Men in the congenital group significantly more often had a testicular volume above 15ml (p = 
0.02). No other statistically significant differences were found when comparing the frequency 
of anomalies found by physical examination and scrotal ultrasound between congenital and 
acquired UDT. 
 
Congenital CNDT vs. Acquired CNDT (Table 1)  
No statistically significant differences were found when comparing the frequency of anomalies 
found by physical examination and scrotal ultrasound between congenital and acquired CNDT. 
 
Congenital group; UDT vs. CNDT (Table 2) 
Congenital UDT in comparison with their CNDT had significantly more often a soft consistency 
(p = 0.01), smaller epididymal diameter (p = 0.004), lower testicular volume (p =  0.01), and 
more often inhomogeneous parenchyma (p = 0.006). 
 
Acquired group; UDT vs. CNDT (Table 2) 
Acquired UDT in comparison with their CNDT more often had a smaller epididymal diameter (p 
= 0.03),  lower testicular volume (p <0.001), a testicular volume <15ml (p = 0.001), and 
inhomogeneous parenchyma (p = 0.006). 
 
Congenital UDT and Acquired UDT vs. Control testes (Table 1) 
Congenital or acquired UDT in comparison with control testes had significantly more often soft 
testicular consistency (congenital UDT vs. control testes p-value <0.001, acquired UDT vs. 
control testes p = 0.001), smaller epididymal diameter (p <0.001), lower testicular volume (p 
<0.001), more often a testicular volume <15ml (congenital UDT vs. control testes p = 0.01, 
acquired UDT vs. control testes p <0.001), and inhomogeneous parenchyma (p <0.001). 
Acquired UDT more often had epididymal cyst(s) in comparison with the control testes (p = 
0.02). 
 
CNDT from the Congenital and CNDT from the Acquired group vs. 
Control testes (Table 1) 
CNDT from both patient groups in comparison with control testes had significantly more often 
soft testicular consistency (congenital CNDT vs. control testes p = 0.005, acquired CNDT vs. 
control testes p = 0.009), epididymal cyst(s) (congenital CNDT vs. control testes p = 0.003, 
acquired CNDT vs. control testes p = 0.01), lower testicular volume (CNDT from the congenital 
group vs. control testes p = 0.003 and CNDT from the acquired group vs. control testes p = 
0.03), and less often testicular cyst(s) (congenital CNDT vs. control testes p = 0.01, acquired 
CNDT vs. control testes p = 0.02). 
CNDT from the congenital group more often had a testicular volume <15ml (p = 0.02),  
inhomogeneous parenchyma (p = 0.005) and TM in comparison with control testes (p = 0.02). 
CNDT from the acquired group had a smaller epididymal diameter than control testes (p = 
0.03). 
 
Acquired group; Spontaneous descended UDT vs. UDT which needed 
orchiopexy 
Acquired UDT which descended spontaneously had significantly more often a larger 
epididymal diameter (median = (range =) spontaneous descend 8.3 mm (2.8 – 13.4) vs. 
orchiopexy 6.8 mm (3.1 – 9), p = 0.01). For the other anomalies no significant differences were 
found (data not shown). 
 
Discussion 
To our knowledge, this is the first study describing results of physical examination and 
ultrasound in men with previously congenital and acquired UDT, in comparison with the CNDT 
and a control group with normally descended testes.  In this study, no statistically significant 
differences between congenital and acquired UDT were found, except for more often a 
testicular volume above 15ml in the congenital group. No differences were found between 
congenital CNDT and acquired CNDT. UDT in comparison with CNDT more often had a soft 
consistency (only for the congenital group), smaller epididymal diameter, lower testicular 
volume, a testicular volume <15ml (only for the acquired group), and inhomogeneous 
parenchyma. Overall, UDT and CNDT from the congenital and acquired groups in comparison 
with control testes more often had a soft testicular consistency, smaller epididymal diameter, 
more often epididymal cyst(s), a lower testicular volume, more often a testicular volume 
<15ml, and inhomogeneous parenchyma.  
Abnormal testicular consistency in undescended testis is thought to be caused by histological 
changes (e.g. reduction of number of cells or seminiferous tubules and subsequent loss of 
testicular mass) (18). In our study we more often found abnormal testicular consistency in 
congenital UDT in comparison with congenital CNDT and in UDT and CNDT in comparison 
with controls. Testicular consistency remains a subjective parameter and we did not use scales 
to standardize our findings. 
An increased epididymal diameter can indicate an obstruction. In this study the median = 
epididymal diameter of all groups was below 9 mm which is normal considering the cut-off 
point of 12 mm used in the literature (14,15). Epididymal diameter of the UDT of both patient 
groups and acquired CNDT was significantly smaller than controls. However, the question 
remains whether a significant difference in epididymal diameter but below 12 mm is clinically 
relevant.  
In our study we found an incidence between 8 and 20% of epididymal cyst(s) in the different 
UDT and CNDT groups. In our control group only 2% of the men had epididymal cyst(s). A 
study comparing men with normally descended testes and men with undescended testes 
found 5% and 9% epididymal cyst (s) respectively (9). Another study reported an incidence of 
epididymal cyst(s) between 2.8% and 7.6% in randomly selected men, including men with a 
history of maldescent, inguinal hernia, torsion of the testicle, and scrotal infections (19).  The 
clinical significance of epididymal cyst(s) remains unclear. It occurs more often in men with 
obstructive azoospermia (20). However, the presence of bilateral epididymal cyst(s) is not 
always associated with azoospermia (21).   
Median = testicular volume of our control group was 15.8ml (range = 8.2 - 27). This was 
significantly higher than that for the UDT and CNDT in both patient groups. Lenz et al., also 
found a smaller testicular volume in UDT (median = 10.5 ml, range = 3.9 – 17.1) in comparison 
with healthy controls (median = 14.1ml, range = 6.0 – 31.8) (19). As both UDT and CNDT are 
smaller, a maldevelopment in both testes rather than an isolated problem in UDT can be 
suggested. Huff et al. and Zivkovic et al. found histological changes in contralateral normally 
descended testes which would support this hypothesis. They found that gonocytes failed to 
disappear and adult dark spermatogonia failed to appear in the UDT and in lesser extent in the 
CNDT (22,23). In our study, UDT were significantly smaller than CNDT in both patient groups. 
This is in line with other studies reporting on differences in testicular volume between 
previously undescended testis and their CNDT (9,24,25). Thus, UDT and CNDT are both smaller 
than the control group and complementary to this is the fact that UDT are also significantly 
smaller in comparison with the CNDT. Two possible explanations for this finding can be 
suggested. First, damage directly occurs because of the underlying condition in both testes 
instead of damage of just the UDT. Histopathological findings demonstrated that the UDT is 
more affected than its CNDT (22). That might explain the even smaller volume of the UDT in 
comparison with the CNDT. Second, the smaller UDT in comparison to the CNDT might be 
caused by possible trauma during surgery. However, testicular volume did not significantly 
differ between men with previous acquired UDT who underwent orchiopexy and those with 
UDT that descended spontaneously, in line with another study (26). We could not find an effect 
of surgery on testicular volume which is assumed in a study by Taskinen et al. They found that 
testicular volume was smaller in patients with no testicular artery detected by ultrasound, 
which the authors ascribed to damage owing to the operation (9). In recent literature the cut-off 
value for testicular volume is debated. In different studies different methods to determine 
testicular volume are used. Also when ultrasound is used different formulas are used to 
calculate testicular volume. Meij-de Vries et al. studied the literature for normative values of 
testicular volume measured by ultrasound in healthy men. They concluded, after recalculating 
every outcome with the same formula, that the testicular volume cut-off value should be at 
13,5ml (24). Despite this, we decided to use the cut-off value of 15ml conform the guidelines on 
male infertility by the European Association of Urology (16).  
A post-pubertal testis normally has a homogeneous texture of medium echogenicity (14). In our 
group none of the control testes were inhomogeneous. One study in a general population 
found that 4.1% of 444 men from the general population had a very irregular pattern or TM (19). 
The incidence of inhomogeneous parenchyma in UDT in the literature varies from 0 to 36% 
(9,19,27-29). Age at evaluation in these studies is different. It is possible that inhomogeneous 
parenchyma develops at later age, because in our study the incidence of inhomogeneous 
parenchyma was between 6.1 and 38%. Comparison of studies is complicated by the fact that 
inhomogeneous parenchyma is a subjective parameter.  
Testicular microlithiasis is associated with increased risk of the condition called carcinoma in 
situ (CIS) in men who also have risk factors for testicular cancer (30). Most testicular germ cell 
tumours have CIS as precursor cell (31). In our study the presence of even one single TM 
counted. Two studies reporting on TM in asymptomatic men and counting every TM found 
prevalences of 3 and 17.8% (29,32). Seven-and-a-half percent of our control group had TM. The 
incidence of TM in men with a history of UDT varies from 3 to 8%, and even up to 42% in men 
with a history of UDT referred for subfertility (9,25,28-30). However, in these studies TM was 
defined differently, varying from counting every TM to counting from >5 TM or it was not 
described. Both patient groups, UDT as well as CNDT, had significantly more often TM in 
comparison with controls. The only other study on TM and the two different types of UDT did 
not find a difference in prevalence of TM between boys with a history of congenital or acquired 
UDT, conform our results (33).  
In our study two experienced physicians specialized in andrology performed physical 
examination and the ultrasound. This could influence our data, especially subjective 
parameters such as testicular consistency or homogenous parenchyma, because of inter 
observer variation. However, a previous study showed a good correlation between three 
investigators when measuring testicular volume by ultrasound (34).  
In this study, the total numbers of testes are relatively small, therefore strong conclusions are 
hampered. We believe that despite small numbers this study adds important information 
about differences between congenital and acquired UDT as our study has certain strengths. 
First, our patients were part of historical cohorts instead of patients with UDT visiting fertility 
clinics, therefore patient selection by analysing only men with fertility problems does not play 
a part in these analyses. Second, the history of the type of UDT is known. In the literature 
mostly acquired UDT is not recognised as a distinct anomaly or history of testis position at 
birth is unknown.  
Our study has a fairly low inclusion rate (28% for the congenital UDT group and 31% for the 
acquired UDT group). The inclusion rate in other studies regarding UDT varied between 29 and 
73% (27,35-39). A possible explanation for our low inclusion rate is the long interval between 
inclusion in the historical cohort and the request for evaluation of fertility parameters. 
Thereby, in our study patients had no regular check-ups in this interval. Patients might be 
more motivated to participate when the treatment is more recent or when follow-up is more 
frequent.   
The patient groups are heterogeneous, meaning for congenital UDT the range of age at 
orchiopexy is wide and for the acquired UDT group half of them had a spontaneous descent 
and the other half needed orchiopexy. At inclusion of the congenital group maximum effort 
was taken to verify previous testis position, and we are convinced that these boys have true 
congenital UDT. Apparently it is clinical practice that congenital UDT can become obvious at 
later age. For the acquired group, the study design (e.g. awaiting spontaneous descent and 
perform orchiopexy in case of non-descent) is the reason for having heterogeneity. We 
performed extra analyses to analyse differences between men who had had orchiopexy and 
men which testis descended spontaneously. We were unable to find significant differences 
except for epididymal diameter which we not consider of clinical relevance. 
In conclusion, we found anomalies by physical examination and scrotal ultrasound in men with 
previous congenital or acquired UDT, with significant differences in the occurrence of 
anomalies between UDT, CNDT, and controls. This study supports our earlier results regarding 
fertility potential in congenital UDT and acquired UDT. We suggested a shared aetiology 
between these groups instead of them being two different entities. The similar anomalies and 
minimal differences found in this study between congenital and acquired UDT further support 
this hypothesis. The finding that CNDT also had statistically significant anomalies, albeit less 
severe than UDT, in comparison with the controls indicates that UDT affects both testes and is 
not an isolated problem of UDT.  
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In this thesis we aimed to elucidate differences between congenital and acquired undescended 
testis (UDT). We found differences in regard to surgical findings, however less differences in 
fertility parameters. We therefore conclude that the condition ‘undescended testis’ is a 
spectrum that contains congenital and acquired UDT. We found little evidence that performing 
orchiopexy as early as possible has an effect on fertility parameters later in life for congenital 
as well as acquired UDT. Unfortunately it seems that we have little influence on fertility 
potential later in life. 
In this chapter we will discuss our main findings in detail by means of answering different 
questions using the outcomes of our studies compared to (recent) literature. We will conclude 
with implications for clinical practice and future perspectives. 
 
Congenital and acquired undescended testes; different conditions with 
respect to anatomy?  
UDT is one of the most frequent urogenital abnormalities, and can be of congenital or acquired 
origin (1-3). The problem with  the literature is that acquired UDT was only recently accepted as 
a distinct condition and most studies do not discriminate between congenital and acquired 
UDT. This complicates the interpretation regarding aetiology, natural course and treatment. 
For the participants of our cohort studies, great effort was put into ascertaining previous testis 
position at the inclusion of the initial studies, some 30 years ago. For congenital UDT much is 
known on the aetiology, natural course, and treatment. However these matters are less clear 
for acquired UDT and are still debated (1,3,4). Congenital UDT are not likely to descent after 12 
months of age, preferably need treatment between 9 and 12 months of age and 18 months at 
the latest, and are associated with infertility (5-8). Two Dutch studies from Eijsbouts et al. and 
Sijstermans et al included only acquired UDT and found that spontaneous descent at puberty 
occurred in 57-71% of patients (9,10). Therefore a ‘wait-and-see’ policy seems justified, although 
long term effects on fertility were until now uninvestigated. Two studies, which made the 
distinction between congenital and acquired UDT, suggest a shared aetiology (11,12). Tanyel 
found that in congenital UDT, obliteration of the processus vaginalis by apoptosis is impeded; 
moreover if this process of obliterating the processus vaginalis is more subtly disturbed but 
persists the testis can descend normally and ascent later in time, i.e.an acquired UDT (11). 
Clarnette and Hutson suggested that in acquired UDT the aetiology of ascent is a persisting 
fibrous remnant of the processus vaginalis, possibly through the above mechanism, which 
prevents natural elongation of the spermatic cord during growth (12). Indeed in our study, a 
wide open processus vaginalis was more often found in congenital UDT and a closed processus 
vaginalis in acquired UDT, which is in line with the above mentioned hypothesis that 
congenital and acquired UDT share the same aetiology but the process of maldescend is partly 
different (chapter 3). Since acquired UDT have been in the scrotum before, it is reasonable to 
assume that these testes have less or less severe anomalies in comparison with congenital 
UDT. We found less epididymal anomalies in acquired UDT, which was in line with a study by 
Guven and Kogan (13).  It seems fair to say that acquired UDT are not a variant of normally 
descended testes since anomalies do occur.  Congenital and acquired UDT share parts of the 
same maldevelopmental process regarding testicular descent since anomalies overlap. 
However, since the anomalies are less profound in acquired UDT we could speculate that 
congenital and acquired UDT are part of a spectrum from sever maldescend to less severe 
maldescend instead of being equally abnormal.  
Another question is where acquired UDT which have descended spontaneously are within this  
spectrum. We do not have anatomical findings of acquired UDT with spontaneous descent 
since they were not operated. Therefore it is difficult to be sure which mechanism underlies 
spontaneous descent.  
In conclusion: 
Congenital UDT and acquired UDT are different conditions with respect to anatomy within a 
spectrum of UDT. In contrast to most studies, in our studies maximum effort was put into 
sorting out previous testicular position to determine UDT of congenital or acquired origin. 
  
Undescended testes; maldevelopment of both testes or isolated 
problem of the undescended testis? 
Nowadays, UDT are accepted to be part of the testicular dysgenesis syndrome (TDS). This 
syndrome  may also result in impaired spermatogenesis, hypospadias and testicular cancer and 
is related to environmental factors such as exposure to endocrine disruptors in utero (14). TDS is 
a developmental disorder, which hypothetically influences both testes in case of unilateral 
UDT. Studies from Huff et al. and Zivkovic et al., which strengthen this hypothesis show 
histological anomalies in the contralateral normally descended testis (CNDT) in comparison 
with normal descended testes from healthy controls (15,16). Furthermore, histopathological 
changes in CNDT are found to be similar but less severe in comparison with UDT (15,16). This is in 
concordance with our observation that in CNDT more anomalies are found with physical 
examination and ultrasound in comparison with healthy controls, albeit less severe than in 
UDT (chapter 4 and chapter 9).   
In conclusion:  
In boys with unilateral UDT both testes are negatively affected. The CNDT is affected to a 
lesser extent than UDT. 
 
Congenital undescended testes; what is the optimal timing of 
orchiopexy for later fertility?  
Evidence at young age 
The recommended timing of orchiopexy for congenital UDT has decreased over the years. The 
guidelines from the European Association of Urology (EAU) nowadays advise orchiopexy 
between 6-12 months of age or 18 months at the latest (17). A Dutch consensus based guideline 
recommended to operate congenital UDT between 6 and 12 months (18). The rational for 
decreasing the age at orchiopexy derives from histological studies (19). During mini puberty, 
gonocytes (neonatal germ cells) transform into adult dark (Ad) spermatogonia which are 
believed to be essential for future fertility (20). In UDT, this transformation is interrupted or 
delayed followed by gonocytes undergoing apoptosis leading to infertility (20). Hutson et al. 
hypothesized that the high temperature in UDT causes not only impaired transformation but 
also prevents apoptosis of the non-maturing gonocytes (21). Furthermore, at the age of 4 years 
transformation from Ad  spermatogonia into primary spermatocytes is defect in UDT (15). 
Cortes et al. showed that no germ cells at orchiopexy is associated with infertility and that the 
youngest patient without germ cells was 18 months of age (22). Based on these observations 
the recommended age for orchiopexy gradually lowered under the age of 12 months (22).The 
reason that most guidelines advice to wait until 6 months of age is the spontaneous descent 
rate. Most testes descent within the first 3 months of age which can be explained by the period 
of high levels of gonadotropins and testosterone in the mini puberty (5,23,24). However, 
according to Kollin et al., spontaneous descent can occur up to 1 year with 8% descending 
between 6-12 months of age (5). According to Hutson, the recommended age of orchiopexy 
between 3-9 months of age is based on 4 assumptions; (1) germ cell loss begins at 3-6 months 
of age, (2) this loss is preventable by placing the testis at the correct temperature in the 
scrotum, (3) no spontaneous descent occurs after 3 months, and (4) early surgery is safe with 
the use of magnifying glasses and adequate training (25). One can debate whether it is 
worthwhile waiting until 12 months of age to await spontaneous descent because a little part 
of orchiopexies can be omitted due to spontaneous decent. The main question is whether it is 
safe to wait with regard to future fertility. Possible evidence that no avoidable damage is done 
by awaiting spontaneous descent is that in a retrospective study by Bilius et al.no differences in 
the prevalence of histological proven risk of infertility between boys operated before or after 
18 months of age were found, implying that UDT is a pre-existent developmental disorder of 
the testis (26). Furthermore in a study by Kollin et al., testes which descended spontaneously 
during the first year of life, had the same testicular volume in comparison with testes which 
had had orchiopexy at 9 months of age(5). On the other hand, a randomized controlled trial by 
the same author found clear beneficial effect on testicular volume when operated at 9 months 
of age in comparison with orchiopexy at three years of age (27). They concluded that this is 
hopeful for future spermatogenesis since testicular volume is an approximate measure for 
spermatogenic activity (27). One could speculate whether the difference would be as profound 
when randomizing between 9 months of age and for example 12 months or 18 months of age 
and furthermore whether testicular volume at this age is a representative of the number of 
germ cells or fertility later in life. Although guidelines over the years advised orchiopexy at 
younger age, in practice age at surgery remains far above the nowadays recommended age of 
6-12 months (28). There are several possible reasons for delayed correction in literature. Firstly, 
general practitioners and primary care providers might still not be aware of the optimal age for 
surgical correction. In two studies from England and Germany only 50% of the general 
practitioners and 59% of primary care paediatricians thought the optimum age of for 
orchiopexy was 12 months of age or younger (28,29). Secondly, in most studies acquired UDT are 
not excluded which could explain a great part of late orchiopexies (30). Thirdly, orchiopexy can 
be technically challenging especially in a small infant. Some surgeons may be hesitant to 
operate before the age of 12 months. Although orchiopexy is advocated as a relative simple 
procedure, Carson et al. and Ein et al. found an overall complication rate of 12% ; containing 
post-operative infection, wound dehiscence, bleeding and testicular atrophy (31,32). Factors 
named to possibly influence complication rates and/or chance of testicular atrophy are 
testicular position (e.g. intra-abdominal testes), operation at younger age, operations by a 
surgeon performing low numbers of orchiopexies, and patients with a remaining open 
processus vaginalis (31,33). If we are to perform every orchiopexy before the age of 12 months 
significant changes in referral patterns are required to save time and have the infant visit a 
paediatric urologist/surgeon before the age of 6 months (34). As long as a no strong positive 
effect of surgery before 6 months of age is found, surgery before that time should not be 
advocated because of the spontaneous descent rate in the first months of life, the anaesthesia 
risk and the increased risk of complications in younger children.  
 
Evidence at adult age 
UDT may lead to fertility problems later in life, especially in bilateral cases (6,35,36). However, 
literature is not consistent on the effect of age at surgery on fertility potential in adulthood. 
The studies are hard to compare due to several reasons; (1) unclear whether groups contain 
only congenital UDT or also acquired UDT, (2) groups containing unilateral UDT, bilateral UDT 
or both, (3) uncertainty about the possible inclusion of retractile testes, (4) different age at 
surgery since recommended age at surgery in guidelines changed over time, and (5) different 
therapeutic strategies. To our knowledge randomized control trials (RCT) regarding age at 
orchiopexy and outcome at adult age are lacking. A systematic review by Chan et al. found 
evidence for the greatest fertility potential when operated before the age of 12 months and a 
decreased chance for testicular malignancy when operated before 10-11 years (37). However, 
the RCT used in this review is describing testicular volume during childhood and not adulthood 
(27). While some studies suggest a positive effect of early orchiopexy on fertility parameters 
(testicular volume, hormonal levels, and semen parameters) later in life (38-40), others cannot 
find a favourable effect of early treatment (41-46).  We were unable to find an age-dependent 
effect of orchiopexy on fertility parameters including testicular volume, endocrinological data 
(luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone, and inhibin B), 
semen analysis (concentration, motility, and morphology), and level of DNA damage (chapter 
4 and chapter 8). However, it should be taken into account that only 8 patients were operated 
before the age of 12 months. The only suggestion of an age related effect was found in 
unilateral UDT when evaluating Sertoli cell function, by using serum Anti-Müllarian hormone 
(AMH) levels. Sertoli cell function was better when operated before 24 months of age in 
comparison with men operated after 24 months of age (chapter 7). In untreated unilateral UDT 
normospermia rates are found up to 38-54%, which means that over a third of men with 
untreated unilateral UDT have normal semen concentrations (47,48). In our study described in 
(chapter 4), successful attempts to fatherhood were lower in the unilateral group in 
comparison with the control group (55% vs. 86%), though not statistically significant. 
However, the numbers of men attempting fatherhood were small. Paternity rate, found by Lee 
and Coughlin showed no significant difference between men with previously unilateral UDT 
and a healthy control group (49). It is possible that men with unilateral UDT have a lower fertility 
potential i.e. smaller testicular volume, abnormal hormonal values and lower semen 
parameters, but the same paternity rates as men with normally descended testes. Most likely 
men with lower fertility potential are still able to father children. The question is whether 
fertility potential in unilateral UDT can be positively influenced by treatment at early age. The 
problem with the evaluation of treatment of unilateral UDT is the contribution of the CNDT, 
which also has signs of maldevelopment (chapter 9). Since anomalies found in CNDT cannot 
be improved by surgical intervention since the testis is already in its right position, it seems 
that if early treatment is effective, this is only the case for bilateral cases as was found in a 
study by Varela-Cives et al (50). In one study by Lee, paternity rate in men with previously 
bilateral UDT was 65.3% and this was significantly lower in comparison with men with 
previously unilateral UDT and a control group in which the paternity rate were 89.7% and 
93.2% respectively (6). We found less fertility potential in bilateral UDT in comparison with a 
control group. However, when comparing bilateral UDT with unilateral UDT, except for 
significantly lower semen concentration and lower AMH levels in bilateral UDT, no significant 
differences were found. The low number of bilateral UDT in our study might explain the less 
explicit differences between uni- and bilateral UDT. There is no question about whether 
congenital UDT need orchiopexy, firstly after 12 months of age they are unlikely to descent, 
secondly surgery before puberty decreases the chance of testicular malignancy (see further 
paragraph), and lastly a growing testis in the groin region is very unpleasant, however, the 
question remains what the right timing would be. 
In conclusion: 
In literature, evidence is contradictory for an age-dependent effect of orchiopexy on fertility 
parameters in unilateral UDT. In our study no clear effect of age at orchiopexy for unilateral 
UDT was found. For bilateral UDT evidence in the literature is somewhat stronger that early 
intervention might positively influences fertility potential, however this could not be confirmed 
in this thesis possibly due to low numbers.  
 
Acquired undescended testes; do opposing treatment modalities have 
different outcomes? 
Acquired UDT are predicted to perform better in comparison with congenital UDT since the 
essential transformation into Ad spermatogonia already occurred before the ascent of the 
testis (25,51). However, Rusnack et al. found similar histopathological changes in acquired UDT 
as are found in congenital UDT (52). Furthermore Foresta et al. found that the total number of 
germ cells was diminished similarly in acquired UDT and CNDT (53). Until now no studies were 
available with long-term follow-up results with regards to fertility potential in adulthood in 
acquired UDT. In our study (chapter 5) fertility parameters in acquired UDT were impaired in 
comparison with controls. Furthermore in our study regarding anomalies found by physical 
examination and scrotal ultrasound in acquired UDT (chapter 9) anomalies were found in the 
UDT, and to lesser extent in the CNDT, in comparison with control testes. Therefore, it is safe 
to say that acquired UDT are not a variant of normally descended testes with just a mechanical 
problem. For acquired UDT two treatment strategies are advocated: immediate surgery at 
diagnosis or a ‘wait-and-see’-protocol. Since >50% of acquired UDT descend spontaneously, 
one could await spontaneous descent, which diminishes the number of orchiopexies. The 
question is, while trying to omit half of orchiopexies with the ‘wait-and-see’-protocol, whether 
possible additional damage by being non-scrotal may enhance fertility problems later in life 
and if so whether this can be prevented by immediate surgery at diagnosis. Most (paediatric) 
surgeons and urologists hypothesize that in spite of the chance of spontaneous descent, 
immediate surgical correction at diagnosis could have positive effects as is assumed for 
congenital UDT (7). This is based on the hypothesis of negative influence of higher thermal 
environment (3,54,55). According to Hutson, fertility in acquired UDT is somewhat impaired since 
higher temperature still negatively influences the testis between roughly 5 to 15 years of age 
(25). In a consensus meeting immediate surgery was advised even though they acknowledged 
that many testes descent spontaneously. It was argued that spermatogenic and endocrine 
function and not anatomical position should be the primary aim for treatment (56).  So far, no 
evidence was available that fertility potential in adulthood is improved with immediate 
surgery. In our study immediate surgery at diagnosis compared with the ‘wait-and-see’-
protocol showed no beneficial effect on fertility potential of immediate surgery (chapter 6). 
Furthermore, men whose testes descended spontaneously had no significant different fertility 
potential compared with men who needed orchiopexy in the ‘wait-and-see’-protocol (chapter 
5). Therefore it seems that there is no clear superior treatment protocol. At least for unilateral 
UDT, surgery at diagnosis does not seem to influence future fertility. The UDT as well as the 
CNDT is anomalous in acquired UDT (chapter 9). The diminished fertility parameters we found 
in unilateral acquired UDT might be due to the development disorder in both testes. Therefore 
we speculate that surgery of the UDT cannot improve fertility parameters. In bilateral UDT, we 
found a possible trend in favour of operation at diagnosis in comparison with the ‘wait-and-
see’- group. Semen concentration and progressive motility was higher in the orchiopexy at 
diagnosis group however without statistical significance. Thereby numbers of bilateral UDT in 
our study are small.  In regard to complication rates due to orchiopexy, one could speculate 
that the complication rate might be lower in acquired UDT than in congenital UDT as operation 
occurs at older age. Furthermore, if intra-abdominal testes indeed account for a higher 
complication rate this will be lower in acquired UDT since an intra-abdominal position does not 
occur in acquired UDT. Unfortunately, to our knowledge no studies are available regarding 
complications in acquired UDT. The Dutch guidelines advise to discuss both treatment options 
(e.g. immediate surgery and ‘wait-and-see’-strategy) for acquired UDT with the patient and 
parents (18). For unilateral UDT immediate surgery at diagnosis does not yield improved fertility 
later in life. For bilateral UDT, patients and parents should be informed that there is an 
unknown effect on future fertility when operating on immediately, but in approximately 50% 
no operation is needed. Further studies with more bilateral UDT patients are needed.  
In conclusion: 
Acquired UDT are not a variant of normally descended testes. For unilateral UDT none of the 
treatment modalities seem to influence future fertility potential. For bilateral UDT a possible 
advantage is found for surgery at diagnosis.  
 
Congenital and acquired undescended testes; different conditions with 
respect to fertility?  
Since the acknowledgement of acquired UDT has happened relatively recent, current long-
term follow-up studies in adults with a history of UDT include a mixture of patients with both 
congenital and acquired UDT. A review from Sijsterman et al. found that only 6 out of 46 
articles made the distinction between congenital and acquired UDT (57). As stated in the former 
paragraph fewer fertility problems are assumed in acquired UDT but similar histopathological 
changes in comparison with congenital UDT are found. One could hypothesize that long-term 
follow-up results are similar between congenital and acquired UDT (52).We confirm this 
hypothesis, showing that there were no significant differences in traditional fertility 
parameters (LH, FSH, testosterone, inhibin B, semen concentration, motility and morphology) 
between men with AUDT and men with CUDT (chapter 5). This is line with a study from Gracia 
et al who found a mean decreased tubular fertility index value in men with acquired UDT, 
possible implying impaired spermatogenesis similar to that in congenital UDT (58). Although no 
differences in traditional fertility parameters could be obtained between congenital and 
acquired UDT, when using sperm DNA damage as a measure for fertility potential more 
evidence of a spectrum of UDT was found (chapter 8). The complete congenital group and 
bilateral congenital group significantly more often had a higher DNA damage compared with 
healthy controls. This was not statistically different for the acquired UDT group. Although the 
bilateral acquired group had the second highest prevalence of a DNA fragmentation index > 
30%. Furthermore, Leydig cell function, represented by non-SHBG bound testosterone levels, 
and Sertoli cell function, represented by AMH levels, were more divergent in bilateral 
congenital UDT in comparison with bilateral acquired UDT. This might argue for a spectrum in 
which acquired UDT has indeed less fertility problems than congenital UDT. 
In conclusion: 
Few differences were found between congenital and acquired UDT. Nevertheless, congenital 
and acquired UDT are different conditions within a spectrum in which bilateral congenital UDT, 
followed by bilateral acquired UDT, are mostly affected in their fertility potential.  
 
Congenital and acquired undescended testes; different conditions with 
respect to risk factors for testicular malignancies? 
Patients with a history of UDT have an increased risk of developing testicular cancer with a 
relative risk of 4.8 (59). There is evidence that surgery before puberty can decrease the relative 
risk, however the relative risk remains higher than in the normal population (60,61). Reducing the 
chance of testicular cancer by timely surgical correction can be explained by the so-called 
‘position theory’ in which the abnormal position causes a higher thermal environment of the 
testis which induces carcinogenetic changes (62). The TDS, in which genetic and endocrine 
disruptors are related to undescended testes and testicular malignancies, would explain the 
inability of surgery to decrease the risk of testicular cancer comparable with the normal 
population(14,62). There is a hypothesis why in acquired UDT the risk for testicular malignancy is 
not increased (21). The high temperature in congenital UDT, during the ‘mini puberty’ around 
the age of 2-3 months, would not only cause impaired transformation of the gonocytes but 
also prevent apoptosis of non-maturing gonocytes (21). These non-matured remaining 
gonocytes are hypothesized to be the source for carcinoma in situ (CIS) (63). CIS is a precursor 
for testicular malignancy (64). In acquired UDT, it is hypothesized that no non-mature 
gonocytes are present to be the source of CIS since the abnormal temperature occurs after the 
essential transformation of gonocytes (21). Anomalies associated with CIS are inhomogeneous 
parenchyma and testicular microlithiasis (65,66). We were unable to find differences in the 
presence of inhomogeneous parenchyma or testicular microlithiasis between congenital and 
acquired UDT as well as congenital and acquired CNDT (chapter 9). In our study population, 
only one patient in the congenital group had a history of testicular cancer in his CNDT. Our 
patients are relatively young because the peak incidence of testicular cancer is in the third and 
fourth decade of life (67). It is possible that if we had a longer follow up more malignancies 
would have occurred. 
In conclusion: 
From literature it appears that acquired UDT have a lower chance of developing testicular 
malignancies than congenital UDT. In our study, we were unable to confirm this possible due 
to small sample sizes and short follow-up time. However no significant differences were found 
between congenital and acquired UDT with regard to ultrasound anomalies associated with 
CIS. 
 
Strengths and limitations of this thesis 
Strengths 
Men participating in this thesis were part of a historical cohort. This group represents the 
overall ‘UDT population’ better than men with a history of UDT visiting fertility clinics. In most 
studies regarding fertility in adult men with previously UDT earlier testicular position during 
childhood is not mentioned. Without this information it is almost impossible to differentiate 
between congenital and acquired UDT at adult age since the information from youth health 
care systems might be difficult to obtain many years later. The benefit of our historical cohort 
is that at primary inclusion of our patients in the initial studies during childhood, some 30 years 
ago, great effort was put into differentiating between congenital and acquired UDT (9,68). Some 
say paternity is the best way to evaluate fertility but mostly paternity is not taken into account 
in studies evaluating fertility potential in men with previously UDT. In this thesis paternity was 
evaluated, but unfortunately, not many participants attempted fatherhood yet. We are 
fortunate to have a control group for comparison of fertility parameters, since in most studies 
regarding UDT and fertility potential a control group is lacking. 
 Limitations 
The inclusion rate is relatively low in our studies. However, our inclusion rates are comparable 
to other long-term follow studies regarding men with a history of UDT. Specific motivations 
for participating can introduce a selection bias especially in fertility studies. One could 
speculate that for example suspected infertility or prolonged intend to fatherhood can be a 
reason for both participation and refusal. Maximum effort was taken to find out whether 
selection bias was to be expected for the participants. Men who did not respond or did not 
participate did not differ significantly from men participating regarding age at orchiopexy, uni- 
or bilateral UDT, and current age. All men who responded but did not want to participate 
received a questionnaire regarding attempting fatherhood, number of pregnancies, time to 
pregnancy, active child-wish, and duration of active child wish. The only difference found was 
observed in the congenital group where men who participated had a longer duration of child-
wish. If there is a selection bias due to fertility problems there is no reason to suspect that this 
is different for our various patient groups (e.g. congenital UDT group, acquired UDT group or 
control group). Unfortunately there are relatively few patients with bilateral UDT included in 
our studies, especially since the evaluation of therapeutic effects is mostly needed for this 
group. When performing physical examinations and scrotal ultrasound for study purposes it is 
best to have little variation among the investigators. For this thesis, three experienced 
physicians performed the physical examinations and ultrasounds. This could influence the 
data, especially subjective parameters such as testicular consistency or homogenous 
parenchyma, because of inter observer variation. However, a previous study showed a good 
correlation between three investigators when measuring testicular volume by ultrasound (69). 
Lastly, in our studies only one semen sample was available. However, semen quality has a 
great biological variation; therefore 2 or more samples would be preferred. On the other hand 
this biological variation is present in all our patient groups and a previous study has shown 
substantial agreement between consecutive semen analyses in young men (70). 
 
Implications for clinical practice based on conclusions of this thesis 
Congenital UDT 
Congenital UDT are not expected to descend after 12 months of age and after this orchiopexy 
is mandatory. The question is what the best time for surgery is. The guidelines advice surgery 
for uni- and bilateral UDT between 6 and 12 months of age because of the possible positive 
effects on fertility potential later in life. In this thesis, unilateral UDT had worse fertility 
potential in comparison with healthy controls, however no effect of age at surgery was found. 
We think that surgery for unilateral UDT in the second year of life will not negatively influence 
fertility outcomes. We recommend early orchiopexy because of the possibility to decrease the 
change of testicular malignancies and complaints of a growing testis in the groin region. More 
importantly, orchiopexy must be performed by a dedicated (paediatric) surgeon or urologist in 
a hospital with optimal facilities for operating children. Parents should be counselled that in 
case of unilateral UDT the concerns for fertility problems are less severe than for bilateral UDT 
and furthermore that surgery will not influence fertility outcomes even if this correction is in 
the second year of life.  
For bilateral UDT, we cannot draw the same conclusion. The negative effect of having bilateral 
UDT on fertility is unmistakable. In this thesis, we found the severest compromised fertility 
potential in bilateral UDT in comparison with a control group and unilateral UDT. We were 
unable to detect a positive effect of early surgery however this might be due to the small 
numbers. Parents should be counselled that despite surgery there still might be fertility 
problems later in life possibly not corrected by early intervention. However, with early surgery 
the boys get the biggest chance of a positive effect. Therefore, we advise to perform surgery 
between 6 and 12 months of age.  
 
Acquired UDT 
Since > 50% descent spontaneously and operation is not without risk we should carefully weigh 
the benefit against the complications of immediate surgical intervention for acquired UDT. In 
this thesis, we found impaired fertility potential in unilateral as well as bilateral acquired UDT 
in comparison with a control group. We were unable to detect a significant positive effect of 
immediate intervention at diagnosis. Also no harm was found for the ‘wait-and-see’ policy. 
This was the case for unilateral and bilateral UDT. The guidelines recommend a discussion with 
parents and patient concerning the possible positive effect of surgery at diagnosis and the 
chance of spontaneous descent. With our results kept in mind for unilateral acquired UDT a 
‘wait-and-see’ policy seems safe and immediate surgery should only be performed if parents 
and/or patient request this. Surgery will not influence fertility potential later in life and this 
should be elucidated. For bilateral UDT, we found a possible trend for early surgical 
intervention but our group was fairly small. Therefore, we feel that when counselling parents 
and/or patient in case of bilateral acquired UDT all treatment modalities should be discussed 
with a preference for immediate surgery.  
 
Future perspectives 
The evaluation of the true effect of early surgery of congenital UDT with respect of fertility 
later in life is problematic. The problem is that the follow-up timing between (early) 
intervention and measurement of the outcome is very long (20-30 years for fertility and 30-40 
years for testicular malignancies). In most fertility studies published nowadays the median age 
of orchiopexy is relatively late, since early operation was not yet recommended. Also at that 
time, as mentioned before, there was no discrimination between congenital and acquired UDT, 
since this distinction is only made recently. Because patients, who have been treated after the 
change of the guidelines, will reach adulthood soon, follow-up studies in the near future will 
contain more patients who had early orchiopexy. Furthermore, hopefully more attention is 
paid to previous testicular position at the initial doctor’s visit to diagnose acquired UDT, which 
might influence treatment and inclusion in potential follow-up studies. 
 Ideally, randomized controlled trials with different treatment modalities and follow-up from 
birth until adulthood, with primary outcomes paternity and malignancy, would be the best way 
to assess the optimal treatment for congenital and acquired UDT. The problem with these 
randomized controlled trials is that they require long follow-up up to 40 years. Also large 
numbers of participants are required to demonstrate differences since the differences 
expected for fertility might be subtle and malignancy is rare. Besides, the emphasis should be 
on bilateral UDT, which is less frequent than unilateral UDT. The realisation of such a trial in 
practice is very complex if not impossible.  
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Undescended testis (UDT) is one of the most frequent urogenital abnormalities, and can be of 
congenital or acquired origin. The problem with most literature is that since acquired UDT was 
only recently accepted as a distinct entity, it does not discriminate between congenital and 
acquired UDT. For congenital UDT much is known on the aetiology, natural course, and 
treatment, however, these matters are less clear for acquired UDT and are still debated. 
Congenital UDT are not likely to descent spontaneously after 12 months of age and are 
associated with an increased risk of fertility problems and testicular malignancies. Over 50% of 
acquired UDT descend spontaneously before or during puberty. For acquired UDT the chance 
of fertility problems and risks for testicular malignancies are unknown. It is hypothesized that 
early treatment in congenital UDT can contribute to less problems in adulthood based on 
histological parameters in childhood, however this needs to be verified in adulthood. For 
acquired UDT there is no consensus on treatment protocols and although less fertility 
problems are expected than in congenital UDT, this needs to be confirmed. This thesis 
analyses outcomes after different treatments for congenital and acquired UDT and elucidates 
differences between congenital and acquired UDT regarding natural course, fertility, 
endocrinology and ultrasound anomalies. Men from the congenital group are participants from 
a historical cohort in which boys were operated upon at several ages during childhood. Men 
from the acquired group were men with a history of acquired UDT who, during childhood, were 
either followed annually until puberty to await spontaneous descent with orchiopexy in case of 
non-descent or were operated upon immediate after diagnosis. At inclusion of the initial 
studies great effort was put into ascertaining previous testis position to differentiate 
congenital from acquired UDT. 
 
Part I – Surgical findings of acquired and congenital undescended 
testes 
We tried to explain why some acquired UDT descend spontaneously while others need 
orchiopexy on the basis of anatomical findings. Anatomical findings during surgery, described 
in chapter 2, suggested that failure of elongation of the spermatic cord is hampered by a 
fibrous string in acquired UDT. Acquired UDT located at the external annulus have limited 
mobility and are unlikely to descend spontaneously. In contrast to this are testes lying in the 
superficial inguinal pouch which are more likely to be mobile pre operatively and therefore we 
hypothesize that they can descent spontaneously since growth of testes under the influence of 
hormones at puberty might cause these testes to overcome the strength of the fibrous string. 
We assume that this is the explanation why some acquired UDT descend spontaneously while 
others do not. Unfortunately, we could not confirm this hypothesis since for obvious reasons 
we do not have anatomical findings from testes which descended spontaneously. In chapter 3, 
anatomical differences between congenital and acquired UDT were described. Most caudal 
testis position pre operatively in congenital UDT was at the inguinal region or at scrotal 
entrance, and at surgery they were found inside or just outside the inguinal canal. In contrast 
to this, acquired UDT could often be brought into an unstable scrotal position and at surgery 
they were most often found in the superficial inguinal pouch. Acquired UDT had fewer 
epididymal anomalies and more often a closed processus vaginalis. Congenital UDT more 
often had wide open processus vaginalis. These results indicate that congenital UDT and 
acquired UDT are two distinct entities. 
 
Part II – Fertility potential in men with congenital UDT compared with 
acquired UDT. Analysing age at surgery for congenital UDT and 
evaluating different treatment protocols for acquired UDT  
In the second part of this thesis regarding traditional fertility parameters (testicular volume, 
LH, FSH, testosterone, inhibin B, and semen analysis), the study in chapter 4 describes that 
fertility potential in congenital UDT is compromised in comparison with healthy controls. We 
could not find evidence that age at orchiopexy (range 0.1 – 14.6 yrs) influenced fertility 
parameters. Men with bilateral congenital UDT had lower sperm concentration in comparison 
with unilateral congenital UDT. The study in chapter 5, showed that men with previously 
acquired UDT have a compromised fertility in comparison with a healthy control group but 
comparable with men with congenital UDT. This indicates that acquired UDT are not a variant 
of normally descended testes. In that study spontaneous descent was awaited until puberty 
followed by orchiopexy in case of non-descent (i.e. ‘wait-and-see’-protocol). No significant 
differences between men who had had spontaneous descent in comparison with men who 
needed orchiopexy after the ‘wait-and-see’ protocol was found. The study in chapter 6, found 
no differences in fertility parameters when comparing men with acquired UDT who had had 
immediate treatment at diagnosis and men with acquired UDT who had the ‘wait-and-see’ 
protocol. Also age at orchiopexy, if operated upon, in acquired UDT had no influence on 
analysed semen parameters. It was thereby concluded that, unfortunately we have little 
influence on fertility potential later in life with our treatment.  
 
Part III – Evaluation of endocrinological function and semen quality 
with less traditional methods  
The study in chapter 7, evaluated Leydig cell function with Insulin-like peptide 3 (INSL3) and 
Sertoli cell function with Anti-Müllerian hormone (AMH) serum levels within and between the 
congenital and acquired UDT groups. Age at surgery in the congenital group and the different 
treatment protocols in the acquired UDT group were also evaluated. Leydig cell function 
evaluated by INSL3 showed impairment for congenital and acquired UDT but did not 
discriminate between the different UDT groups. No effect of age at surgery in the congenital 
group or the ‘wait-and-see’-protocol in the acquired group on Leydig cell function was found. 
Sertoli cell function was most affected in the bilateral congenital group. Sertoli cell function 
evaluated by AMH showed an advantage for early operation in unilateral congenital UDT. 
Sertoli cell function was more negatively affected in congenital UDT in comparison with 
acquired UDT and in bilateral congenital UDT in comparison with unilateral congenital UDT. 
No effect on Sertoli cell function of the ‘wait-and-see’ protocol was found in acquired UDT.  In 
the study described in chapter 8, sperm DNA damage was analysed using Sperm Chromatin 
Structure Assay (SCSA). We found no significant differences between congenital and acquired 
UDT. Furthermore, we could not find an effect of age at orchiopexy on the level of sperm DNA 
damage in men with congenital UDT. Also no significant differences between men with 
acquired UDT who had had spontaneous descent in comparison with men needing orchiopexy 
could be detected. The highest level of DNA damage was found in the bilateral congenital 
group. 
 
Part IV – Anomalies found by physical examination and scrotal 
ultrasound 
In the study described in chapter 9, we observed more anomalies by physical examination and 
scrotal ultrasound in men with previously congenital and acquired UDT in comparison with a 
control group. Congenital UDT were more often > 15ml in comparison with acquired UDT. No 
differences were found when comparing contralateral normally descended testes (CNDT) from 
the congenital group with those of the acquired group. CNDT also showed significant 
anomalies in comparison with a control group, albeit less severe in comparison with UDT in the 
congenital as well as the acquired group.   
 
Part V- Discussion 
In this thesis we were unable to find a significant effect of age at surgery on fertility parameters 
for congenital UDT. For unilateral congenital UDT we therefore think that surgery in the 
second year of life will not negatively influence outcomes. More importantly, we recommend 
that a dedicated surgeon or urologist performs the orchiopexy in a hospital with optimal 
facilities for operating children.  We do recommend surgery at early age because congenital 
UDT are not expected to descent after 12 months of age, also the chance of testicular 
malignancies decreases when operated before puberty , and because of possible complaints of 
a growing testis in the groin. Parents should be counselled that the intervention will not 
influence fertility outcomes but that few fertility problems in unilateral congenital UDT are 
expected. For bilateral congenital UDT, we advise to perform surgery between 6 to 12 months 
of age even though we were unable to detect a significant positive effect of early surgery on 
fertility parameters, possibly due to low numbers. Parents should be counselled that despite 
surgery there still might be fertility problems later in life possibly not corrected by early 
intervention. However, with early surgery the boys get the biggest chance of a positive effect.  
For acquired UDT, we found impaired fertility potential for unilateral and bilateral UDT in 
comparison with a control group but comparable to the congenital UDT group. For unilateral 
and bilateral UDT, we were unable to detect a positive effect of immediate intervention at 
diagnosis. Also no harm was found of the ‘wait-and-see’ policy. Thereby, the chance of a 
spontaneous descent is > 50 %. We therefore advice to discuss the different treatment 
strategies with patient and parents. For unilateral acquired UDT a ‘wait-and-see’ protocol 
seems safe and immediate intervention will not influence fertility potential. Orchiopexy at 
diagnosis should only be performed if patients/parents request this. For bilateral, a possible 
trend towards early intervention was found. Therefore, we feel that when counselling parents 






De niet ingedaalde testikel (NIT) (enkel- of dubbelzijdig) is een van de meest voorkomende 
urogenitale afwijkingen en kan van aangeboren of verworven origine zijn. Een aangeboren NIT 
is een testikel die nooit tot in de balzak (scrotum) is ingedaald. Een verworven NIT 
daarentegen heeft aanvankelijk een scrotale positie gehad maar heeft jaren later een positie 
boven het scrotum, in het liesgebied, ingenomen. In de de meeste literatuur wordt er geen 
onderscheid gemaakt tussen aangeboren en verworven NIT. Het is nog niet zo lang dat 
verworven NIT een aparte entiteit is. Over de etiologie, spontaan beloop en behandeling van 
aangeboren NIT is relatief veel bekend. Daarentegen is de verworven NIT veel minder bekend 
en nog steeds onderwerp van discussie. Aangeboren NIT dalen na de leeftijd van 12 maanden 
niet meer spontaan in en zijn geassocieerd met een verhoogd risico op fertiliteitproblemen en 
teelbalkanker. Meer dan 50% van verworven NIT dalen spontaan in voor of tijdens de 
puberteit. Over het risico van fertiliteitproblemen en teelbalkanker bij verworven NIT is weinig 
bekend. Behandeling van de aangeboren NIT is operatie op jonge leeftijd waarbij de testikel in 
de balzak wordt gefixeerd (orchidopexie). De hypothese dat behandeling van aangeboren NIT 
op zeer jonge leeftijd kan bijdragen aan minder problemen op volwassen leeftijd is gebaseerd 
op histologische studies bij kinderen, maar dit moet geverifieerd worden bij volwassen. Voor 
verworven NIT is er geen consensus over het te volgen behandelingsprotocol, spontane 
indaling afwachten tot de puberteit of operatie na stellen van de diagnose. Er worden minder 
fertiliteitproblemen verwacht bij verworven NIT echter dit moet bevestigd worden.  
Dit proefschrift analyseert uitkomsten van verschillende behandelingen van aangeboren en 
verworven NIT bij volwassen mannen. Ook wordt er gekeken naar de verschillen tussen 
aangeboren en verworven NIT betreffende natuurlijk beloop, fertiliteitparameters, en 
echografische afwijkingen. Mannen in de aangeboren groep komen uit een historisch cohort 
waarin jongens op verschillende leeftijden tijdens de kindertijd geopereerd werden vanwege 
hun NIT. Mannen uit de verworven groep zijn mannen met een voorgeschiedenis van 
verworven NIT die op verschillende manieren behandeld werden tijdens hun kindertijd. Een 
deel werd jaarlijks gevolgd waarbij spontane indaling tot in de puberteit  werd afgewacht. Zij 
ondergingen een operatie als de testikel niet spontaan indaalde (afwachtend-beleid). Een 
ander deel werd na het vaststellen van een verworven NIT direct geopereerd. Bij de primaire 
inclusie van beide groepen werd veel aandacht gegeven aan het achterhalen van eerder 
vastgestelde posities van de testikel op de kinderleeftijd. Op die manier kon zo goed mogelijk 
worden vastgesteld of de testikel een aangeboren of verworven NIT was. 
 
Deel I- Chirurgische bevindingen bij aangeboren en verworven niet 
ingedaalde testikels 
In dit proefschrift wordt vanuit de bij operatie gevonden anatomische afwijkingen getracht een 
verklaring te vinden waarom sommige verworven NIT spontaan indalen en voor andere een 
orchidopexie nodig is. Anatomische bevindingen tijdens de operatie van verworven NIT, 
beschreven in hoofdstuk 2, suggereren dat het onvermogen van het meegroeien en dus langer 
worden van de zaadstreng (funiculus spermaticus) wordt veroorzaakt door een fibreuze streng. 
Verworven NIT gelokaliseerd bij de annulus externus hebben beperkte bewegelijkheid en het is 
onwaarschijnlijk dat deze testikels spontaan zullen indalen. Dit in tegenstelling tot testikels die 
boven de uitgang van het lieskanaal liggen (superficial inguinal pouch) en meer mobiel zijn. De 
hypothese is dat deze testikels spontaan kunnen indalen doordat, door de groei van de 
testikels onder invloed van hormonen tijdens de puberteit, de zwaarder geworden testikels de 
weerstand van de fibreuze streng kunnen overwinnen. Het is aannemelijk dat dit een 
verklaring is waarom sommige verworven NIT spontaan indalen en andere een operatie nodig 
hebben. Helaas kan deze hypothese niet duidelijk bevestigd worden  omdat er uiteraard geen 
anatomische bevindingen beschikbaar zijn van testikels die spontaan indaalden. In hoofdstuk 
3, worden anatomische verschillen tussen aangeboren en verworven NIT beschreven. De 
laagste pre operatieve positie van een aangeboren NIT was in het liesgebied of bij de ingang 
van het scrotum. Tijdens de operatie werden aangeboren NIT gevonden in of net buiten het 
lieskanaal. Dit in tegenstelling tot verworven NIT, welke vaak voor de operatie in een instabiele 
scrotale positie gebracht konden worden. Verworven NIT werden tijdens de operatie vaak in de 
superficial inguinal pouch gevonden. Verworven NIT hadden minder bijbal (epididymis) 
afwijkingen en vaker een gesloten uitstulping van het buikvlies (processus vaginalis). 
Aangeboren NIT hadden vaker een wijd open processus vaginalis. Op basis van deze resultaten 
concluderen wij dat aangeboren en verworven NIT twee verschillende vormen van NIT zijn. 
 
Deel II- Fertiliteitparameters bij mannen met aangeboren NIT in 
vergelijking met verworven NIT. Analyse van invloed van leeftijd bij 
operatie van aangeboren NIT en evaluatie van verschillende 
behandelingsprotocollen van verworven NIT  
Het tweede deel van dit proefschrift beschrijft fertiliteitparameters (testikel volume, LH, FSH, 
testosteron, inhibine B en semenanalyse). In de studie beschreven in hoofdstuk 4 worden 
minder goede fertiliteitparameters gevonden bij mannen met een voorgeschiedenis van 
aangeboren NIT in vergelijking met een controle groep. Wij konden geen relatie vinden tussen 
de leeftijd bij operatie (range 0.1 – 14.6 jaar) en fertiliteitparameters. Mannen met dubbelzijdig 
aangeboren NIT hadden lagere semen concentraties in vergelijking met mannen met 
enkelzijdige aangeboren NIT. De studie beschreven in hoofdstuk 5 liet zien dat mannen met 
een voorgeschiedenis van verworven NIT verminderde fertiliteitparameters hebben in 
vergelijking met een controle groep. Significante verschillen in fertiliteitparameters tussen 
aangeboren NIT en verworven NIT konden niet worden gevonden. Dit laat zien dat verworven 
NIT geen variant zijn van normaal ingedaalde testikels. Ook  werden er geen significante 
verschillen gevonden tussen mannen met een spontane indaling en mannen die een 
orchidopexie moesten ondergaan. Mannen die als kind direct na het stellen van de diagnose 
verworven NIT een operatie ondergingen hadden ook geen significant betere 
fertiliteitparameters in vergelijk met de mannen bij wie een afwachtend beleid werd gevoerd 
(hoofdstuk 6). In de verworven groep had de leeftijd van operatief ingrijpen geen invloed op 
semenparameters. Geconcludeerd kan worden dat de verschillende behandelingsvormen op 
de kinderleeftijd weinig invloed lijken te hebben op fertiliteitparameters op volwassen leeftijd. 
 
Deel III- Evaluatie van hormonale functie van de testikel en semen 
kwaliteit  
De studie beschreven in hoofdstuk 7, evalueert Leydig cel functie met insuline-like peptide 3 
(INSL3) en Sertoli cel functie met Anti-Müller hormoon (AMH). De verschillen tussen de twee 
NIT groepen werd geanalyseerd. Ook werd leeftijd bij operatie in de aangeboren groep en het 
effect van een afwachtend-beleid in de verworven groep geëvalueerd. De Leydig cel functie 
van zowel de aangeboren als verworven NIT is verminderd maar de verschillen zijn niet 
significant. Noch  leeftijd bij operatie in de aangeboren NIT groep alsook de uitkomst van het 
afwachtend-beleid binnen de verworven NIT groep bleek invloed te hebben op de Leydig cel 
functie. Sertoli cel functie was het sterkst verminderd in de groep van dubbelzijdige 
aangeboren NIT. In de aangeboren NIT groep liet de Sertoli cel functie, geëvalueerd met AMH, 
een voordeel zien ten gunste van vroeg opereren. In vergelijking met de verworven NIT was de 
Sertoli cel functie van de aangeboren NIT het sterkst afwijkend. Hetzelfde werd gevonden 
t.a.v. dubbelzijdige aangeboren NIT in vergelijking met enkelzijdige aangeboren NIT. Het 
afwachtend-beleid in de verworven NIT groep liet geen negatief effect zien op Sertoli cel 
functie. In de studie beschreven in hoofdstuk 8 werd DNA schade in semen geanalyseerd met 
behulp van Sperm Chromatin Structure Assay (SCSA). Er werd geen significant verschil 
gevonden tussen aangeboren en verworven NIT. Er werd geen effect van leeftijd van operatie 
gevonden op de mate van DNA schade in aangeboren NIT. Ook werd er in de verworven NIT 
groep geen significant verschil gevonden tussen mannen wiens testikels spontaan indaalden 
versus mannen die een orchidopexie nodig hadden. De meeste DNA schade werd gevonden in 
het semen van mannen met dubbelzijdig aangeboren NIT. 
 
Deel IV-Afwijkingen gevonden bij lichamelijk onderzoek en scrotale 
echografie 
In de studie beschreven in hoofdstuk 9, werden bij lichamelijk onderzoek en scrotale 
echografie, in vergelijking met een controle groep, meer afwijkingen gevonden in aangeboren 
dan in de verworven NIT. Aangeboren NIT hadden vaker een volume boven de 15ml in 
vergelijking met verworven NIT. Er werd geen verschil gevonden tussen de contralaterale 
normaal ingedaalde testikel (CNIT) in de aangeboren groep in vergelijking met de CNIT van de 
verworven groep. De CNIT had echter significant meer afwijkingen in vergelijking met testikels 
uit de controle groep, maar wel minder ernstig dan de gevonden afwijkingen in de aangeboren 
alsook de verworven NIT groep.  
 
Deel V- Discussie 
In dit proefschrift werd bij aangeboren NIT geen duidelijke relatie tussen leeftijd bij operatie en 
fertiliteitsparameters op latere leeftijd aangetoond. Voor enkelzijdige aangeboren NIT is het 
niet waarschijnlijk dat een operatie voor het tweede levensjaar een positieve invloed zal 
hebben op latere fertiliteit. Belangrijker is dat de operatie uitgevoerd wordt door een 
betrokken, ervaren (kinder)chirurg of uroloog in een centrum met goede faciliteiten voor 
operaties bij kinderen. Het advies is wel om de operatie op jonge leeftijd uit te voeren omdat 
aangeboren NIT niet meer indalen na de leeftijd van 12 maanden, een operatie voor de 
puberteit de kans op teelbalkanker verkleint, en omdat operatie mogelijke klachten van een 
groeiende testikel in de lies regio in de puberteit voorkomt. Ouders moeten uitleg krijgen dat 
de operatie geen invloed heeft op fertiliteitparameters later maar dat er ook weinig problemen 
te verwachten zijn bij enkelzijdige NIT. Voor dubbelzijdige aangeboren NIT is het advies om de 
operatie te verrichten tussen 6 en 12 maanden, ondanks het feit dat wij geen duidelijk effect 
van leeftijd bij operatie hebben aangetoond (mogelijk veroorzaakt door kleine aantallen). 
Ouders moeten worden ingelicht dat ondanks operatie op jonge leeftijd er later nog steeds 
fertiliteitsproblemen kunnen zijn welke mogelijk niet worden beïnvloed door vroeg ingrijpen. 
Maar door vroeg opereren krijgen de jongens wel de grootste kans op een positief effect. 
Bij verworven NIT werden, in vergelijking met een controle groep, slechtere 
fertiliteitparameters gevonden zowel bij enkelzijdige als dubbelzijdige NIT. Deze afwijkingen 
komen overeen met de gevondenen afwijkingen in de aangeboren NIT groep. Voor zowel 
enkelzijdige als dubbelzijdige NIT werd geen positief effect gevonden van directe operatie bij 
diagnose. Ook vonden wij geen schadelijk effect van het afwachtend beleid. Omdat > 50% van 
verworven NIT spontaan kunnen indalen, is het advies 0m de verschillende behandel 
strategieën, afwachten tot de puberteit of operatie na stellen van de diagnose, met ouders en 
patiënt te bespreken. Bij enkelzijdig NIT lijken beide hiervoor genoemde behandelstrategieën 
niet bij te dragen aan betere fertiliteit op latere leeftijd. Orchidopexie bij diagnose zou alleen 
uitgevoerd moeten worden indien ouders/ patiënten dit wensen. Voor dubbelzijdige verworven 
NIT werd een mogelijke trend gevonden ten gunste van directe interventie na het stellen van 
de diagnose en heeft orchidopexie als behandeling de voorkeur. 
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